Sentence,class,file
"http://dx.doi.org/ 10.1146/annurev.physiol.67.032003.154341 Hartzell, H.C., K. Yu, Q. Xiao, L.-T. Chien, and Z. Qu.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1113/jphysiol.2008.163709 Hengl, T., H. Kaneko, K. Dauner, K. Vocke, S. Frings, and F.  Möhrlen.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1113/jphysiol.2013.251660 Armstrong, C.M.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1085/jgp.58.4.413 Berg, J., H. Yang, and L.Y.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1242/jcs .093260 Billig, G.M., B. Pál, P. Fidzinski, and T.J. Jentsch.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1038/nn.2821 Caputo, A., E. Caci, L. Ferrera, N. Pedemonte, C. Barsanti, E.  Sondo, U. Pfeffer, R. Ravazzolo, O. Zegarra-Moran, and L.J.V.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"322:590– 594. http://dx.doi.org/10.1126/science.1163518 Cenedese, V., G. Betto, F. Celsi, O.L.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1085/jgp.201110764 Centinaio, E., E. Bossi, and A. Peres.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
http://dx.doi.org/10.1007/s000180050079,Non-OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1085/jgp.108.4.233 Pusch, M., U. Ludewig, A. Rehfeldt, and T.J. Jentsch.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10 .1085/jgp.116.6.825 Rasche, S., B. Toetter, J. Adler, A. Tschapek, J.F.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/ 10.1093/chemse/bjq007 Rock, J.R., and B.D.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1113/ jphysiol.2010.194407 Sanders, K.M., M.H.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1016/j .cell.2008.09.003 Scudieri, P., E. Sondo, L. Ferrera, and L.J.V.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10 .1113/expphysiol.2011.058198 Scudieri, P., E. Sondo, E. Caci, R. Ravazzolo, and L.J.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1042/BJ20130348 Smith, S.S., E.D.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"114:799– 818. http://dx.doi.org/10.1085/jgp.114.6.799 Stephan, A.B., E.Y.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.5546-08.2009 Terashima, H., A. Picollo, and A. Accardi.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10 .1016/j.ceca.2005.06.018 Wright, E.M., and J.M.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
http://dx.doi .org/10.1073/pnas.1102147108channels.,OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1124/pr .111.005009 Huang, W.C., S. Xiao, F. Huang, B.D.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1016/j.neuron.2012.01.033 Ishikawa, T., and D.I.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"115:59– 80. http://dx.doi.org/10.1085/jgp.115.1.59 Lalonde, M.R., M.E.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.4161/chan.2.4.6704 Leblanc, N., J. Ledoux, S. Saleh, A. Sanguinetti, J. Angermann, K.  O’Driscoll, F. Britton, B.A.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1139/y05-040 Linsdell, P., A. Evagelidis, and J.W.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"78:2973– 2982. http://dx.doi.org/10.1016/S0006-3495(00)76836-6 Maurya, D.K., and A. Menini.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1016/j.ceca.2003.10.006 Perez-Cornejo, P., and J. Arreola.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1016/j.bbrc.2004.02.097 Petersen, O.H.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi .org/10.1016/j.ceca.2005.06.024 Pifferi, S., G. Pascarella, A. Boccaccio, A. Mazzatenta, S. Gustincich,  A. Menini, and S. Zucchelli.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1007/s00424- 009-0684-9 Pifferi, S., V. Cenedese, and A. Menini.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
http://dx.doi.org/10.1085/jgp.201210937,Non-OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/10.1038/nature07313 Yellen, G. 1997.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi.org/ 10.1085/jgp.110.2.83 Yu, K., C. Duran, Z. Qu, Y.Y.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi .org/10.1161/CIRCRESAHA.112.264440 Yu, K., J. Zhu, Z. Qu, Y.Y.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
"http://dx.doi .org/10.1085/jgp.201311047 Zhang, Y., and P.S.",OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
http://dx.doi.org/10.1016/j.cbpa.2006.09.020,OADS,/arxiv_data1/oa_pdf/4a/fa/JGP_201411182.PMC4035747.pdf
© 2014 McKeown and Kraft  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi - cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10.1016/j.neuron.2006   .07.01 0 Lyubarsky, A.L., L.L.",OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10.1210/   endo.138.4.509 2 Pepperberg, D.R., M.C.",OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10.1017/S095252380000644 1 Rajala, A., R.E.",OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10.1074/jbc.M60884520 0 Rajala, R.V., and R.E.",OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"98:95– 130. http://dx.doi.org/10.1085/jgp.98.1.9 5 Waldbillig, R.J., R.T. Fletcher, G.J.",Non-OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10   .1523/JNEUROSCI.4750-10.201 1 Bauer, P.J.",Non-OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10.1021/bi001516 y Breton, M.E., A.W.",Non-OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10.1038/3500060 1 Chen, J., M.L.",OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2868-10.201 0 Dizhoor, A.M., E.V.",OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10.1007/s11010-   009-0328- 6 Gal, A., U. Orth, W. Baehr, E. Schwinger, and T. Rosenberg.",Non-OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10.1038/ng0594-6 4 Gordon, S.E., D.L.",OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"664:273– 282. http://dx.doi.org/10.1007/978-1-4419-1399-9_3 1 Kang Derwent, J.J., N.M. Qtaishat, and D.R.",Non-OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10.1126/science   .278571 6 Krajewski, J.L., C.W.",OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10   .1085/jgp.20030893 8 Krispel, C.M., D. Chen, N. Melling, Y.J.",OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
http://dx.doi.org/10.1111/j.1471-4159.1991.tb06347.,Non-OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .2973-07.200 8 Woodruff, M.L., A. Rajala, G.L.",Non-OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
"http://dx.doi.org/10.1074/jbc.M113.51704 5 Zick, Y., A.M. Spiegel, and R. Sagi-Eisenberg.",OADS,/arxiv_data1/oa_pdf/42/09/JGP_201411163.PMC4035749.pdf
Comm Assoc Inform Syst 2002; 9: Article 6. http://aisel.aisnet.org/cais/vol9/iss1/6 .,Non-OADS,/arxiv_data1/oa_pdf/04/9f/pthy-46-165.PMC4035753.pdf
Sprouts: Working Papers on Informa- tion Systems 2009; 9: Article 37. http://sprouts.aisnet.org/9-37/ 18.,Non-OADS,/arxiv_data1/oa_pdf/04/9f/pthy-46-165.PMC4035753.pdf
J Assoc Inf Syst 2007; 8 (4): Article 12. http://aisel.aisnet.org/jais/vol8/iss4/1219.,Non-OADS,/arxiv_data1/oa_pdf/04/9f/pthy-46-165.PMC4035753.pdf
17 May 2012; cited 11 Dec 2013. https://www.cancercare.on.ca/cms/one.aspx?portalId=1377& pageId=48158168 CASATI et al.,Non-OADS,/arxiv_data1/oa_pdf/04/9f/pthy-46-165.PMC4035753.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpRisk Management and Healthcare Policy 2014:7 91–98Risk Management and Healthcare Policy Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
"Or use: http://dvpr.es/1hPhWX QDove press submit your manuscript | www.dovepress.co m Dove press  91PeRsPectivesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/RMHP .S6147 3Maximizing the benefit of health workforce  secondment in Botswana: an approach   for strengthening health systems   in resource-limited settings Jessica s Grignon1,2 Jenny H Ledikwe1,2 Ditsapelo Makati2 Robert Nyangah2 Baraedi W sento2 Bazghina-werq semo1,2 1Department of Global Health,   University of Washington, Seattle,   WA, UsA; 2international training  and Education Center for Health,   Gaborone, Botswana correspondence: Bazghina-werq semo   PO Box Ac46, AcH, Riverwalk,  Gaborone, Botswana   tel +267 390 0925   Fax +267 390 0952   email bazsemo@uw.ed uAbstract:  To address health systems challenges in limited-resource settings, global health  initiatives, particularly the President’ s Emergency Plan for AIDS Relief, have seconded health  workers to the public sector.",Non-OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
Available from: http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
"Available from: http://pdf.usaid.gov/pdf_docs/ PNACX273.pd f. Accessed May 1, 2013.",Non-OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
"Available from: http://www.who.int/hiv/pub/meetingreports/ TTRmeetingrepor t2.pd f. Accessed June 23, 2013.",Non-OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
Available from: http://www.who.int/healthsystems/ publications /MPS_academic_case_studies_Book_01 .pdf.,Non-OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
"Available from: http://r4d.dfid.gov.uk/PDF/Outputs/ HIV_AIDS/ghi_comparative_paper.pd f. Accessed August 19, 2013.",Non-OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
"Avail - able from: http://www.impactalliance.org/file_download.php?location = S_U&filename =11546909101Alan_Fowler-2004.pd f. Accessed August  19, 2013.",OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
"Available from: http://www.hiv.gov.bw/ sites/default/files/documents/baisiii_report%5B1%5D.pd f. Accessed  April 2, 2014.",OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
Available from: http://www.moh.gov.,Non-OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
"Available from: http://csis.org/files/publication/121128_Stash_PEP - FARBotswana_Web.pd f. Accessed May 1, 2013.",Non-OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
Available from: http://www.pepfar.,Non-OADS,/arxiv_data1/oa_pdf/5d/02/rmhp-7-091.PMC4036141.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/c3/prbm-7-155.PMC4036142.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPsychology Research and Behavior Management 2014:7 155–160Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  155HyPotHesisopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PRBM.S4138 6A proposal for including nomophobia   in the new DsM-V Nicola Luigi Bragazzi1,2 Giovanni Del Puente2 1school of Public Health, Department  of Health sciences (DissAL),   University of Genoa, Genoa,   italy; 2DiNoGMi, Department  of Neuroscience, Rehabilitation,   ophthalmology, Genetics, Maternal  and Child Health, section of  Psychiatry, University of Genoa,   Genoa, italy Correspondence: Nicola Luigi Bragazzi   school of Public Health, Department   of Health sciences (DissAL), University  of Genoa, Via Antonio Pastore 1,   16132 Genoa, italy   tel +39 01 0353 7664   Fax +39 01 0353 7669   email robertobragazzi@gmail.co mAbstract:  The Diagnostic and Statistical Manual of Mental Disorders  (DSM) is considered to  be the gold standard manual for assessing the psychiatric diseases and is currently in its fourth  version (DSM-IV), while a fifth (DSM-V) has just been released in May 2013.",Non-OADS,/arxiv_data1/oa_pdf/36/c3/prbm-7-155.PMC4036142.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/36/c3/prbm-7-155.PMC4036142.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/36/c3/prbm-7-155.PMC4036142.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/c5/tcrm-10-363.PMC4036143.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 363–366Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  363ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/TCRM.S6295 4Rheumatoid arthritis in Jordan: a cross   sectional study of disease severity   and associated comorbidities Khaldoon M alawneh1 Basheer Y Khassawneh1 Mahmoud h ayesh1 Mahmoud smadi2 1Department of Medicine,    College of Medicine, King   abdullah University hospital,    Jordan University of science and   T echnology, irbid, Jordan;    2Department of Math and statistics,   College  of science, Jordan University  of science and T echnology,    irbid, Jordan Correspondence: Khaldoon M alawneh   Department of Medicine, College   of Medicine, King abdullah University   hospital, Jordan University of science   and Technology, PO Box  3030, irbid,   Jordan  22110  email kma1234@msn.co mAbstract:  Treating rheumatoid arthritis (RA) to target is advocated using disease activity  measures.",Non-OADS,/arxiv_data1/oa_pdf/a4/c5/tcrm-10-363.PMC4036143.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/a4/c5/tcrm-10-363.PMC4036143.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/c5/tcrm-10-363.PMC4036143.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/02/tacg-7-081.PMC4036145.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpThe Application of Clinical Genetics 2014:7 81–91The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  81Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S3559 8Influence of oncogenic transcription factors   on chromatin conformation and implications   in prostate cancer Yeqing Angela Yang1 Jung Kim1 Jindan Yu1,2 1Division of Hematology/Oncology,   Department of Medicine,  2Robert H  Lurie Comprehensive Cancer Center,   Northwestern University, Feinberg  School of Medicine, Chicago, IL, USA Correspondence: Jindan Yu   Division of Hematology/Oncology,  Department of Medicine, Robert H  Lurie Comprehensive Cancer Center,  Northwestern University, Feinberg  School of Medicine,  303 east Superior  Street, Lurie  5-117, Chicago,   iL 60611, USA   Tel +1 312 503 1761  Fax +1 312 503 0189  email jindan-yu@northwestern.ed uAbstract:  In recent years, facilitated by rapid technological advances, we are becoming more  adept at probing the molecular processes, which take place in the nucleus, that are crucial for  the hierarchical regulation and organization of chromatin architecture.",Non-OADS,/arxiv_data1/oa_pdf/2f/02/tacg-7-081.PMC4036145.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/2f/02/tacg-7-081.PMC4036145.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/02/tacg-7-081.PMC4036145.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3a/4a/tacg-7-093.PMC4036146.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpThe Application of Clinical Genetics 2014:7 93–104The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  93Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S5738 6Angelman syndrome: review of clinical   and molecular aspects Lynne M Bird 1Department of Pediatrics, University  of California, Division of Genetics,   Rady Children’s Hospital,    San Diego, California, USA Correspondence: Lynne M Bird   Rady Children’s Hospital, San Diego,   Division of Dysmorphology/Genetics,   3020 Children’s way #5031,   San Diego, CA 92123, USA   Tel +1 858 966 5840   Fax +1 858 966 8550   email lbird@rchsd.or gAbstract:  “Angelman syndrome” (AS) is a neurodevelopmental disorder whose main features  are intellectual disability, lack of speech, seizures, and a characteristic behavioral profile.",Non-OADS,/arxiv_data1/oa_pdf/3a/4a/tacg-7-093.PMC4036146.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/3a/4a/tacg-7-093.PMC4036146.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/4a/tacg-7-093.PMC4036146.pdf
Available from: http://clinicaltrials.gov/show /NCT01281475.,Non-OADS,/arxiv_data1/oa_pdf/3a/4a/tacg-7-093.PMC4036146.pdf
Available from: http://clinicaltrials.gov/ show /NCT01531582.,Non-OADS,/arxiv_data1/oa_pdf/3a/4a/tacg-7-093.PMC4036146.pdf
"Preprocessing  and statistical analysis were performed using the SPM8 package (Wellcome Department of  Imaging Neuroscience, London, UK; http://www.fil.ion.ucl.ac.uk/ spm/) running on Matlab  7.6 (MathWorks, Natick, Mass., USA).",OADS,/arxiv_data1/oa_pdf/23/11/dee-0004-0095.PMC4036148.pdf
"We used  two sets of probabilistic maps:  one for the caudate nucleus, putamen and thalamus, derived from  the International Consortium  for Brain Mapping atlas (http://www.loni.ucla.edu/atlases), and  one for the amygdala, based  on cytoarchitectonic examination, as described in Amunts et al.",OADS,/arxiv_data1/oa_pdf/23/11/dee-0004-0095.PMC4036148.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/2b/ezt389.PMC4036404.pdf
"In the UK, 28-day readmission rate is a key hospital performance indicator [ http://www.nchod.nhs.uk ]; therefore, we based our analysis on emergency readmissionswhere the duration of discharge was <29 days.",Non-OADS,/arxiv_data1/oa_pdf/d6/2b/ezt389.PMC4036404.pdf
"Lyon, France: International Agency for Research on Cancer 2010.http://globocan.iarc.fr (17 May 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/d6/2b/ezt389.PMC4036404.pdf
"NICE clinical guideline 121. http://guidance.nice.org.uk ( 17 May 2013, date last accessed ).",Non-OADS,/arxiv_data1/oa_pdf/d6/2b/ezt389.PMC4036404.pdf
"http://www.ncri.ie/pubs/pub ﬁles/ CompletenessQuality.pdf (17 May 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/d6/2b/ezt389.PMC4036404.pdf
"2004. http://www.sahru.tcd.ie/services/deprivation/Depri vationFiles/DeprivationReport2013.pdf (01 June 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/d6/2b/ezt389.PMC4036404.pdf
", 1995 ) and class E genes that  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which  permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.© The Author 2014.",Non-OADS,/arxiv_data1/oa_pdf/a5/9e/eru089.PMC4036497.pdf
The MADS box and K box domains were identified by an NCBI conserved domain search ( http://www.ncbi.nlm.nih.gov/Structure/cdd/ wrpsb.cgi ?,OADS,/arxiv_data1/oa_pdf/a5/9e/eru089.PMC4036497.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/0e/rru-6-043.PMC4036597.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpResearch and Reports in Urology 2014:6 43–50Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  43ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RRU.S5944 4simultaneous laparoscopic management of  ureteropelvic junction obstruction and renal  lithiasis: the combined experience of two  academic centers and review of the literature Konstantinos g  stravodimos1 stilianos giannakopoulos2 stavros i Tyritzis1 aristeides alevizopoulos1 stefanos Papadoukakis1 stavros T ouloupidis2 constantinos a  constantinides1 1Department of Urology, athens  University Medical school, laiko  hospital, athens,  2Department of  Urology, Democritus University of  Thrace, alexandroupolis, greece correspondence: stilianos  giannakopoulos   Department of Urology, Democritus  University of Thrace, Dragana,  alexandroupolis 68100, greece   Tel +30 25 5102 4976  Fax +30 25 5103 0419  email stgian@otenet.g rIntroduction:  Approximately one out of five patients with ureteropelvic junction obstruction  (UPJO) present lithiasis in the same setting.",Non-OADS,/arxiv_data1/oa_pdf/89/0e/rru-6-043.PMC4036597.pdf
Available from: http://www.uroweb.org/gls/pdf/21_Urolithiasis_LRV4.,Non-OADS,/arxiv_data1/oa_pdf/89/0e/rru-6-043.PMC4036597.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/89/0e/rru-6-043.PMC4036597.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/0e/rru-6-043.PMC4036597.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4f/36/ppa-8-727.PMC4036702.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 727–754Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  727REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6134 0Effectiveness of music therapy: a summary  of systematic reviews based on randomized  controlled trials of music interventions Hiroharu Kamioka1 Kiichiro Tsutani2 Minoru Yamada3 Hyuntae Park4 Hiroyasu Okuizumi5 Koki Tsuruoka6 Takuya Honda7 Shinpei Okada8 Sang-Jun Park8 Jun Kitayuguchi9 Takafumi Abe9 Shuichi Handa5 Takuya Oshio10 Y oshiteru Mutoh11 1Faculty of Regional Environment Science,   T okyo University of Agriculture, T okyo,   Japan; 2Department of Drug Policy  and Management, Graduate School of  Pharmaceutical Sciences, The University  of T okyo, T okyo, Japan; 3Kyoto University  Graduate School Research, Kyoto, Japan;   4Department of Functioning Activation,   National Center for Geriatrics and  Gerontology, Aichi, Japan; 5Mimaki Onsen  (Spa) Clinic, T omi, Nagano, Japan; 6Graduate  School of Social Services, Japan College of  Social Work, T okyo, Japan; 7Japanese Society  for the Promotion of Science, T okyo,   Japan; 8Physical Education and Medicine  Research Foundation, T omi, Nagano, Japan;   9Physical Education and Medicine Research  Center Unnan, Shimane, Japan; 10Social  Welfare Service Corporation CARE- PORT MIMAKI, T omi, Nagano, Japan; 11The  Research Institute of Nippon Sport Science  University, T okyo, Japan Correspondence: Hiroharu Kamioka   Faculty of Regional Environment Science,  Tokyo University of Agriculture,   1-1-1 Sakuragaoka, Setagaya-ku,   Tokyo 156-8502, Japan   Tel/fax +81 3 5477 2587   Email h1kamiok@nodai.ac.j pObjective:  The objective of this review was to summarize evidence for the effectiveness of  music therapy (MT) and to assess the quality of systematic reviews (SRs) based on randomized  controlled trials (RCTs).",Non-OADS,/arxiv_data1/oa_pdf/4f/36/ppa-8-727.PMC4036702.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/4f/36/ppa-8-727.PMC4036702.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/36/ppa-8-727.PMC4036702.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/24/ppa-8-755.PMC4036814.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 755–761Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  755OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S6321 4Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Ostrov et al Running head recto: Patient preferences and satisfaction in a multispecialty infusion center DOI: http://dx.doi.org/10.2147/PPA.S63214 Patient preferences and satisfaction  in a multispecialty infusion center Barbara e Ostrov1 Kristine reynolds2 lisabeth V scalzi1 1Departments of Pediatrics and  Medicine, 2Department of n ursing,   Penn state hershey Medical center,   hershey, PA, UsA correspondence: Barbara e Ostrov Divisions of Pediatric rheumatology and  rheumatology, Departments of Pediatrics  and Medicine, Penn state hershey Medical  center, Mc hO85, 500 University Drive,  hershey, PA 17033, UsA T el +1 717 531 6700 Fax +1 717 531 3999 email bostrov@hmc.psu.ed uPurpose:  Direct feedback from patients about their preferred modes of medication  administration  has been increasingly sought by providers to develop care programs that best match patient  goals.",Non-OADS,/arxiv_data1/oa_pdf/13/24/ppa-8-755.PMC4036814.pdf
Available from: http://icorehealthcare.com/ media/422047/trend_report_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/13/24/ppa-8-755.PMC4036814.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/13/24/ppa-8-755.PMC4036814.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/e3/jep-6-001.PMC4037148.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Experimental Pharmacology 2014:6 1–9Journal of Experimental Pharmacology Dove press submit your manuscript | www.dovepress.co m Dove press  1Original rEsEarchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JEP .S5349 7acute administration of methylphenidate   alters the prefrontal cortex neuronal activity   in a dose–response characteristic catherine M claussen nachum Dafny Department of neurobiology and  anatomy, University of Texas health  science center Medical school at  houston, houston, TX, Usa correspondence: nachum Dafny   Department of neurobiology and  anatomy, University of Texas health  science center Medical school at  houston, 6431 Fannin street – MsB  7.208B, houston, TX 77030, Usa   Tel +1 713 500 5616   Fax +1 713 500 0621   Email n achum.dafny@uth.tmc.ed uAbstract:  The prefrontal cortex (PFC) is part of the collective structures known as the motive  circuit.",Non-OADS,/arxiv_data1/oa_pdf/a4/e3/jep-6-001.PMC4037148.pdf
"Journal of Experimental Pharmacology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-experimental-pharmacology-journa lThe Journal of Experimental Pharmacology is an international, peer- reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of laboratory and experimental  pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/a4/e3/jep-6-001.PMC4037148.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/e3/jep-6-001.PMC4037148.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/95/ijn-9-2399.PMC4037247.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2399–2407International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2399RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5501 5Nanosilver particles in medical applications:  synthesis, performance, and toxicity Liangpeng Ge1–5,* Qingtao Li2,3,6,* Meng wang2,3 Jun Ouyang6 Xiaojian Li7 Malcolm MQ Xing2,3 1Chongqing Academy of Animal  Sciences, Chongqing, People’s  Republic of China; 2Department  of Mechanical and Manufacturing  engineering, Department of  Biochemistry and Medical Genetics,   University of Manitoba, winnipeg,   Canada; 3Manitoba Institute of Child  Health, winnipeg, Canada; 4Key  Laboratory of Pig Industry Sciences,   Ministry of Agriculture, Chongqing,   People’s Republic of China; 5Key  Laboratory of Pig Industry Sciences,   Chongqing, People’s Republic of  China; 6School of Basic Medical  Science, Southern Medical University,   Guangzhou, People’s Republic of  China; 7Department of Plastic Surgery,   Nanfang Hospital, Guangzhou, People’s  Republic of China *These authors contributed equally to  this work  Correspondence: Malcolm MQ Xing   Department of Mechanical engineering,   75A Chancellors Circle, University of   Manitoba, winnipeg, MB R3T 5v6, Canada   Tel +1 204 480 1396   Fax +1 204 275 7507   email xing@cc.umanitoba.c a    Xiaojian Li   Department of Plastic Surgery,   Southern Hospital, Guangzhou,   People’s Republic of China, 510515   Tel +86 137 9810 3669   email lixj1999@smu.edu.c nAbstract : Nanosilver particles (NSPs), are among the most attractive nanomaterials, and have  been widely used in a range of biomedical applications, including diagnosis, treatment, drug  delivery, medical device coating, and for personal health care.",Non-OADS,/arxiv_data1/oa_pdf/5e/95/ijn-9-2399.PMC4037247.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5e/95/ijn-9-2399.PMC4037247.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/95/ijn-9-2399.PMC4037247.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/0a/oajsm-5-123.PMC4037248.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2014:5 123–127Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  123Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S6136 1Genetic aspects of athletic performance:   the African runners phenomenon Rodrigo Luiz vancini1 João Bosco Pesquero2 Rafael Júlio Fachina3,4 Marília dos Santos Andrade1 João Paulo Borin3 Paulo César Montagner3 Claudio Andre Barbosa   de Lira5 1Centro de educação Física e  Desportos, Universidade Federal do  espírito Santo, vitória, espírito Santo,   Brazil;  2Departamento de Biofísica,   Universidade Federal de São Paulo,   São Paulo, Brazil;  3Departamento  de Ciência do esporte, Faculdade  de educação Física, Universidade  estadual de Campinas, Campinas,   Brazil;  4Confederação Brasileira de  Basquetebol, Rio de Janeiro, Brazil;   5Setor de Fisiologia Humana e do  exercício, Faculdade de educação  Física, Universidade Federal de Goiás,   Goiânia, Brazil Correspondence: Claudio Andre Barbosa  de Lira   Faculdade de educação Física,  Universidade Federal de Goiás,   Campus Samambaia, Caixa Postal  131,  CeP: 74001-970 Goiânia, Goiás, Brazil   Tel +55 64 8142 8455  email andre.claudio@gmail.co mAbstract:  The current dominance of African runners in long-distance running is an intriguing  phenomenon that highlights the close relationship between genetics and physical performance.",Non-OADS,/arxiv_data1/oa_pdf/70/0a/oajsm-5-123.PMC4037248.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/70/0a/oajsm-5-123.PMC4037248.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/0a/oajsm-5-123.PMC4037248.pdf
"Available from: http://www.iahsaa.org/Sports_Medicine_Wellness/ Performance/GSSI-Do_Genes_Determine_Champions.pd f. Accessed:  May 2, 2014.",Non-OADS,/arxiv_data1/oa_pdf/70/0a/oajsm-5-123.PMC4037248.pdf
"IranMede x (IRANIAN MEDLINE, available  at http://www.iranmedex.com ) and SID (Sc i-entific Information Database, available at  http://www.SID.ir) were used to find domestic  articles and Pubmed search was carried out to  determine  international papers.",OADS,/arxiv_data1/oa_pdf/69/7c/jod-11-67.PMC4037268.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/27/57/opth-8-977.PMC4037296.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 977–980Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  977Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6037 7Journal name: Clinical Ophthalmology Journal Designation: Case Series Y ear: 2014 Volume: 8 Running head verso: Kato et al Running head recto: Treatment of CNLDO with dacryoendoscope DOI: http://dx.doi.org/10.2147/OPTH.S60377 Probing of congenital nasolacrimal duct  obstruction with dacryoendoscope Kumiko Kato Koichi Matsunaga Yuko Takashima Mineo Kondo Department of Ophthalmology   Mie University school of Medicine,   Tsu, JapanBackground:  A congenital nasolacrimal duct obstruction (CNLDO) is a relatively common  disease in infants.",Non-OADS,/arxiv_data1/oa_pdf/27/57/opth-8-977.PMC4037296.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/27/57/opth-8-977.PMC4037296.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 980Kato et al perform dacryoendoscopic probing for CNLDO with only  the 0.7 mm probe.,Non-OADS,/arxiv_data1/oa_pdf/27/57/opth-8-977.PMC4037296.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/b5/opth-8-959.PMC4037297.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 959–963Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  959Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6137 2Journal name: Clinical Ophthalmology Journal Designation: Case Series Y ear: 2014 Volume: 8 Running head verso: Ikeda et al Running head recto: Nuclear sclerosis after lens-sparing vitrectomy DOI: http://dx.doi.org/10.2147/OPTH.S61372 Progression of nuclear sclerosis based on changes  in refractive values after lens-sparing vitrectomy  in proliferative diabetic retinopathy Tsunehiko ikeda1 Masahiro Minami1 Kimitoshi Nakamura2 T eruyo Kida1 Masanori Fukumoto1 Takaki sato1 eisuke ishizaki1 1Department of Ophthalmology,   Osaka Medical College, Osaka, Japan;   2Nakamura eye Clinic, Nagano, JapanBackground:  Nuclear sclerosis (NS) based on the Emery–Little classification and refractive  values after lens-sparing vitrectomy was compared between proliferative diabetic retinopathy  (DR) patients and nondiabetic patients.",Non-OADS,/arxiv_data1/oa_pdf/aa/b5/opth-8-959.PMC4037297.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/aa/b5/opth-8-959.PMC4037297.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 963Nuclear sclerosis after lens-sparing vitrectomy  12.,Non-OADS,/arxiv_data1/oa_pdf/aa/b5/opth-8-959.PMC4037297.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dd/3d/ndt-10-879.PMC4037298.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 879–885Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  879OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S6264 7Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Izci et al Running head recto: Temperament, character traits, and alexithymia in panic disorder DOI: http://dx.doi.org/10.2147/NDT.S62647 T emperament, character traits, and alexithymia   in patients with panic disorder correspondence: Filiz izci   erenkoy Training and research  hospital for Psychiatry, erenkoy ruh  ve sinir hastaliklari egitim ve arastirma  hastanesi,19 mayis Mah, sinan ercan cad  34000, Kadikoy, istanbul   T el +50 5450 3013   email drfiliz2008@hotmail.co mFiliz izci1 Bulent Kadri gültekin1 sema saglam2 Merve iris Koc1 selma Bozkurt Zincir1 Murad atmaca3 1Department of Psychiatry, erenkoy  Training and research hospital for  Psychiatry, istanbul; 2Department   of Psychiatry, adiyaman Training  and research hospital, adiyaman,   3Firat University school of Medicine  Department of Psychiatry, elazig,   T urkeyBackground:  The primary aim of the present study was to compare temperament and character  traits and levels of alexithymia between patients with panic disorder and healthy controls.",Non-OADS,/arxiv_data1/oa_pdf/dd/3d/ndt-10-879.PMC4037298.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/dd/3d/ndt-10-879.PMC4037298.pdf
"Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 885T emperament, character traits, and alexithymia in panic disorder 15.",Non-OADS,/arxiv_data1/oa_pdf/dd/3d/ndt-10-879.PMC4037298.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/53/4b/ndt-10-865.PMC4037299.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 865–867Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  865Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6181 6Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Case report Y ear: 2014 Volume: 10 Running head verso: Saito et al Running head recto: ECT for patient with schizophrenia and hemophilia DOI: http://dx.doi.org/10.2147/NDT.S61816 Nobuyoshi saito Katsutoshi shioda Koichi Nisijima T oshiyuki Kobayashi satoshi Kato Department of psychiatry, Jichi  Medical University, T ochigi, Japan Correspondence: Katsutoshi shioda Department of psychiatry, Jichi Medical  University, 3311-1 Yakushiji shimotsuke,  T ochigi 329-0498, Japan T el +81 285 58 7364 Fax +81 285 44 6198 email kazs@jichi.ac.j psecond case report of successful  electroconvulsive therapy for a patient   with schizophrenia and severe hemophilia a Abstract:  Electroconvulsive therapy (ECT) is used for medication-resistant and   life-threatening mental disorders, and therefore it occupies an important position in psychiatric  treatment.",Non-OADS,/arxiv_data1/oa_pdf/53/4b/ndt-10-865.PMC4037299.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/53/4b/ndt-10-865.PMC4037299.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 867eCT for patient with schizophrenia and hemophilia References 1.,Non-OADS,/arxiv_data1/oa_pdf/53/4b/ndt-10-865.PMC4037299.pdf
The  full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/28/55/ndt-10-869.PMC4037300.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 869–878Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  869OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5946 8Factors associated with early response to   olanzapine and clinical and functional outcomes   of early responders treated for schizophrenia   in the People’s republic of china Wenyu Ye1 William Montgomery2 Zbigniew Kadziola3 li liu4 haibo Xue4 Michael D stensland5 Tamas Treuer6 1real World analytics, eli lilly and  company, indianapolis, iN, Usa;   2global Patient Outcomes and real  World evidence, eli lilly australia  Pty ltd, West ryde, australia; 3real  World analytics capabilities, eli lilly  gmbh, Vienna, austria; 4lilly suzhou  Pharmaceutical co, ltd, shanghai  Branch, People’s republic of china;   5agile Outcomes research, inc.,   rochester, MN, Usa; 6Neuroscience  research, eli lilly and company,   Budapest, hungary correspondence: William Montgomery   eli lilly australia Pty ltd,   112 Wharf rd, West ryde   NsW 2114, australia   Tel +61 2 9325 4335   Fax +61 2 9325 4334   email montgomery_bill@lilly.co mBackground:  The aims of this analysis were to identify factors associated with early response  (at 4 weeks) to olanzapine treatment and to assess whether early response is associated with better  longer-term outcomes for patients with schizophrenia in the People’ s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/28/55/ndt-10-869.PMC4037300.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/28/55/ndt-10-869.PMC4037300.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/55/ndt-10-869.PMC4037300.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/ce/ndt-10-841.PMC4037301.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 841–864Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  841Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5809 6Olanzapine in Chinese patients with schizophrenia  or bipolar disorder: a systematic literature review Hai Bo Haber Xue1 Li Liu1 Hena Zhang2 william Montgomery3 Tamás Treuer4 1Lilly Suzhou Pharmaceutical Co,    Ltd, Shanghai Branch, Shanghai,    2China Pharmaceutical University,   Nanjing, People’s Republic of China;   3eli Lilly Australia Pty Ltd, west Ryde,   Australia; 4eli Lilly & Co, Budapest,   Hungary Correspondence: Hai Bo Haber Xue   Medical Affairs, Lilly Suzhou  Pharmaceutical Co, Ltd, Shanghai Branch,  21F, 1 Corporate Avenue,   222 Hu Bin Road 200021, Shanghai,  People’s Republic of China   Tel +86 21 2302 1333   Fax +86 21 2302 1487   email xue_hai_bo_haber@lilly.co mBackground:  Despite the burden of schizophrenia and bipolar disorder in the Chinese  population, country-specific data to guide practitioners regarding antipsychotic therapy are  lacking.",Non-OADS,/arxiv_data1/oa_pdf/2c/ce/ndt-10-841.PMC4037301.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/2c/ce/ndt-10-841.PMC4037301.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/ce/ndt-10-841.PMC4037301.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 509–521International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  509RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S4735 7Pertuzumab in human epidermal growth-factor  receptor 2-positive breast cancer: clinical   and economic considerations Nathan WD Lamond Tallal Y ounis Department of Medicine, Dalhousie  University at the Queen elizabeth II  Health Sciences Centre, Halifax,    NS, Canada Correspondence: Tallal Younis   Department of Medicine, Dalhousie  University at the Queen elizabeth II  Health Sciences Centre, Suite 454,  Bethune Building, 1276 South Park Street,  Halifax, NS B3H 2Y9, Canada   Tel +1 902 473 6054   Fax +1 902 473 6186   email tallal.younis@cdha.nshealth.c aAbstract:  In the absence of specific therapy, the 15%–20% of breast cancers demonstrating  human epidermal growth-factor receptor 2 (HER2) protein overexpression and/or gene ampli - fication are characterized by a more aggressive phenotype and poorer prognosis compared  to their HER2-negative counterparts.",Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available  from: http://www.ema.europa.eu/ema/index.jsp?curl =pages/ medicines/human/medicines/002547/human_med_001628.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available from: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd- smd/drug-med/sbd_smd_2013_perjeta_158419-eng.php.,OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available from: http://www.fda.gov/Drugs/  InformationOnDrugs/ApprovedDrugs/ucm370449.htm.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available from: http://clinicaltrials.gov/ show/NCT01669239.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available from: http://clinicaltrials.gov/show/ NCT01796197.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available  from: http://clinicaltrials.gov/show/NCT01358877.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available from: http://clinicaltrials.gov/show/ NCT01276041.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available from: http://clinicaltrials.gov/show/ NCT01565083.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available  from: http://clinicaltrials.gov/show/NCT01491737.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available from: http://clinicaltrials.gov/show/NCT01120184.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available from: http://clinicaltrials.gov/show/NCT01572038.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available from: http://clinicaltrials.gov/show/NCT01777958.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available  from: http://clinicaltrials.gov/show/NCT01597414.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available from: http://www.pcodr.ca/wcpc/ portal/Home/FindaReview/PerjetaHerceptinMBC?afrLoop =230412 9379749000&_afrWindowMode =0&_adf.ctrl-state =fgpie73cf_134.,OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available from: http://guidance.nice.org.uk/index.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Available at: http://guidance.nice.org.uk/TAG/322/ Consultation/DraftGuidance.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/1e/ijwh-6-509.PMC4037302.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/06/ijgm-7-227.PMC4037303.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 227–235International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  227OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S6129 7Efficacy and tolerability of celecoxib and naproxen  versus placebo in Hispanic patients with knee  osteoarthritis Margaret Noyes Essex Regina Behar Michael A O’Connell Pritha Bhadra Brown Pfizer Inc, New Y ork, NY, USA Correspondence: Margaret Noyes Essex   Medical Affairs, Pfizer Inc,  235 east  42nd   Street, New York, NY  10017, USA   Tel +1 212 733 8018  email margaret.essex@pfizer.co mBackground:  Celecoxib is an effective treatment for osteoarthritis (OA).",Non-OADS,/arxiv_data1/oa_pdf/b4/06/ijgm-7-227.PMC4037303.pdf
Available from: https://www.census.,OADS,/arxiv_data1/oa_pdf/b4/06/ijgm-7-227.PMC4037303.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/b4/06/ijgm-7-227.PMC4037303.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/06/ijgm-7-227.PMC4037303.pdf
"Available from: http://www.hispanichealth.org/assets/ resource_library/hispanic_report04.pd f. Accessed October  28, 2013.",OADS,/arxiv_data1/oa_pdf/b4/06/ijgm-7-227.PMC4037303.pdf
"Available from: http://www.ptcommunity.com/ptJournal/ fulltext/32/9/PTJ3209471.pd f. Accessed April  22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b4/06/ijgm-7-227.PMC4037303.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/38/opth-8-965.PMC4037304.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 965–972Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  965Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6029 2The efficacy of bromfenac ophthalmic solution  0.07% dosed once daily in achieving zero-to-   trace anterior chamber cell severity following  cataract surgery steven M silverstein1 Mitchell a Jackson2 Damien F Goldberg3 Mauricio Muñoz4 On behalf of the Bromfenac  Ophthalmic solution 0.07%  Once Daily study group 1silverstein eye Centers, Kansas   City, MO, Usa; 2Jacksoneye, inc., lake  Villa, il, Usa; 3Wolstan & Goldberg  eye associates, T orrance, C a, Usa;   4Bausch + Lomb, Irvine, CA, USA Correspondence: steven M silverstein   Silverstein Eye Centers, 4240 Blue Ridge  Blvd #100, Kansas City, MO, 64133 USA   Tel +1 816 358 3600   email ssilverstein@silversteineyecenters.",Non-OADS,/arxiv_data1/oa_pdf/9e/38/opth-8-965.PMC4037304.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9e/38/opth-8-965.PMC4037304.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/38/opth-8-965.PMC4037304.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/5a/opth-8-955.PMC4037305.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 955–958Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  955Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6336 8Journal name: Clinical Ophthalmology Journal Designation: Case Series Y ear: 2014 Volume: 8 Running head verso: Kida et al Running head recto: Macular edema with retinal vein occlusion and systemic hypertension DOI: http://dx.doi.org/10.2147/OPTH.S63368 Treatment of systemic hypertension is important  for improvement of macular edema associated  with retinal vein occlusion T eruyo Kida seita Morishita Keigo Kakurai Hiroyuki suzuki Hidehiro Oku Tsunehiko ikeda Department of Ophthalmology,    Osaka Medical College, Osaka, JapanBackground:  We report our findings in three cases of unilateral macular edema associated  with retinal vein occlusion (RVO) that improved after successful treatment of systemic hyper - tension alone.",Non-OADS,/arxiv_data1/oa_pdf/b2/5a/opth-8-955.PMC4037305.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b2/5a/opth-8-955.PMC4037305.pdf
"Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 958Kida et al Relevant to our cases, CRVOs and BRVOs are both   associated with macular edema.",Non-OADS,/arxiv_data1/oa_pdf/b2/5a/opth-8-955.PMC4037305.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/mder-7-139.PMC4037306.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2014:7 139–147Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  139ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S6172 8a proposed framework to improve   the safety of medical devices in a canadian  hospital context Julie Polisena1,2 Jeffrey Jutai3 Rana chreyh4 1canadian agency for Drugs and  T echnologies in health, Ottawa, On ,   canada;  2Department of Epidemiology  and community Medicine,   Faculty of Medicine, University  of Ottawa, Ottawa, On , canada;   3interdisciplinary school of health  sciences, Faculty of health sciences,   University of Ottawa, Ottawa, On ,   canada;  4Biomedical Engineering,   The Ottawa hospital, Ottawa, On ,   canada correspondence: Julie Polisena   caDTh  600-865 carling ave,   Ottawa On K1s  5s8 canada   Tel +1 613 226 2553  Fax +1 613 226 5392  Email juliep@cadth.c aPurpose:  Medical devices are used to monitor, replace, or modify anatomy or physiological  processes.",Non-OADS,/arxiv_data1/oa_pdf/d8/eb/mder-7-139.PMC4037306.pdf
Available from: http://www.mddionline.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/mder-7-139.PMC4037306.pdf
Available from: http://www.hc-sc.gc.ca/dhp-mps/md-im/ qualsys/index-eng.php .,OADS,/arxiv_data1/oa_pdf/d8/eb/mder-7-139.PMC4037306.pdf
Available from:  http://www.fda.gov/aboutfda/centersoffices/ officeofmedicalproductsandt obacco/cdrh/cdrhreports/ucm301912.htm .,OADS,/arxiv_data1/oa_pdf/d8/eb/mder-7-139.PMC4037306.pdf
Available from: http://www.fda.gov/downloads/MedicalDevices/Safety/  CDRHPostmarketSurveillance/UCM348845.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/mder-7-139.PMC4037306.pdf
Available from: http://www.oag-bvg.gc.ca/internet/English/ parl_oag_201106_06_e_35374.html .,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/mder-7-139.PMC4037306.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2014:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 147safety of medical devices 10.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/mder-7-139.PMC4037306.pdf
"Available from: http://www.xerafy.com/ userfiles/misc/resources/whitepapers/Five%20Myths%20About%20 the%20Healthcare%20Industry%20White%20Paper.pd f. Accessed  November  11, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d8/eb/mder-7-139.PMC4037306.pdf
Available  from: http://www.hc-sc.gc.ca/dhp-mps/medeff/cmdsnet-resscmm-eng.,OADS,/arxiv_data1/oa_pdf/d8/eb/mder-7-139.PMC4037306.pdf
Available  from: http://www.fda.gov/medicaldevices/safety/ medsunmedicalprod uctsafetynetwork/default.htm .,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/mder-7-139.PMC4037306.pdf
"Available from:  http://www.patientsafetyinstitute.ca/English/ toolsResources/Inciden - tAnalysis/Documents/ Canadian%20 Incident%20Analysis%20Frame - work.PD F. Accessed February  26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d8/eb/mder-7-139.PMC4037306.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6d/3b/opth-8-973.PMC4037307.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 973–976Clinical Ophthalmology Purpose:  To evaluate the impact of intravitreal bevacizumab combined with laser vascular  ablation in the management of advanced Coats’ disease presenting with exudative retinal  detachment.,Non-OADS,/arxiv_data1/oa_pdf/6d/3b/opth-8-973.PMC4037307.pdf
"Intravitreal anti-vascular endothelial growth factor (VEGF) has been reported to  be effective as adjunctive therapy to reduce subretinal fluid and exudation both alone Dove press submit your manuscript | www.dovepress.co m Dove press  973Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6281 6Journal name: Clinical Ophthalmology Journal Designation: Case Series Y ear: 2014 Volume: 8 Running head verso: Villegas et al Running head recto: Treatment of advanced Coats’ disease DOI: http://dx.doi.org/10.2147/OPTH.S62816 advanced Coats’ disease treated with intravitreal  bevacizumab combined with laser vascular ablation Victor M Villegas1 aaron s Gold1 audina M Berrocal2 Timothy G Murray1 1Ocular Oncology and retina,   Miami, FL, Usa; 2Department of  Ophthalmology, Bascom Palmer eye  institute, Miller school of Medicine,   University of Miami, Miami, FL, Usa Correspondence: Timothy G Murray   Murray Ocular Oncology and retina,  6705 red road, suite 412, Miami,   FL 33143, Usa   email tmurray@murraymd.co m",Non-OADS,/arxiv_data1/oa_pdf/6d/3b/opth-8-973.PMC4037307.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6d/3b/opth-8-973.PMC4037307.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 976Villegas et al all cases.,Non-OADS,/arxiv_data1/oa_pdf/6d/3b/opth-8-973.PMC4037307.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/43/a5/opth-8-945.PMC4037314.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 945–948Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  945Case RepOR topen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S6231 2Journal name: Clinical Ophthalmology Journal Designation: Case Report Y ear: 2014 Volume: 8 Running head verso: Fernández-López et al Running head recto: Choroidal neovascularization after intraocular foreign body DOI: http://dx.doi.org/10.2147/OPTH.S62312 Choroidal neovascularization after intraocular  foreign body ester Fernández-López Mari Carmen Desco- esteban  adriana Fandiño-López Mikhail Hernández-Díaz amparo Navea Department of Vitreoretinal Diseases,   FIsaBIO Oftalmología Médica,   Valencia, spainAbstract:  We report an unusual case of choroidal neovascularization secondary to intraocular  foreign body (IOFB) penetrating trauma.",Non-OADS,/arxiv_data1/oa_pdf/43/a5/opth-8-945.PMC4037314.pdf
Or use: http://dvpr.es/1iRDsg uVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/43/a5/opth-8-945.PMC4037314.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/43/a5/opth-8-945.PMC4037314.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 948Fernández-López et al Disclosure The authors report no conflicts of interest in this work.,Non-OADS,/arxiv_data1/oa_pdf/43/a5/opth-8-945.PMC4037314.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/55/ott-7-761.PMC4037325.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 761–770OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  761Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S4923 3Treating advanced non-small-cell lung cancer   in Chinese patients: focus on icotinib Jun-Li Liang1 Xiao-Cang Ren2 Qiang Lin2 1Department of Radiation Oncology,   Hebei Medical University Fourth  Hospital, Shijiazhuang, People’s  Republic of China;  2Department of  Oncology, North China Petroleum  Bureau General Hospital of Hebei  Medical University, Renqiu, Hebei  Province, People’s Republic of China Correspondence: Qiang Lin   Department of Oncology, North China  Petroleum Bureau General Hospital of  Hebei Medical University,  8 Huizhan  Avenue, Renqiu, Hebei Province  062552,  People’s Republic of China   Tel +86 317 272 1951  Fax +86 317 272 2381  email billhappy001@163.co m or zyy_ linqiang@hotmail.co mAbstract:  Icotinib hydrochloride is an orally administered small-molecule reversible tyrosine  kinase inhibitor that has been independently researched and developed and has independent  intellectual property rights in the People’ s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/16/55/ott-7-761.PMC4037325.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/16/55/ott-7-761.PMC4037325.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/55/ott-7-761.PMC4037325.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/d0/hiv-6-081.PMC4037326.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpHIV/AIDS – Research and Palliative Care 2014:6 81–90HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  81ReVIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S3917 8Critical appraisal of elvitegravir in the treatment   of HIV-1/AIDS Krishan K Pandey Institute for Molecular Virology,    Saint Louis University Health   Sciences Center, St Louis, MO, USA Correspondence: Krishan K Pandey   Institute for Molecular Virology,   Saint Louis University Health Sciences   Center, 1100 S. Grand Blvd,   Saint Louis, MO  63104, USA   Tel +1 314 977 8787  Fax +1 314 977 8798  email pandeykk@slu.ed uAbstract:  Human immunodeficiency virus type  1 (HIV -1) integrase inhibitors belong to a  novel class of antiretroviral drugs with high potency and better tolerability.",Non-OADS,/arxiv_data1/oa_pdf/41/d0/hiv-6-081.PMC4037326.pdf
"Available from: http://aidsinfo.nih.gov/ contentfiles/lvguidelines /AdultandAdolescentGL.pd f. Accessed  January 13,  2014.",Non-OADS,/arxiv_data1/oa_pdf/41/d0/hiv-6-081.PMC4037326.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/41/d0/hiv-6-081.PMC4037326.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/d0/hiv-6-081.PMC4037326.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/53/ff/ott-7-751.PMC4037327.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 751–759OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  751Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S4942 9Clinical potential of bevacizumab   in the treatment of metastatic and locally   advanced cervical cancer: current evidence Matthew w Jackson Chad G Rusthoven Christine M Fisher Tracey e Schefter Department of Radiation   Oncology, University of Colorado,    Denver, CO, USA Correspondence: Tracey e Schefter   Department of Radiation Oncology,  University of Colorado, 1665 Aurora  Court, Suite 1032 MS F706, Aurora,  Denver, CO 80045, USA   email tracey.schefter@ucdenver.ed uAbstract:  The addition of bevacizumab to established therapies for metastatic and locally  advanced cervical cancer is an area of evolving research and a potential strategy toward improving  historically suboptimal outcomes for women with advanced disease.",Non-OADS,/arxiv_data1/oa_pdf/53/ff/ott-7-751.PMC4037327.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/53/ff/ott-7-751.PMC4037327.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/ff/ott-7-751.PMC4037327.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/58/ott-7-729.PMC4037328.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 729–737OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  729ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S6103 3Investigation and analysis of oncologists’  knowledge of morphine usage in cancer   pain treatment Weiran Liu1,* Shumin Xie2,* Lin Yue3,* Jiahao Liu2 Stephanie Mu-Lian Woo4 Weilin Liu2 Adam R Miller5 Jing Zhang6 Lijun Huang7 Lei Zhang8,* 1Tianjin Medical University Cancer Institute  and Hospital, National Clinical Research  Center for Cancer, Key Laboratory of  Cancer Prevention and Therapy, Department  of Anesthesia, Tianjin, People’s Republic  of China;  2The Xiangya Medical School of  Central-South University, Changsha, People’s  Republic of China;  3Tianjin Medical University  Cancer Institute and Hospital, National  Clinical Research Center for Cancer, Key  Laboratory of Cancer Prevention and  Therapy, Outpatient Service, Tianjin, People’s  Republic of China;  4Harvard University,  Cambridge, MA, USA;  5Indiana University  School of Medicine, Indianapolis, IN, USA;   6Tianjin Medical University, Tianjin, People’s  Republic of China;  7Hunan Provincial Tumor  Hospital, Department of Lymphoma and  Hematology, Changsha, People’s Republic of  China; 8Tianjin Medical University Cancer  Institute and Hospital, National Clinical  Research Center for Cancer, Key Laboratory  of Cancer Prevention and Therapy, Tianjin  Lung Cancer Center, Department of Thoracic  Surgery, Tianjin, People’s Republic of China *These authors contributed equally to this  paper Correspondence: Lei Zhang   Tianjin Medical University Cancer  Institute and Hospital, National Clinical  Research Center for Cancer, Key  Laboratory of Cancer Prevention and  Therapy, Tianjin Lung Cancer Center,  Department of Thoracic Surgery, Tianjin   300060, People’s Republic of China   Tel +86 22 2334 0123   Fax +86 22 2335 9984   Email chinaray728@gmail.co mPurpose:  To examine oncologists’ knowledge of cancer pain and morphine’ s clinical  application in the People’ s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/cb/58/ott-7-729.PMC4037328.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/cb/58/ott-7-729.PMC4037328.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/58/ott-7-729.PMC4037328.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/45/d0/copd-9-513.PMC4037329.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 513–523International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  513OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S58478Chronic disease self-management and exercise   in COPD as pulmonary rehabilitation:   a randomized controlled trial helen l Cameron-T ucker1 richard Wood-Baker1 Christine Owen2 lyn Joseph3 e haydn Walters1 1Centre of research excellence for  Chronic respiratory Disease and  lung aging, school of Medicine,   University of Tasmania, hobart, T as,   australia; 2Faculty of education,   University of Tasmania, hobart, T as,   australia; 3Department of respiratory  Medicine, royal hobart hospital,   hobart, T as, australia Correspondence: helen l Cameron- Tucker   school of Medicine, University of Tasmania,  Medical science 1 Building, Private Bag 23,   hobart, Tas 7000, australia   Tel +61 3 6226 4893   Fax +61 3 6226 7704   email cameronh@utas.edu.a uPurpose:  Both exercise and self-management are advocated in pulmonary rehabilitation for  people with chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/45/d0/copd-9-513.PMC4037329.pdf
http://www.blackwell-synergy.,Non-OADS,/arxiv_data1/oa_pdf/45/d0/copd-9-513.PMC4037329.pdf
"Available from: http://www.aihw.gov.au/publications/cvd/aas/aas.pd f.  Accessed 20 April, 2004.",OADS,/arxiv_data1/oa_pdf/45/d0/copd-9-513.PMC4037329.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/45/d0/copd-9-513.PMC4037329.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/d0/copd-9-513.PMC4037329.pdf
"Available from: http://www.uri.edu/research/cprc/Measures/ Exercise04.ht m. Accessed September 20, 2004.",OADS,/arxiv_data1/oa_pdf/45/d0/copd-9-513.PMC4037329.pdf
Available from: http://www.copdx.org.au /.,Non-OADS,/arxiv_data1/oa_pdf/45/d0/copd-9-513.PMC4037329.pdf
"Available at http://www.who.int/mediacentre/ factsheets/fs307/en/index.html (cited 29 July 2013, last accessed on 29 July 2013).",Non-OADS,/arxiv_data1/oa_pdf/98/a4/icb2013113a.PMC4037497.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ The Supplementary Information that accompanies this paper is available on the Immunology and Cell Biology website (http://www.nature.com/icb)Murine model of asthma and inﬂuenza comorbidity AE Samarasinghe et al 459 Immunology and Cell Biology",Non-OADS,/arxiv_data1/oa_pdf/98/a4/icb2013113a.PMC4037497.pdf
"The current study reports the  first MYOC  screening in four generations of a large Malay Molecular Vision  2014; 20:714-723 <http://www.molvis.org/molvis/v 20/714> Received 20 June 2013 | Accepted 24 May 2014 | Published 27 May 2014© 2014 Molecular Vision 714Identification of MYOC  gene mutation and polymorphism in a  large Malay family with juvenile-onset open angle glaucoma Z Mimiwati,1 K Nurliza,1 M Marini,3 AT Liza-Sharmini2 1Department of Ophthalmology, University Malaya, Lembah Pantai, Kuala Lumpur Malaysia; 2Department of Ophthalmology,  School of Medical Sciences, University Sains Malaysia Health Campus, Kota Bharu, Kelantan, Malaysia; 3Human Genome  Centre, School of Medical Sciences, University Sains Malaysia, Health Campus, Kota Bharu, Kelantan, Malaysia Purpose:  To screen for mutations in the coding region of the myocilin  (MYOC ) gene in a large Malay family with  juvenile-onset open angle glaucoma (JOAG).",Non-OADS,/arxiv_data1/oa_pdf/71/e8/mv-v20-714.PMC4037532.pdf
Molecular Vision  2014; 20:714-723 <http://www.molvis.org/molvis/v 20/714> © 2014 Molecular Vision  715family with JOAG.,Non-OADS,/arxiv_data1/oa_pdf/71/e8/mv-v20-714.PMC4037532.pdf
Molecular Vision  2014; 20:714-723 <http://www.molvis.org/molvis/v 20/714> © 2014 Molecular Vision  716her second marriage.,Non-OADS,/arxiv_data1/oa_pdf/71/e8/mv-v20-714.PMC4037532.pdf
"Molecular Vision  2014; 20:714-723 <http://www.molvis.org/molvis/v 20/714> © 2014 Molecular Vision  717Asn480Lys, in this family.",Non-OADS,/arxiv_data1/oa_pdf/71/e8/mv-v20-714.PMC4037532.pdf
Molecular Vision  2014; 20:714-723 <http://www.molvis.org/molvis/v 20/714> © 2014 Molecular Vision  718Table  2. c linical  charac TeriSTic of JoaG proband S. ID  Sex  Visual acuity Age IOP VCDR CCT HRT(RNFL thickness) Visual fieldTreatment   OD OS  OD OS OD OS OD OS OD OS OD OS II:3 F NPL NPL 38 35 10 Nil Nil Nil Nil Nil Nil Severe Severe No II:7 F NPL 6/12 25 Nil 12 0.9 0.9 Nil 510 Nil Borderline Severe Severe Surgical II:11 F 6/15 6/15 40 16 20 0.9 0.5 551 527 Abnormal Abnormal Severe Severe Surgical II:14 M NPL 6/7.5 40 58 58 Nil 0.7 557 539 Nil Abnormal Severe Severe Surgical III:2 F NPL NPL 42 42 42 Nil Nil 539 480 Nil Nil Severe Severe No III:3 F 6/6 6/7.5 40 56 56 0.9 0.9 468 469 Borderline Normal Severe Severe Medical III:5* M 6/7.5 6/7.5 47 24 16 0.8 0.2 515 497 Borderline Normal Severe Severe Nil III:6 F 6/6 6/6 40 20 24 0.5 0.4 Nil Nil Nil Nil Mild Normal Medical III:7 M NPL NPL 36 46 45 1 0.9 Nil Nil Abnormal Abnormal Severe Severe Nil III:8 F HM 6/24 31 11 17 0.9 0.8 Nil Nil Normal Normal Severe Severe Medical III:19 F NPL 6/12 36 60 40 0.9 0.3 533 502 Normal Nil Severe Normal Surgical III:20 F 6/6 NPL 34 16 16 0.9 0.9 Nil Nil Normal Normal Severe Severe Surgical III:21 M 6/7.5 6/7.5 29 32 32 0.7 0.6 466 439 Normal Normal Severe Moderate Both III:23 M 6/6 6/6 32 20 23 0.5 0.3 510 512 Normal Normal Normal Mild Surgical III:24* F 6/6 6/6 37 49 33 0.7 0.5 517 509 Normal Abnormal Normal Normal Medical III:25* M 6/6 6/6 34 49 49 0.8 0.9 517 506 Nil Nil Normal Severe Medical III:27 F PL 6/9 17 30 22 0.9 0.9 Nil Nil Normal Normal Severe Severe Surgical III:28* M 6/7.5 6/6 23 28 35 0.4 0.5 501 506 Abnormal Abnormal Normal Normal Medical III:36 M 6/18 6/6 32 50 50 0.9 0.9 504 499 Normal Abnormal Severe Moderate Both III:39 F 6/6 6/6 24 16 14 0.5 0.7 510 513 Nil Nil Normal Normal Medical III:40 F 6/9 6/6 25 20 19 0.5 0.3 487 488 Normal Normal Normal Normal Medical III:41* M 6/6 6/6 30 50 54 0.3 0.3 563 560 Normal Normal Normal Normal Medical III:42* M 6/6 6/6 25 29 37 0.6 0.7 557 556 Normal Normal Normal Normal Medical III:43 F 6/5 6/5 16 24 22 0.3 0.3 519 529 Nil Nil Normal Normal Medical III:59* M 6/7.5 6/7.5 22 27 25 0.4 0.3 557 565 Abnormal Borderline Normal Normal Medical III:62* M 6/6 6/6 17 36 36 0.8 0.7 537 554 Abnormal Abnormal Severe Severe Medical III:63* M 6/7.5 6/7.5 16 38 40 0.6 0.9 527 532 Abnormal Abnormal Moderate Severe Medical IV:1 M NPL NPL 16 44 5 0.9 0.9 488 536 Abnormal Abnormal Severe Severe No IV:6 M 6/9 6/7.5 33 53 54 0.9 0.9 531 534 Normal Normal Severe Severe Medical IV:11* F 6/6 6/6 31 34 25 0.4 0.4 454 455 Normal Normal Normal Normal Medical IV:15* M 6/7.5 6/7.5 18 26 26 0.6 0.4 465 466 Normal Normal Mild Moderate Medical IV:48 F 6/12 6/9 13 33 33 0.4 0.4 565 562 Normal Normal Normal Normal Both,Non-OADS,/arxiv_data1/oa_pdf/71/e8/mv-v20-714.PMC4037532.pdf
Molecular Vision  2014; 20:714-723 <http://www.molvis.org/molvis/v 20/714> © 2014 Molecular Vision  719*Newly diagnosed juvenile-onset open angle glaucoma (11 cases); AGE*: Age at diagnosis; IOP: Intraocular pressure; VCDR: Vertical cup disc ratio; CCT: Central corneal  thickness; HRT: Heidelberg retinal tomography II; RNFL: Retinal nerve fiber layer; Nil: not done or not available; NPL: no perception to light; HM: hand movement.,Non-OADS,/arxiv_data1/oa_pdf/71/e8/mv-v20-714.PMC4037532.pdf
Molecular Vision  2014; 20:714-723 <http://www.molvis.org/molvis/v 20/714> © 2014 Molecular Vision  720in five of our probands.,Non-OADS,/arxiv_data1/oa_pdf/71/e8/mv-v20-714.PMC4037532.pdf
Molecular Vision  2014; 20:714-723 <http://www.molvis.org/molvis/v 20/714> © 2014 Molecular Vision  721Table  3.,Non-OADS,/arxiv_data1/oa_pdf/71/e8/mv-v20-714.PMC4037532.pdf
Molecular Vision  2014; 20:714-723 <http://www.molvis.org/molvis/v 20/714> © 2014 Molecular Vision  722was not measured in all probands.,Non-OADS,/arxiv_data1/oa_pdf/71/e8/mv-v20-714.PMC4037532.pdf
Molecular Vision  2014; 20:714-723 <http://www.molvis.org/molvis/v 20/714> © 2014 Molecular Vision  723populations.,Non-OADS,/arxiv_data1/oa_pdf/71/e8/mv-v20-714.PMC4037532.pdf
"TLR4 as a PRR has been Molecular Vision  2014; 20:704-713 <http://www.molvis.org/molvis/v 20/704> Received 22 January 2014 | Accepted 24 May 2014 | Published 27 May 2014© 2014 Molecular Vision 704Toll-like receptor 4 polymorphisms and their haplotypes modulate  the risk of developing diabetic retinopathy in type 2 diabetes  patients Kanhaiya Singh,1 Shri Kant,2 Vivek Kumar Singh,3 Neeraj K. Agrawal,4 Sanjeev K. Gupta,5 Kiran Singh1 1Department of Molecular & Human Genetics, Banaras Hindu University, Varanasi, India; 2Department of Ophthalmology,  Institute of Medical Sciences, Banaras Hindu University, Varanasi, India; 3Department of Mining Engineering, Indian Institute  of Technology, Banaras Hindu University, Varanasi, India; 4Department of Endocrinology and Metabolism, Institute of Medical  Sciences, Banaras Hindu University, Varanasi, India; 5Department of Surgery, Institute of Medical Sciences, Banaras Hindu  University, Varanasi, India Purpose:  Persistent in ﬂammation and impaired neovascularization in type 2 diabetes mellitus (T2DM) patients may  lead to development of macro- and microvascular complications.",Non-OADS,/arxiv_data1/oa_pdf/60/b8/mv-v20-704.PMC4037533.pdf
"Molecular Vision  2014; 20:704-713 <http://www.molvis.org/molvis/v 20/704> © 2014 Molecular Vision  705shown to predominantly interact with microorganism-derived  lipopolysaccharides, but other interacting molecules, such as  heat shock proteins 60 and 70, fibrinogen, and fibronectin,  are also known [ 14].",Non-OADS,/arxiv_data1/oa_pdf/60/b8/mv-v20-704.PMC4037533.pdf
Molecular Vision  2014; 20:704-713 <http://www.molvis.org/molvis/v 20/704> © 2014 Molecular Vision  706Table  2. pcr condi Tions for Tlr4 snp s geno Typing .,Non-OADS,/arxiv_data1/oa_pdf/60/b8/mv-v20-704.PMC4037533.pdf
"Molecular Vision  2014; 20:704-713 <http://www.molvis.org/molvis/v 20/704> © 2014 Molecular Vision  707rs1927911 , and rs1927914 , were analyzed using PCR restric - tion fragment length polymorphism (PCR-RFLP) as reported  previously [ 10].",OADS,/arxiv_data1/oa_pdf/60/b8/mv-v20-704.PMC4037533.pdf
Molecular Vision  2014; 20:704-713 <http://www.molvis.org/molvis/v 20/704> © 2014 Molecular Vision  7082).,Non-OADS,/arxiv_data1/oa_pdf/60/b8/mv-v20-704.PMC4037533.pdf
Molecular Vision  2014; 20:704-713 <http://www.molvis.org/molvis/v 20/704> © 2014 Molecular Vision  709Table  4. o bserved  geno Type frequencies  for sTudied  snp s among  dr cases .,Non-OADS,/arxiv_data1/oa_pdf/60/b8/mv-v20-704.PMC4037533.pdf
"Molecular Vision  2014; 20:704-713 <http://www.molvis.org/molvis/v 20/704> © 2014 Molecular Vision  710inflammatory diseases, such as Crohn’s disease, and gastric  cancer and gastric lymphoma in different cohorts, including  Indians [ 25,26].",Non-OADS,/arxiv_data1/oa_pdf/60/b8/mv-v20-704.PMC4037533.pdf
"Molecular Vision  2014; 20:704-713 <http://www.molvis.org/molvis/v 20/704> © 2014 Molecular Vision  711expression of TLR4 mediated by this variant could explain  the different susceptibility of various diseases, including  cancer, among different ethnic groups [ 10,17].",Non-OADS,/arxiv_data1/oa_pdf/60/b8/mv-v20-704.PMC4037533.pdf
Molecular Vision  2014; 20:704-713 <http://www.molvis.org/molvis/v 20/704> © 2014 Molecular Vision  712Study.,Non-OADS,/arxiv_data1/oa_pdf/60/b8/mv-v20-704.PMC4037533.pdf
Molecular Vision  ####; ###:704-713 <http://www.molvis.org/molvis/v ###/#### > © Copyright Year Copyright Holder  71326.,Non-OADS,/arxiv_data1/oa_pdf/60/b8/mv-v20-704.PMC4037533.pdf
"Molecular Vision  2014; 20:683-690 <http://www.molvis.org/molvis/v 20/683> Received 24 July 2013 | Accepted 24 May 2014 | Published 27 May 2014© 2014 Molecular Vision 683Regeneration of corneal endothelial cells following keratoplasty in  rats with bullous keratopathy Laura Bredow,1 Johannes Schwartzkopff,2 Thomas Reinhard1 1University Eye Hospital Freiburg, Freiburg, Germany; 2Ophthalmology Clinic Schwartzkopff/Knapp, Freiburg, Germany Purpose:  Little is known about the behavior of the endothelial cell (EC) layer following keratoplasty.",Non-OADS,/arxiv_data1/oa_pdf/29/1c/mv-v20-683.PMC4037534.pdf
Molecular Vision  2014; 20:683-690 <http://www.molvis.org/molvis/v 20/683> © 2014 Molecular Vision  684Transplantations were performed between green fluorescent  protein (GFP) transgenic and wild-type rats to monitor EC  origin aside from cell density and morphology.,OADS,/arxiv_data1/oa_pdf/29/1c/mv-v20-683.PMC4037534.pdf
"Molecular Vision  2014; 20:683-690 <http://www.molvis.org/molvis/v 20/683> © 2014 Molecular Vision  685RESULTS Induction of bullous keratopathy:  Injection of BAK into  the anterior chamber resulted in bullous keratopathy, which  was clinically evident after 3 days.",Non-OADS,/arxiv_data1/oa_pdf/29/1c/mv-v20-683.PMC4037534.pdf
Molecular Vision  2014; 20:683-690 <http://www.molvis.org/molvis/v 20/683> © 2014 Molecular Vision  686Perforating keratoplasty in hosts with bullous keratopathy  (group ‘bullous host’): Clinical follow-up— Eyes with bullous keratopathy  received a corneal transplant with a healthy endothelium.,Non-OADS,/arxiv_data1/oa_pdf/29/1c/mv-v20-683.PMC4037534.pdf
"Molecular Vision  2014; 20:683-690 <http://www.molvis.org/molvis/v 20/683> © 2014 Molecular Vision  687of endothelial precursors in the posterior limbal area, from  where these cells might migrate to the endothelial periphery  and, perhaps, to wounded areas of the corneal endothelium  when needed [ 8,14,15].",Non-OADS,/arxiv_data1/oa_pdf/29/1c/mv-v20-683.PMC4037534.pdf
Molecular Vision  2014; 20:683-690 <http://www.molvis.org/molvis/v 20/683> © 2014 Molecular Vision  688in rabbits [ 17-19].,Non-OADS,/arxiv_data1/oa_pdf/29/1c/mv-v20-683.PMC4037534.pdf
Molecular Vision  2014; 20:683-690 <http://www.molvis.org/molvis/v 20/683> © 2014 Molecular Vision  689repopulating this transplant.,Non-OADS,/arxiv_data1/oa_pdf/29/1c/mv-v20-683.PMC4037534.pdf
Molecular Vision  2014; 20:683-690 <http://www.molvis.org/molvis/v 20/683> © 2014 Molecular Vision  690bilateral limbal stem cell insufficiency.,Non-OADS,/arxiv_data1/oa_pdf/29/1c/mv-v20-683.PMC4037534.pdf
Avail - able at: http://www.molvis.org/molvis/v16/a254/ .,Non-OADS,/arxiv_data1/oa_pdf/29/1c/mv-v20-683.PMC4037534.pdf
"OPA1 consists of five  domains: the mitochondrial target signal (MTS), N-terminal  coiled-coil domain, GTPase domain, dynamin central region, Molecular Vision  2014; 20:691-703 <http://www.molvis.org/molvis/v 20/691> Received 20 January 2014 | Accepted 24 May 2014 | Published 27 May 2014© 2014 Molecular Vision 691First report of OPA1  screening in Greek patients with autosomal  dominant optic atrophy and identification of a previously  undescribed OPA1  mutation Smaragda Kamakari,1 George Koutsodontis,1 Miltiadis Tsilimbaris,2 Athanasios Fitsios,3 Georgia Chrousos3 1Ophthalmic Genetics Unit, OMMA Ophthalmological Institute of Athens, Greece; 2Department of Ophthalmology, School of  Medicine, University of Crete, Iraklion, Greece; 3Pediatric Ophthalmology Department, MITERA Childrens’ Hospital, Athens,  Greece Purpose:  To describe the genotype–phenotype correlation in four Greek pedigrees with autosomal dominant optic  atrophy (ADOA) and OPA1  mutations.",Non-OADS,/arxiv_data1/oa_pdf/bc/5d/mv-v20-691.PMC4037535.pdf
Molecular Vision  2014; 20:691-703 <http://www.molvis.org/molvis/v 20/691> © 2014 Molecular Vision  692and C-terminal coiled-coil domain.,Non-OADS,/arxiv_data1/oa_pdf/bc/5d/mv-v20-691.PMC4037535.pdf
Molecular Vision  2014; 20:691-703 <http://www.molvis.org/molvis/v 20/691> © 2014 Molecular Vision  693Table  1.,Non-OADS,/arxiv_data1/oa_pdf/bc/5d/mv-v20-691.PMC4037535.pdf
Molecular Vision  2014; 20:691-703 <http://www.molvis.org/molvis/v 20/691> © 2014 Molecular Vision  694Exon Primer (5’-3’) CAGCTCCTACTCCCTTCAGA Exon 21 TTTTTCATGTTAACCATTGAAGTATG GAGGCTGATACCCCAGTATACAA Exon 22 TTTTTCCATATTTACTAAGCTGTCAA TCACCACTGTGAACTCAGAACTC Exon 23 TTCCTTTATTTCAACTGCCTTCA AATGCCTGAATTAAAATGAACAA Exon 24 TCAAGCACCAAATTATGAACCA GCAGATTCCTGCTTCTCAGC Exon 25 TGTACAACTTCTCAGTGTGGTTGA GCATATTTTGACAACTGTTGCTT Exon 26 AAGCTTAGGACATATCTACTGGTTCT TGGGAAGTATTTTGGCATCC Exon 27 TCTTTATTCATTTATAAAAACGATGC AAATGGGAAAGGTGGAAAGG Exon 28 CCTCCTGATTTGTGATACCTTTG CAAGCAGGATGTAAATGAAGCA,Non-OADS,/arxiv_data1/oa_pdf/bc/5d/mv-v20-691.PMC4037535.pdf
Molecular Vision  2014; 20:691-703 <http://www.molvis.org/molvis/v 20/691> © 2014 Molecular Vision  695pseudoisochromatic plates ranged from severely compro - mised (1/15 correct plates) to quite normal (14/15 correct  plates).,Non-OADS,/arxiv_data1/oa_pdf/bc/5d/mv-v20-691.PMC4037535.pdf
Molecular Vision  2014; 20:691-703 <http://www.molvis.org/molvis/v 20/691> © 2014 Molecular Vision  696 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/bc/5d/mv-v20-691.PMC4037535.pdf
Molecular Vision  2014; 20:691-703 <http://www.molvis.org/molvis/v 20/691> © 2014 Molecular Vision  697substance of neuroretinal rim tissue; Figure 7).,Non-OADS,/arxiv_data1/oa_pdf/bc/5d/mv-v20-691.PMC4037535.pdf
"Molecular Vision  2014; 20:691-703 <http://www.molvis.org/molvis/v 20/691> © 2014 Molecular Vision  698(family F1) had a heterozygous 3-bp in-frame deletion,  c.876_878delTGT, in exon 9 that is predicted to result in a  premature termination codon (p.(Val294fsx667); Figure 1B).",Non-OADS,/arxiv_data1/oa_pdf/bc/5d/mv-v20-691.PMC4037535.pdf
"Molecular Vision  2014; 20:691-703 <http://www.molvis.org/molvis/v 20/691> © 2014 Molecular Vision  699follows: a previously undescribed heterozygous splice-site  mutation, c.784–1G>T, in intron 7, a previously reported  heterozygous in-frame deletion mutation, c.876_878delTGT/p.",Non-OADS,/arxiv_data1/oa_pdf/bc/5d/mv-v20-691.PMC4037535.pdf
Molecular Vision  2014; 20:691-703 <http://www.molvis.org/molvis/v 20/691> © 2014 Molecular Vision  700Table  2.,Non-OADS,/arxiv_data1/oa_pdf/bc/5d/mv-v20-691.PMC4037535.pdf
Molecular Vision  2014; 20:691-703 <http://www.molvis.org/molvis/v 20/691> © 2014 Molecular Vision  701ptosis or ophthalmoplegia) in the past medical history of our  patient carrying the same OPA1  mutation.,Non-OADS,/arxiv_data1/oa_pdf/bc/5d/mv-v20-691.PMC4037535.pdf
Molecular Vision  2014; 20:691-703 <http://www.molvis.org/molvis/v 20/691> © 2014 Molecular Vision  70211.,Non-OADS,/arxiv_data1/oa_pdf/bc/5d/mv-v20-691.PMC4037535.pdf
Molecular Vision  ####; ###:691-703 <http://www.molvis.org/molvis/v ###/#### > © Copyright Year Copyright Holder  703of dominant optic atrophy due to OPA1  mutations.,Non-OADS,/arxiv_data1/oa_pdf/bc/5d/mv-v20-691.PMC4037535.pdf
"We used light-damaged albino rats  as an animal model to investigate changes in gap junction  expression during the complex series of events following light Molecular Vision  2014; 20:670-682 <http://www.molvis.org/molvis/v 20/670> Received 8 December 2013 | Accepted 24 May 2014 | Published 27 May 2014© 2014 Molecular Vision 670Gap junction proteins in the light-damaged albino rat Cindy X. Guo,1,3 Henry Tran,1 Colin R. Green,2,3 Helen V .",Non-OADS,/arxiv_data1/oa_pdf/e8/2e/mv-v20-670.PMC4037536.pdf
"Molecular Vision  2014; 20:670-682 <http://www.molvis.org/molvis/v 20/670> © 2014 Molecular Vision  671damage that may comprise oxidative stress, inflammation,  and vascular reactions.",Non-OADS,/arxiv_data1/oa_pdf/e8/2e/mv-v20-670.PMC4037536.pdf
Molecular Vision  2014; 20:670-682 <http://www.molvis.org/molvis/v 20/670> © 2014 Molecular Vision  672from the orbit.,Non-OADS,/arxiv_data1/oa_pdf/e8/2e/mv-v20-670.PMC4037536.pdf
"Molecular Vision  2014; 20:670-682 <http://www.molvis.org/molvis/v 20/670> © 2014 Molecular Vision  673dissection of the eye from the orbit, the posterior segment  of the eye was isolated.",Non-OADS,/arxiv_data1/oa_pdf/e8/2e/mv-v20-670.PMC4037536.pdf
"Molecular Vision  2014; 20:670-682 <http://www.molvis.org/molvis/v 20/670> © 2014 Molecular Vision  674chemiluminescence with maximum emission at a wavelength  of 430 nm, which was subsequently detected on a FujiFilm  LAS-4000 imager (GE Healthcare, Buckinghamshire, UK).",Non-OADS,/arxiv_data1/oa_pdf/e8/2e/mv-v20-670.PMC4037536.pdf
"Molecular Vision  2014; 20:670-682 <http://www.molvis.org/molvis/v 20/670> © 2014 Molecular Vision  675Quantification indicated a significant decrease in the inner  plexiform layer labeling (Figure 2L, Student t test, p<0.001).",Non-OADS,/arxiv_data1/oa_pdf/e8/2e/mv-v20-670.PMC4037536.pdf
"Molecular Vision  2014; 20:670-682 <http://www.molvis.org/molvis/v 20/670> © 2014 Molecular Vision  676RPE was significantly increased in the short-term following  light damage (Figure 3A,B; one-way ANOVA, p<0.01 for 6 h  and p<0.05 for 0 h).",Non-OADS,/arxiv_data1/oa_pdf/e8/2e/mv-v20-670.PMC4037536.pdf
"Molecular Vision  2014; 20:670-682 <http://www.molvis.org/molvis/v 20/670> © 2014 Molecular Vision  677DISCUSSION In the present study, we have documented that 24 h intense  light exposure results in changes in the expression of  connexin proteins in the light-damaged albino rat eye.",Non-OADS,/arxiv_data1/oa_pdf/e8/2e/mv-v20-670.PMC4037536.pdf
Molecular Vision  2014; 20:670-682 <http://www.molvis.org/molvis/v 20/670> © 2014 Molecular Vision  678 Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/e8/2e/mv-v20-670.PMC4037536.pdf
Molecular Vision  2014; 20:670-682 <http://www.molvis.org/molvis/v 20/670> © 2014 Molecular Vision  679and protein levels of Cx36 were significantly decreased after  dark-adaptation in the mouse retina [ 36].,Non-OADS,/arxiv_data1/oa_pdf/e8/2e/mv-v20-670.PMC4037536.pdf
Molecular Vision  2014; 20:670-682 <http://www.molvis.org/molvis/v 20/670> © 2014 Molecular Vision  680these inflammatory cells.,Non-OADS,/arxiv_data1/oa_pdf/e8/2e/mv-v20-670.PMC4037536.pdf
Molecular Vision  2014; 20:670-682 <http://www.molvis.org/molvis/v 20/670> © 2014 Molecular Vision  68117.,Non-OADS,/arxiv_data1/oa_pdf/e8/2e/mv-v20-670.PMC4037536.pdf
Molecular Vision  2014; 20:670-682 <http://www.molvis.org/molvis/v 20/670> © 2014 Molecular Vision  68246.,Non-OADS,/arxiv_data1/oa_pdf/e8/2e/mv-v20-670.PMC4037536.pdf
http://www.ich.org/ﬁleadmin/Public_Web_Site/ICH_ Products/Guidelines/Efﬁcacy/E 6_R1/Step4/E6_R1__Guideline.,Non-OADS,/arxiv_data1/oa_pdf/fd/42/40262_2014_Article_136.PMC4037587.pdf
http://www.dndi.org/media-centre/events/events-2011/216-media- centre/events/980-barcelona.html .,Non-OADS,/arxiv_data1/oa_pdf/fd/42/40262_2014_Article_136.PMC4037587.pdf
Daily Med; 2007. http://dailymed.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/fd/42/40262_2014_Article_136.PMC4037587.pdf
"1-4) More adverse cardiovascu- lar events occur in patients with MVD than those without MVD, and Review http://dx.doi.org/10.4070/kcj.2014.44.3.131 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Current Status of Coronary Intervention in Patients  with ST-Segment Elevation Myocardial Infarction and  Multivessel Coronary Artery Disease Min Chul Kim, MD, Myung Ho Jeong, MD, Sang Hyung Kim, MD,  Young Joon Hong, MD, Ju Han Kim, MD, and Youngkeun Ahn, MD Department of Cardiovascular Medicine, Heart Center, Chonnam National University Hospital, Gwangju, Korea Primary percutaneous coronary intervention (PCI) is a standard interventional treatment modality for ST-segment elevation myocardial  infarction (STEMI).",Non-OADS,/arxiv_data1/oa_pdf/48/3c/kcj-44-131.PMC4037633.pdf
"Correspondence: Myung Ho Jeong, MD, Department of Cardiovascular  Medicine, Heart Center, Chonnam National University Hospital, 42 Jebong- ro, Dong-gu, Gwangju 501-757, KoreaTel: 82-62-220-6243, Fax: 82-62-228-7174E-mail: myungho@chollian.net  • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.a lack of accurate guidelines makes it difficult for cardiologists to  determine the extent of revascularization.5)6) Two interventional strategies have been used for managing STEMI  with MVD.",Non-OADS,/arxiv_data1/oa_pdf/48/3c/kcj-44-131.PMC4037633.pdf
132 Multivessel PCI in STEMI http://dx.doi.org/10.4070/kcj.2014.44.3.131 www.e-kcj.org Interventional Strategies for ST-Segment Elevation  Myocardial Infarction with Multivessel Coronary  Artery Disease The current American College of Cardiology/American Heart As- sociation (ACC/AHA) and European revascularization guidelines for  STEMI recommend CVR during primary PCI as the primary interven-tional strategy in patients with MVD.,Non-OADS,/arxiv_data1/oa_pdf/48/3c/kcj-44-131.PMC4037633.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.131 www.e-kcj.org MACE compared to CVR.,OADS,/arxiv_data1/oa_pdf/48/3c/kcj-44-131.PMC4037633.pdf
"134 Multivessel PCI in STEMI http://dx.doi.org/10.4070/kcj.2014.44.3.131 www.e-kcj.org prevalence of three-vessel disease (60% vs. 57%), presentation with  resuscitation (48% vs. 46%), and STEMI (83% vs. 87%) were similar between the two patient groups who received another interven-tional strategy when MVR and CVR were compared.",Non-OADS,/arxiv_data1/oa_pdf/48/3c/kcj-44-131.PMC4037633.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.131 www.e-kcj.org short- and long-term MACE occurred more often in the MVR group,  the primary endpoint was similar after excluding patients with shock in analyses limited to randomized controlled trials.",Non-OADS,/arxiv_data1/oa_pdf/48/3c/kcj-44-131.PMC4037633.pdf
"136 Multivessel PCI in STEMI http://dx.doi.org/10.4070/kcj.2014.44.3.131 www.e-kcj.org tion, and myocardial irreversibility.44)45) In addition, CMRI can predict  functional recovery of the left ventricle after PCI.46) However, be- cause there are no available data on the clinical benefits of CMRI- guided intervention for assessing the significance of non-IRA, the fractional flow reserve (FFR) procedure is practical for determining the level of ischemia using a pressure wire.",Non-OADS,/arxiv_data1/oa_pdf/48/3c/kcj-44-131.PMC4037633.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.131 www.e-kcj.org tivessel disease in patients presenting with ST-segment elevation  myocardial infarction: a pairwise and network meta-analysis.,Non-OADS,/arxiv_data1/oa_pdf/48/3c/kcj-44-131.PMC4037633.pdf
138 Multivessel PCI in STEMI http://dx.doi.org/10.4070/kcj.2014.44.3.131 www.e-kcj.org 45.,OADS,/arxiv_data1/oa_pdf/48/3c/kcj-44-131.PMC4037633.pdf
"6)Editorial http://dx.doi.org/10.4070/kcj.2014.44.3.139 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Coronary Circulation; Macro or Micro, That It the Question Bon-Kwon Koo, MD Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, Korea Correspondence: Bon-Kwon Koo, MD, Department of Internal Medicine,  Cardiovascular Center, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, KoreaTel: 82-2-2072-2062, Fax: 82-2-3675-0805E-mail: bkkoo@snu.ac.kr • The author has no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Although there have been studies assessing microvascular func- tion in patients with non-ST segment elevation myocardial infarc- tion, most of those patients had significant epicardial coronary ar-tery disease.",Non-OADS,/arxiv_data1/oa_pdf/e0/a5/kcj-44-139.PMC4037634.pdf
140 Micro- or Macrovascular Coronary Circulation http://dx.doi.org/10.4070/kcj.2014.44.3.139  www.e-kcj.orgtests and between measurement of troponin I and CFR/IMR were  not reported in this manuscript.,Non-OADS,/arxiv_data1/oa_pdf/e0/a5/kcj-44-139.PMC4037634.pdf
"1) Recent studies have shown that Original Article http://dx.doi.org/10.4070/kcj.2014.44.3.141 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Association between Cardiac Troponin Level and Coronary Flow  Reserve in Patients without Coronary Artery Disease: Insight  from a Thermodilution Technique Using an Intracoronary Pressure Wire Kyungil Park, MD1,2, Minkwan Kim, MD2, Young-Rak Cho, MD1,2, Jong-Sung Park, MD1,2,   Tea-Ho Park, MD1,2, Moo Hyun Kim, MD1,2, and Young-Dae Kim, MD1,2 1Regional Cardiocerebrovascular Center, Dong-A University Hospital, Busan,  2Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea Background and Objectives: Cardiac troponins are associated with increased mortality, even among patients with no coronary artery dis - ease.",Non-OADS,/arxiv_data1/oa_pdf/19/7d/kcj-44-141.PMC4037635.pdf
"Received: January 8, 2014 / Revision Received: March 25, 2014 / Accepted: April 4, 2014 Correspondence: Young-Dae Kim, MD, Regional Cardiovascular Center, Dong-A University Hospital, Division of Cardiology, Department of Internal Medi - cine, Dong-A University College of Medicine, 26 Daesingongwon-ro, Seo-gu, Busan 602-714, Korea Tel: 82-51-240-5959, Fax: 82-51-242-5852, E-mail: kimyd@dau.ac.kr • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.cardiac troponins can detect myocardial injury precisely and may  predict short- and long-term mortality, even among those with no significant obstructive coronary artery disease, because high cardi-ac troponin levels have been associated with anatomical and func-tional conditions that place patients at risk of future cardiovascular events.",Non-OADS,/arxiv_data1/oa_pdf/19/7d/kcj-44-141.PMC4037635.pdf
"142 Cardiac Troponin and CFR from Thermodilution Technique http://dx.doi.org/10.4070/kcj.2014.44.3.141 www.e-kcj.org Functional impairment in the coronary microcirculation is thought  to be a major pathway in the development of myocardial injury in  normal epicardial vessels.5)6) Coronary flow reserve (CFR) provides  information on both epicardial and microvascular resistance.7) In the  absence of epicardial artery disease, CFR is an important index of coronary microcirculatory function.",OADS,/arxiv_data1/oa_pdf/19/7d/kcj-44-141.PMC4037635.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.141 www.e-kcj.org times during hyperemia and baseline.,Non-OADS,/arxiv_data1/oa_pdf/19/7d/kcj-44-141.PMC4037635.pdf
144 Cardiac Troponin and CFR from Thermodilution Technique http://dx.doi.org/10.4070/kcj.2014.44.3.141 www.e-kcj.org Table 2.,Non-OADS,/arxiv_data1/oa_pdf/19/7d/kcj-44-141.PMC4037635.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.141 www.e-kcj.org (Fig.,OADS,/arxiv_data1/oa_pdf/19/7d/kcj-44-141.PMC4037635.pdf
"146 Cardiac Troponin and CFR from Thermodilution Technique http://dx.doi.org/10.4070/kcj.2014.44.3.141 www.e-kcj.org with cardiac markers.18) Thus, CFR has been considered to be a mark - er of coronary microvascular response.",OADS,/arxiv_data1/oa_pdf/19/7d/kcj-44-141.PMC4037635.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.141 www.e-kcj.org tality and adverse cardiac events in patients with atrial fibrillation.,Non-OADS,/arxiv_data1/oa_pdf/19/7d/kcj-44-141.PMC4037635.pdf
"148 Copyright © 2014 The Korean Society of CardiologyKorean Circulation Journal Original Article http://dx.doi.org/10.4070/kcj.2014.44.3.148 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Clinical Outcomes in Patients with Intermediate Coronary Stenoses: MINIATURE Investigators (Korea MultIceNter TrIal on Long-Term Clinical Outcome According to the Plaque Burden and Treatment Strategy in Lesions with MinimUm Lumen ARea lEss Than 4 mm 2   Using Intravascular Ultrasound) Young Joon Hong, MD1, Yun Ha Choi, MS1, Soo Young Park, BS1, Chang Wook Nam, MD2, Jang Hyun Cho, MD3,   Won Yu Kang, MD4, Sang Rok Lee, MD5, Sung Yun Lee, MD6, Sang Wook Kim, MD7, Sang Yeob Lim, MD8,   Kyung Ho Yun, MD9, Jung Sun Kim, MD10, Jin Won Kim, MD11, Woong Chol Kang, MD12, Ki Seok Kim, MD13,   Jin Ho Choi, MD14, Joong Wha Chung, MD15, Soo Joong Kim, MD16, Youngkeun Ahn, MD1, and Myung Ho Jeong, MD1 1Division of Cardiology, Chonnam National University School of Medicine, Gwangju,   2Division of Cardiology, Keimyung University College of Medicine, Dongsan Medical Center, Daegu,   3Division of Cardiology, Saint Carollo Hospital, Suncheon, 4Division of Cardiology, Gwangju Veterans Hospital, Gwangju,   5Division of Cardiology, Chonbuk National University College of Medicine, Jeonju, 6Division of Cardiology, Inje University College of Medicine, Ilsan Paik Hospital, Goyang,   7Division of Cardiology, Chung-Ang University College of Medicine, Seoul, 8Division of Cardiology, Korea University College of Medicine, Ansan Hospital, Ansan,   9Division of Cardiology, Wonkwang University College of Medicine, Iksan, 10Division of Cardiology, Yonsei University College of Medicine, Severance Hospital, Seoul,   11Division of Cardiology, Korea University Guro Hospital, Seoul, 12Division of Cardiology, Gachon University Gil Medical Center, Incheon,   13Division of Cardiology, Jeju National University College of Medicine, Jeju, 14Division of Cardiology, Samsung Medical Center, Seoul,   15Division of Cardiology, Chosun University College of Medicine, Gwangju, 16Division of Cardiology, KyungHee University Medical Center, Seoul, Korea Background and Objectives: We evaluated the two-year clinical outcomes in patients with angiographically intermediate lesions accord - ing to the plaque burden and treatment strategy.",Non-OADS,/arxiv_data1/oa_pdf/5a/20/kcj-44-148.PMC4037636.pdf
"Received: January 5, 2014 / Revision Received: February 4, 2014 / Accepted: February 21, 2014 Correspondence: Myung Ho Jeong, MD, Principal Investigator of Korea Acute Myocardial Infarction Registry, Director of Cardiovascular Convergence  Research Center Nominated by Korea Ministry of Health and Welfare, Chonnam National University Hospital, 671 Jebong-ro, Dong-gu, Gwangju 501-757, Korea Tel: 82-62-220-6243, Fax: 82-62-228-7174, E-mail: myungho@chollian.net • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/20/kcj-44-148.PMC4037636.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.148 www.e-kcj.org Introduction Clinical decision making and the management of intermediate  coronary stenosis, defined by a diameter stenosis of 30% to 70%  continues to be a therapeutic dilemma for cardiologists.1)2) Intra- vascular ultrasound (IVUS) examination and functional assessment of coronary stenosis have been used to define the severity of such lesions and to designate patients to the most appropriate therapy.",Non-OADS,/arxiv_data1/oa_pdf/5a/20/kcj-44-148.PMC4037636.pdf
Subjects and Methods Patient population The investigators of the Korean MultIceNter TrIal on Long-Term  Clinical Outcome According to the Plaque Burden and Treatment Strategy in Lesions with MinimUm Lumen ARea LEss Than 4 mm 2  Using Intravascular Ultrasound (MINIATURE) study were selected of 16 major percutaneous coronary intervention centers in Korea (http://miniaturestudy.or.kr).,Non-OADS,/arxiv_data1/oa_pdf/5a/20/kcj-44-148.PMC4037636.pdf
"150 Outcome of Intermediate Coronary Stenosis and Plaque Burden http://dx.doi.org/10.4070/kcj.2014.44.3.148 www.e-kcj.org Coronary angiographic findings Coronary angiogram was analyzed by a validated QCA system  (Philips H5000 or Allura DCI program, Philips Medical Systems, Am - sterdam, North Holland, the Netherlands).",OADS,/arxiv_data1/oa_pdf/5a/20/kcj-44-148.PMC4037636.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.148 www.e-kcj.org Results Baseline characteristics, coronary angiography and  intravascular ultrasound findings The baseline characteristics, coronary angiography and IVUS find - ings are summarized in Table 1.",OADS,/arxiv_data1/oa_pdf/5a/20/kcj-44-148.PMC4037636.pdf
152 Outcome of Intermediate Coronary Stenosis and Plaque Burden http://dx.doi.org/10.4070/kcj.2014.44.3.148 www.e-kcj.org in both groups.,Non-OADS,/arxiv_data1/oa_pdf/5a/20/kcj-44-148.PMC4037636.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.148 www.e-kcj.org two-year MACE included acute myocardial infarction {odds ratio  (OR)=2.87; 95% confidence interval (CI) 1.43–6.12, p=0.014 }, dia- betes mellitus (OR=2.46; 95% CI 1.24–5.56, p=0.028) and non-statin  therapy (OR=2.32; 95% CI 1.18–5.24, p=0.034).",Non-OADS,/arxiv_data1/oa_pdf/5a/20/kcj-44-148.PMC4037636.pdf
"154 Outcome of Intermediate Coronary Stenosis and Plaque Burden http://dx.doi.org/10.4070/kcj.2014.44.3.148 www.e-kcj.org and the course of atherosclerosis.19-22) So, optimal medical therapy  is needed to treat patients with angiographically intermediate le- sions with IVUS MLA <4 mm2 with 50–70% of plaque burden.",Non-OADS,/arxiv_data1/oa_pdf/5a/20/kcj-44-148.PMC4037636.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.148 www.e-kcj.org ogy Clinical Expert Consensus Document on Standards for Acquisi- tion, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS).",Non-OADS,/arxiv_data1/oa_pdf/5a/20/kcj-44-148.PMC4037636.pdf
"The standard of care revolves around the  use of intravenous loop diuretics, sometimes supported by adjunc-Original Article http://dx.doi.org/10.4070/kcj.2014.44.3.156 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Pilot Study of Target Weight Guided Treatment in Acute Heart  Failure Using Ultrafiltration or Usual Care: Effect on Sodium Removal Eugene S. Chung, MD, Thomas M. O’Brien, MD, Santosh Menon, MD,  Cheryl Bartone, BS, Wojciech Mazur, MD, and Dean J. Kereiakes, MD The Christ Hospital Heart and Vascular Center, Cincinnati, OH, USA Background and Objectives: In the Ultrafiltration versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart  Failure trial, ultrafiltration (UF) removed volume more effectively than usual care (UC).",Non-OADS,/arxiv_data1/oa_pdf/c0/2f/kcj-44-156.PMC4037637.pdf
"Received: January 9, 2014 Revision Received: March 6, 2014Accepted: March 25, 2014 Correspondence: Eugene S. Chung, MD, The Christ Hospital Heart and  Vascular Center, 2123 Auburn Ave, Ste 100, Cincinnati, OH 45219, USATel: 1-513-721-9243, Fax: 1-513-721-9249E-mail: chunge@ohioheart.org This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.tive therapy with vasodilators and inotropic agents.2) However, in- hospital mortality as well as short-term outcomes remain problem - atic, with 30-day readmission rates of patients that have not im- proved significantly despite increased awareness over 20%.5) Loop  diuretic therapy may have a direct deleterious effect on cardiac func - tion,6) and the use of higher doses of loop diuretics may be associ- ated with poorer outcomes,7) although the presence of a causal rela - tionship is unproven.",Non-OADS,/arxiv_data1/oa_pdf/c0/2f/kcj-44-156.PMC4037637.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.156 www.e-kcj.org sions were observed in the UF treated group.,OADS,/arxiv_data1/oa_pdf/c0/2f/kcj-44-156.PMC4037637.pdf
158 Ultrafiltration in Acute Heart Failure http://dx.doi.org/10.4070/kcj.2014.44.3.156 www.e-kcj.org calculated by considering the relative volumes.,Non-OADS,/arxiv_data1/oa_pdf/c0/2f/kcj-44-156.PMC4037637.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.156 www.e-kcj.org ed with UF yielded similar results with regard to volumes removed,  total Na removed, and length of hospital stay.",OADS,/arxiv_data1/oa_pdf/c0/2f/kcj-44-156.PMC4037637.pdf
"160 Ultrafiltration in Acute Heart Failure http://dx.doi.org/10.4070/kcj.2014.44.3.156 www.e-kcj.org patients undergoing UF therapy rapidly becomes diluted, so that  when the Na concentrations of both urine and ultrafiltrate are mea - sured, the total amount of Na removed by the two treatment methods is similar.",Non-OADS,/arxiv_data1/oa_pdf/c0/2f/kcj-44-156.PMC4037637.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.156 www.e-kcj.org 8.,Non-OADS,/arxiv_data1/oa_pdf/c0/2f/kcj-44-156.PMC4037637.pdf
"162 Copyright © 2014 The Korean Society of CardiologyKorean Circulation Journal Introduction Aortic aneurysm (AA) can be life-threatening and aorta size is the  best criterion for determining if an intervention is necessary to pre - vent ruptures, dissections or aneurysm-related deaths.1) However, Original Article http://dx.doi.org/10.4070/kcj.2014.44.3.162 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Aortic Aneurysm Screening in a High-Risk Population: A Non-Contrast Computed Tomography Study in Korean Males with Hypertension In-Jeong Cho, MD1, Sung-Yeol Jang, MD1, Hyuk-Jae Chang, MD1,2, Sanghoon Shin, MD1,   Chi Young Shim, MD1,2, Geu-Ru Hong, MD1, and Namsik Chung, MD1 1Division of Cardiology, Severance Cardiovascular Hospital, 2Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea Background and Objectives: Screening strategies for aortic aneurysm (AA) according to risk factors and ethnicity are controversial.",Non-OADS,/arxiv_data1/oa_pdf/33/73/kcj-44-162.PMC4037638.pdf
"Received: February 21, 2014 Revision Received: March 26, 2014Accepted: April 14, 2014 Correspondence: Hyuk-Jae Chang, MD, Division of Cardiology, Severance  Cardiovascular Hospital, Yonsei University College of Medicine, 50-1 Yon-sei-ro, Seodaemun-gu, Seoul 120-752, KoreaTel: 82-2-2228-8454, Fax: 82-2-393-2041E-mail: hjchang@yuhs.ac • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.even large AAs seldom cause symptoms,2)3) although the incidence  of aortic disease increases with age.4)5) Therefore, it is important for  clinicians to be cautious in their evaluation of patients at risk.",Non-OADS,/arxiv_data1/oa_pdf/33/73/kcj-44-162.PMC4037638.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.162 www.e-kcj.org in elderly men who are current or past smokers,7) but the screening  strategy for TAA in elderly subjects is not well-established, even  though it is a fatal disease.8)9) The more widespread applications of  cardiac CT and thoracic CT for cardiovascular risk stratification and lung cancer screening have made it possible to measure thoracic aortic diameter using non-contrast CT, resulting in several success-ful case reports.",Non-OADS,/arxiv_data1/oa_pdf/33/73/kcj-44-162.PMC4037638.pdf
164 Aortic Aneurysm in High-Risk Population  http://dx.doi.org/10.4070/kcj.2014.44.3.162 www.e-kcj.org Maximal ascending aorta diameter (ATA MAX) was measured in the  axial plane from just above the aortic root to the aortic arch perpen - dicular to the aortic axis.,Non-OADS,/arxiv_data1/oa_pdf/33/73/kcj-44-162.PMC4037638.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.162 www.e-kcj.org nary artery disease were observed in 171 patients (34.5%), 318 pa- tients (64.1%) and 256 patients (51.6%), respectively.",OADS,/arxiv_data1/oa_pdf/33/73/kcj-44-162.PMC4037638.pdf
166 Aortic Aneurysm in High-Risk Population  http://dx.doi.org/10.4070/kcj.2014.44.3.162 www.e-kcj.org Table 2.,Non-OADS,/arxiv_data1/oa_pdf/33/73/kcj-44-162.PMC4037638.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.162 www.e-kcj.org cantly higher in current/past smokers compared to nonsmokers  (p=0.046).,Non-OADS,/arxiv_data1/oa_pdf/33/73/kcj-44-162.PMC4037638.pdf
"168 Aortic Aneurysm in High-Risk Population  http://dx.doi.org/10.4070/kcj.2014.44.3.162 www.e-kcj.org Previous studies consistently demonstrated a relationship be- tween smoking and AAA.11) The present study, which involved a high- risk population of Asian males, found that AAA was independently  associated with smoking history in addition to dyslipidemia.",Non-OADS,/arxiv_data1/oa_pdf/33/73/kcj-44-162.PMC4037638.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.162 www.e-kcj.org for Cardiovascular Angiography and Interventions, Society of Interven - tional Radiology, Society of Thoracic Surgeons, and Society for Vas- cular Medicine.",Non-OADS,/arxiv_data1/oa_pdf/33/73/kcj-44-162.PMC4037638.pdf
"The vascular surgery, including carotid end-Original Article http://dx.doi.org/10.4070/kcj.2014.44.3.170 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Clinical Utility of Coronary CT Angiography with Stress Perfusion CT in Preoperative Cardiac Risk Evaluation Sung-A Chang, MD1,4, Sung Mok Kim, MD2,4, Seung-Hyuk Choi, MD1,   Yeon Hyeon Choe, MD2,4, Young-Wook Kim, MD3, and Duk-Kyung Kim, MD1,4 1Division of Cardiology, Departments of Medicine, 2Radiology, and 3Vascular Surgery, 4Cardiovascular Imaging Center, Samsung Medical Center, Sungkyunkwan University  School of Medicine, Seoul, Korea Background and Objectives: Vascular surgery carries high operative risk.",Non-OADS,/arxiv_data1/oa_pdf/43/09/kcj-44-170.PMC4037639.pdf
"Received: August 30, 2013 Revision Received: February 11, 2014Accepted: March 18, 2014 Correspondence: Duk-Kyung Kim, MD, Division of Cardiology, Department  of Medicine, Cardiovascular Imaging Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, KoreaTel: 82-2-3410-3413, Fax: 82-2-3410-1679E-mail: dkkim@skku.edu • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.arterectomy and endovascular aneurysm repair, carries intermedi- ate surgical risk, while the aortic/major vascular surgery and peri-pheral vascular surgery carry higher risk.",Non-OADS,/arxiv_data1/oa_pdf/43/09/kcj-44-170.PMC4037639.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.170 www.e-kcj.org Subjects and Methods Study subjects The patients scheduled for the elective vascular surgery were in- cluded in this study (age >20 year old).,Non-OADS,/arxiv_data1/oa_pdf/43/09/kcj-44-170.PMC4037639.pdf
172 Preoperative Cardiac CT in Vascular Surgery http://dx.doi.org/10.4070/kcj.2014.44.3.170 www.e-kcj.org sponding stenosis were considered artifacts.,Non-OADS,/arxiv_data1/oa_pdf/43/09/kcj-44-170.PMC4037639.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.170 www.e-kcj.org of iodine contrast used was 130 ±9 mL.,OADS,/arxiv_data1/oa_pdf/43/09/kcj-44-170.PMC4037639.pdf
"174 Preoperative Cardiac CT in Vascular Surgery http://dx.doi.org/10.4070/kcj.2014.44.3.170 www.e-kcj.org Perioperative cardiac events Overall, four patients (4.4%) experienced cardiovascular events  (Table 5).",Non-OADS,/arxiv_data1/oa_pdf/43/09/kcj-44-170.PMC4037639.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.170 www.e-kcj.org cular surgery.,Non-OADS,/arxiv_data1/oa_pdf/43/09/kcj-44-170.PMC4037639.pdf
176 Preoperative Cardiac CT in Vascular Surgery http://dx.doi.org/10.4070/kcj.2014.44.3.170 www.e-kcj.org dovascular repair of abdominal aortic aneurysm.,Non-OADS,/arxiv_data1/oa_pdf/43/09/kcj-44-170.PMC4037639.pdf
"BMCs are Original Article http://dx.doi.org/10.4070/kcj.2014.44.3.177 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Angiopoietin-Like 4 Is Involved in the Poor Angiogenic Potential  of High Glucose-Insulted Bone Marrow Stem Cells Yong Sook Kim, PhD1,2, Hea Jin Kang, BS1,3, Moon Hwa Hong, BS1, Wan Seok Kang, MS1,3,   Nakwon Choe, MS4, Hyun Kook, MD4, Myung Ho Jeong, MD2,5, and Youngkeun Ahn, MD1,2,5 1Research Laboratory of Cardiovascular Regeneration, Chonnam National University Hospital, Gwangju,   2Cardiovascular Convergence Research Center, Chonnam National University Hospital, Gwangju,   3Center for Molecular Medicine, Graduate School, Chonnam National University, Gwangju,  4Department of Pharmacology and Medical Research Center for Gene Regulation, Chonnam National University Medical School, Gwangju,  5Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea Background and Objectives: Diabetes is reported to reduce the function or number of progenitor cells.",Non-OADS,/arxiv_data1/oa_pdf/6a/46/kcj-44-177.PMC4037640.pdf
"Received: January 16, 2014 Revision Received: February 21, 2014Accepted: March 13, 2014 Correspondence: Youngkeun Ahn, MD, Department of Cardiology, Cardio - vascular Center, Chonnam National University Hospital, 42 Jebong-ro, Dong-gu, Gwangju 501-757, KoreaTel: 82-62-220-4764, Fax: 82-62-224-4764E-mail: cecilyk@hanmail.net  • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.able to differentiate into vascular lineage cells and can be directly  incorporated into newly formed vessels.1) Myocardial infarction re- mains a major cause of morbidity and mortality, and cell therapy has been aroused as a promising option for cardiac repair.",Non-OADS,/arxiv_data1/oa_pdf/6a/46/kcj-44-177.PMC4037640.pdf
"178 Angptl4 in Bone Marrow Stem Cells http://dx.doi.org/10.4070/kcj.2014.44.3.177 www.e-kcj.org with dysfunction of stem cells, and the responsible factors for dia- betes-related dysfunction in stem cells need to be explored.",Non-OADS,/arxiv_data1/oa_pdf/6a/46/kcj-44-177.PMC4037640.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.177 www.e-kcj.org 3000 Imaging System, Fuji Photo Film, Tokyo, Japan).",OADS,/arxiv_data1/oa_pdf/6a/46/kcj-44-177.PMC4037640.pdf
"180 Angptl4 in Bone Marrow Stem Cells http://dx.doi.org/10.4070/kcj.2014.44.3.177 www.e-kcj.org group, p<0.01).",Non-OADS,/arxiv_data1/oa_pdf/6a/46/kcj-44-177.PMC4037640.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.177 www.e-kcj.org rebounded to basal level in part (Table 2).,OADS,/arxiv_data1/oa_pdf/6a/46/kcj-44-177.PMC4037640.pdf
"182 Angptl4 in Bone Marrow Stem Cells http://dx.doi.org/10.4070/kcj.2014.44.3.177 www.e-kcj.org fection, tube formation assay was performed.",Non-OADS,/arxiv_data1/oa_pdf/6a/46/kcj-44-177.PMC4037640.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.177 www.e-kcj.org mine the sequence of the pathway, miR-132 was quantified in Ag- nptl4-overexpressed hBMCs, and there was no significant change in miR-132 levels.",OADS,/arxiv_data1/oa_pdf/6a/46/kcj-44-177.PMC4037640.pdf
"In this report, we present a case where an initially unsuccessful antegrade SA due to failure to re-enter the distal true lumen was rescued by using a retrograde subintimal approach through the distal SFA.Case Report http://dx.doi.org/10.4070/kcj.2014.44.3.184 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Retrograde Distal Superficial Femoral Artery Approach in the Supine Position for Chronic Superficial Femoral Artery Occlusion Sanghoon Shin, MD, Seunghwan Kim, MD, Young-Guk Ko, MD,  Myeung-Ki Hong, MD, Yangsoo Jang, MD, and Donghoon Choi, MD Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea Subintimal angioplasty is an effective method for the treatment of long superficial femoral artery (SFA) occlusions.",Non-OADS,/arxiv_data1/oa_pdf/e8/fd/kcj-44-184.PMC4037641.pdf
"Received: October 11, 2012 Revision Received: December 12, 2012Accepted: January 9, 2013 Correspondence: Donghoon Choi, MD, Division of Cardiology, Severance  Cardiovascular Hospital, Yonsei University Health System, Yonsei Universi-ty College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, KoreaTel: 82-2-2228-8449, Fax: 82-2-2227-7732E-mail: cdhlyj@yuhs.ac • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case An 81-year-old male patient visited our hospital for right leg  pain at rest (Fontaine class III).",Non-OADS,/arxiv_data1/oa_pdf/e8/fd/kcj-44-184.PMC4037641.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.184 www.e-kcj.org distal to the occlusion was not possible (Fig.,Non-OADS,/arxiv_data1/oa_pdf/e8/fd/kcj-44-184.PMC4037641.pdf
"186 Feasibility of Retrograde Distal Superficial Femoral Artery Approach http://dx.doi.org/10.4070/kcj.2014.44.3.184 www.e-kcj.org Vascular, Menlo Park, CA, USA) or the Outback catheter (Perclose,  CA, USA), were developed to overcome re-entry failure and they are being widely used.",Non-OADS,/arxiv_data1/oa_pdf/e8/fd/kcj-44-184.PMC4037641.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.184 www.e-kcj.org or dissection and worsens limb ischemia, the stent cannot be in- serted, and only techniques such as long-duration ballooning can be used as alternatives.",Non-OADS,/arxiv_data1/oa_pdf/e8/fd/kcj-44-184.PMC4037641.pdf
188 Feasibility of Retrograde Distal Superficial Femoral Artery Approach http://dx.doi.org/10.4070/kcj.2014.44.3.184 www.e-kcj.org 9.,Non-OADS,/arxiv_data1/oa_pdf/e8/fd/kcj-44-184.PMC4037641.pdf
"1)2) Herein, we report a patient who was diagnosed with NTBE  with an unusual clinical presentation: mesenteric venous thrombosis.Case Report http://dx.doi.org/10.4070/kcj.2014.44.3.189 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Nonbacterial Thrombotic Endocarditis in a Patient  with Bowel Infarction due to Mesenteric Vein Thrombosis Hyue Mee Kim, MD1, Hack-Lyoung Kim, MD1, Hak Seung Lee, MD1, Ji-Hyun Jung, MD1,   Chee Hae Kim, MD1, Sooyeon Oh, MD1, Jung Ho Kim, MD2, and Joo-Hee Zo, MD1 1Departments of Internal Medicine and 2Pathology, Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea Ante mortem cases of venous thrombosis in patients with nonbacterial thrombotic endocarditis (NBTE) have not yet been reported.",Non-OADS,/arxiv_data1/oa_pdf/9f/92/kcj-44-189.PMC4037642.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case  A healthy 37-year-old man visited our emergency room with fe- ver, abdominal pain and bloody diarrhea, which had all started five  days ago.",Non-OADS,/arxiv_data1/oa_pdf/9f/92/kcj-44-189.PMC4037642.pdf
"190 Mesenteric Vein Thrombosis in NBTE http://dx.doi.org/10.4070/kcj.2014.44.3.189 www.e-kcj.org Although the abdominal pain resolved after surgical resection of  the ischemic bowel, the patient became febrile.",Non-OADS,/arxiv_data1/oa_pdf/9f/92/kcj-44-189.PMC4037642.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.189 www.e-kcj.org Due to the patient’s poor response to antibiotics and high risk of  systemic embolization, the cardiac masses were excised through an  open-heart surgery.",Non-OADS,/arxiv_data1/oa_pdf/9f/92/kcj-44-189.PMC4037642.pdf
"192 Mesenteric Vein Thrombosis in NBTE http://dx.doi.org/10.4070/kcj.2014.44.3.189 www.e-kcj.org eurysms, which are not usually valves.8) Therefore, left ventricular  thrombi are formed in an akinetic or a dyskinetic apex or in diffuse  left ventricular dysfunction.8) The few reported cases of mural th- rombi of the left ventricle with normal systolic function and without regional wall motion abnormality have been associated with hyper - coagulable states, such as myeloproliferative disorder or eosinophilic endocarditis predisposing thrombus formation.",Non-OADS,/arxiv_data1/oa_pdf/9f/92/kcj-44-189.PMC4037642.pdf
"Her physical examination showed Case Report http://dx.doi.org/10.4070/kcj.2014.44.3.193 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Aorta-Right Atrial Tunnel: An Interesting Type  of a Congenital Coronary Artery Anomaly Atila Iyisoy, MD, Turgay Celik, MD, Murat Celik, MD, and Cemal Sag, MD Department of Cardiology, School of Medicine, Gulhane Military Medical Academy, Etlik, Ankara, Turkey An 18-year-old girl with an aortico-right atrial tunnel originating from the left sinus of Valsalva, in which the left anterior descending and  circumflex coronary arteries arose independently from the different parts of the tunnel, was reported.",OADS,/arxiv_data1/oa_pdf/bf/09/kcj-44-193.PMC4037643.pdf
"Received: January 16, 2013 Revision Received: February 28, 2013Accepted: March 18, 2013 Correspondence: Murat Celik, MD, Department of Cardiology, Gulhane  School of Medicine, 06018 Etlik-Ankara, TurkeyTel: 90-312-3044261, Fax: 90-312-3044250E-mail: drcelik00@hotmail.com • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.a grade 3/6 heart murmur, best heard along the upper right sternal  border.",Non-OADS,/arxiv_data1/oa_pdf/bf/09/kcj-44-193.PMC4037643.pdf
194 Aorta-Right Atrial Tunnel http://dx.doi.org/10.4070/kcj.2014.44.3.193 www.e-kcj.org riorly and drained into the RA with a narrow opening.,Non-OADS,/arxiv_data1/oa_pdf/bf/09/kcj-44-193.PMC4037643.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.3.193 www.e-kcj.org similar to the aortic one,3) the findings of which may be pertinent  to the proposal of Gajjar et al.2)  In the reported cases, the tunnels originated mostly from the left  sinus of Valsalva,2-6) two from the right sinus of Valsalva2)7) and one  from the non-coronary sinus of Valsalva.1) In relation to the ascend - ing aorta, the tunnels arising from the left sinus of Valsalva coursed  posteriorly, whereas the tunnels originating from the right sinus of Valsalva travelled anteriorly.",Non-OADS,/arxiv_data1/oa_pdf/bf/09/kcj-44-193.PMC4037643.pdf
"3) Here, we present a rare  case of multidirectional CAFs accompanied by persistent left supe-rior vena cava (PLSVC) and right-sided aortic arch in a patient who had surgical correction of tetralogy of Fallot (TOF) as a young adult.Case Report http://dx.doi.org/10.4070/kcj.2014.44.3.196 Print ISSN 1738-5520 • On-line ISSN 1738-5555 An Adult Case of Tetralogy of Fallot Accompanied by Multiple  Anomalies Including Multidirectional Coronary Artery Fistulas Jae Joong Lee, MD, Jae Young Cho, MD, Yun Ho Lee, MD, Byung Hyun Lee, MD,  Chang Gyu Park, MD, Hong Seog Seo, MD, Dong Joo Oh, MD, and Jin Oh Na, MD Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea Multidirectional coronary artery fistulas (CAFs) are rare in patients with tetralogy of Fallot (TOF).",Non-OADS,/arxiv_data1/oa_pdf/3d/18/kcj-44-196.PMC4037644.pdf
"Received: September 8, 2013 Revision Received: October 14, 2013Accepted: October 15, 2013 Correspondence: Jin Oh Na, MD, Cardiovascular Center, Korea University  Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 152-703, KoreaTel: 82-2-2626-3025, Fax: 82-2-863-1109E-mail: jinona@medimail.co.kr • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case A 46-year-old male who had undergone cardiac surgery for TOF  24 years previous visited our hospital with symptoms of atypical  chest pain and dyspnea of New York Heart Association class I.",Non-OADS,/arxiv_data1/oa_pdf/3d/18/kcj-44-196.PMC4037644.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.196 www.e-kcj.org anches.,Non-OADS,/arxiv_data1/oa_pdf/3d/18/kcj-44-196.PMC4037644.pdf
198 Multiple Anomalies Accompanied with Tetralogy of Fallot http://dx.doi.org/10.4070/kcj.2014.44.3.196 www.e-kcj.org The clinical symptoms and signs related to CAFs are variable.,Non-OADS,/arxiv_data1/oa_pdf/3d/18/kcj-44-196.PMC4037644.pdf
http://dx.doi.org/10.4070/kcj.2014.44.3.196 www.e-kcj.org tients with CAFs currently exist.,Non-OADS,/arxiv_data1/oa_pdf/3d/18/kcj-44-196.PMC4037644.pdf
"In our retrospective study of 249 patients with CS of varying etiology, hospital mortality was high, Letter to the Editor http://dx.doi.org/10.4070/kcj.2014.44.3.200 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Statins for Patients with Cardiogenic Shock Sébastien Champion, MD Réanimation Polyvalente, Centre Hospitalier Universitaire de la Réunion, Saint Denis, France Received: October 17, 2013 / Accepted: October 28, 2013 Correspondence: Sébastien Champion, MD, Réanimation Polyvalente,  Centre Hospitalier Universitaire de la Réunion, Route de Bellepierre, Saint De-nis, 97400, FranceTel: 33-1-49958442, Fax: 33-1-49958964E-mail: champion.seb@wanadoo.fr • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.46%.4)5) Fifty patients survived the acute phase, but died in hospital.",Non-OADS,/arxiv_data1/oa_pdf/22/c4/kcj-44-200.PMC4037645.pdf
"201 Sébastien Champion http://dx.doi.org/10.4070/kcj.2014.44.3.200  www.e-kcj.orgtrends (1975 to 2005) in the magnitude of, management of, and hos - pital death rates associated with cardiogenic shock in patients with  acute myocardial infarction: a population-based perspective.",Non-OADS,/arxiv_data1/oa_pdf/22/c4/kcj-44-200.PMC4037645.pdf
"202 Statins for Patients with Cardiogenic Shock http://dx.doi.org/10.4070/kcj.2014.44.3.200  www.e-kcj.orgResponse Author’s Reply to the Letter from Sébastien Champion Doo Sun Sim, MD and Myung Ho Jeong, MD Chonnam National University Hospital, Gwangju, Korea We are delighted that our article “Effect of Early Statin Treatment  in Patients with Cardiogenic Shock Complicating Acute Myocardial  Infarction” published in Korean Circulation Journal1) has aroused in - terest and comment on the efficacy of statin therapy in patients with acute myocardial infarction and cardiogenic shock (CS).",Non-OADS,/arxiv_data1/oa_pdf/22/c4/kcj-44-200.PMC4037645.pdf
"203 Copyright © 2014 The Korean Society of CardiologyKorean Circulation Journal Erratum http://dx.doi.org/10.4070/kcj.2014.44.3.203 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Erratum to: Effect of High Dose Rosuvastatin Loading before Primary Percutaneous Coronary Intervention on Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction Ji Won Kim, MD, Kyeong Ho Yun, MD, Eun Kyoung Kim, MD, Yong Cheol Kim, MD, Dai-Yeol Joe, MD, Jum Suk Ko, MD, Sang Jae Rhee, MD, Eun Mi Lee, MD, Nam Jin Yoo, MD, Nam-Ho Kim, MD, Seok Kyu Oh, MD, and Jin-Won Jeong, MD Department of Cardiovascular Medicine, Regional Cardiocerebrovascular Center, Wonkwang University Hospital, Iksan, Korea Korean Circ J 2014;44(2):76-81 http://dx.doi.org/10.4070/kcj.2014.44.2.76 On page 76, reference no.",Non-OADS,/arxiv_data1/oa_pdf/26/d1/kcj-44-203.PMC4037646.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.145 ORIGINAL ARTICLE Correlations between Anti-Mast Cell Autoantibodies  and Chronic Idiopathic Urticaria Liwei Sun, Kang Erxun, Jie Li1, Jian Yang2, Chunyu Han Departments of Dermatology and 1Clinical Laboratory, Yantai Yuhuangding Hospital of Qingdao University Medical College,  2Blood Center in Yantai, Yantai, China Background:  The etiology of chronic idiopathic urticaria  (CIU) is not completely clear.",Non-OADS,/arxiv_data1/oa_pdf/2a/2b/ad-26-145.PMC4037664.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.150 ORIGINAL ARTICLE Effect of Emollients Containing Vegetable-Derived  Lactobacillus  in the T reatment of Atopic Dermatitis  Symptoms: Split-Body Clinical Trial Seung Bae Park, Myung Im, Young Lee,  Jeung Hoon Lee, Jeongheui Lim1, Yong-Ha Park1,  Young Joon Seo Department of Dermatology, Chungnam National University School of Medicine, Daejeon,  1Department of Applied Microbiology and Biotechnology, Yeungnam University, Gyeongsan, Korea Background: Atopic dermatitis (AD) patients suffer from  xerosis.",Non-OADS,/arxiv_data1/oa_pdf/99/1c/ad-26-150.PMC4037665.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.156 ORIGINAL ARTICLE Pilot Study of the Efficacy of 578 nm Copper Bromide  Laser Combined with Intralesional Corticosteroid Injection for T reatment of Keloids and Hypertrophic Scars In Pyeong Son, Kui Young Park, Beomjoon Kim, Myeung Nam Kim Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea Background:  Treatments including intralesional corticosteroid  injection, pressure therapy, cryotherapy, and various laser  therapies have had limited success for keloids and hyper-trophic scars.",Non-OADS,/arxiv_data1/oa_pdf/dc/fc/ad-26-156.PMC4037666.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.162 ORIGINAL ARTICLE A Clinicopathologic Study of Thirty Cases of Acquired  Perforating Dermatosis in Korea Seo Wan Kim, Mi Sun Kim, June Hyunkyung Lee, Sook-Ja Son, Kui Young Park1, Kapsok Li1,  Seong Jun Seo1, Tae Young Han Department of Dermatology, Eulji General Hospital, Eulji University,  1Department of Dermatology,  Chung-Ang University College of Medicine, Seoul, Korea Background:  Acquired perfor ating dermatosis (APD) is  histopathologically characterized by transepidermal elimi- nation of materials from th e upper dermis.",Non-OADS,/arxiv_data1/oa_pdf/ae/ff/ad-26-162.PMC4037667.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.172 ORIGINAL ARTICLE Intralesional Methotrexate for the Treatment of  Keratoacanthoma: Retrospective Study and Review of the Korean Literature  Min Gun Yoo, Il-Hwan Kim Department of Dermatology, Korea University College of Medicine, Seoul, Korea Background:  Although intralesional methotrexate (MTX) is  an effective, nonsurgical treatment of keratoacanthoma (KA),  there have not been many repor ts of on the MTX treatment  for KA in Korea.",Non-OADS,/arxiv_data1/oa_pdf/af/50/ad-26-172.PMC4037668.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.177 ORIGINAL ARTICLE Long-T erm Survival Analysis and Clinical Follow-Up in  Acral Lentiginous Malignant Melanoma Undergoing Sentinel Lymph Node Biopsy in Korean Patients Su-Young Jeon, Jin-Woo Hong, Suee Lee1, Sung Yong Oh1, Young-Seoub Hong2,  Ki-Ho Kim, Ki-Hoon Song Departments of Dermatology, 1Internal Medicine and 2Pathology, Dong-A University College of Medicine, Busan, Korea Background: In cutaneous malignant melanoma (MM) with  clinically uninvolved regional lymph nodes, sentinel lymph  node (SLN) status is the most powerful indicator of both overall survival (OS) and disease-free survival (DFS).",Non-OADS,/arxiv_data1/oa_pdf/3a/14/ad-26-177.PMC4037669.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.184 ORIGINAL ARTICLE A Prospective, Long-T erm Follow-Up Study of 1,444 nm  Nd:YAG Laser: A New Modality for Treating Axillary Bromhidrosis  Sung Kyu Jung, Hee Won Jang, Hee Joo Kim, Sa ng Geun Lee, Kyung Goo Lee, Sun Yae Kim,  Sang Min Yi, Jae Hwan Kim, Il-Hwan Kim Department of Dermatology, Korea University College of Medicine, Seoul, Korea Background: Surgery for bromhidrosis has a high risk of  complications such as hematoma and necrosis.",Non-OADS,/arxiv_data1/oa_pdf/0e/7a/ad-26-184.PMC4037670.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.189 ORIGINAL ARTICLE Clinical Characteristics of Cholinergic Urticaria in Korea  Jung Eun Kim, Young Sun Eun, Young Min Park , Hyun Jeong Park, Dong Su Yu, Hoon Kang,  Sang Hyun Cho, Chul Jong Park, Si Yong Kim, Jun Young Lee Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea Background: Cholinergic urticaria is a type of physical  urticaria characterized by he at-associated wheals.",Non-OADS,/arxiv_data1/oa_pdf/23/ec/ad-26-189.PMC4037671.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.195 ORIGINAL ARTICLE Prognostic and Clinicopathologic Associations of BRAF   Mutation in Primary Acral Lentiginous Melanoma in Korean Patients: A Preliminary Study Jin-Woo Hong, Suee Lee1, Dae-Cheol Kim2, Ki-Ho Kim, Ki-Hoon Song Departments of Dermatology, 1Internal Medicine and 2Pathology, Dong-A University College of Medicine, Busan, Korea Background:  In the majority of melanomas, the RAS/RAF/  MEK/ERK signaling pathway is constitutively activated, due  to oncogenic mutations in the BRAF  and NRAS  genes.",Non-OADS,/arxiv_data1/oa_pdf/e8/43/ad-26-195.PMC4037672.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.203 ORIGINAL ARTICLE Immunohistochemical Analysis of Interleukin-17  Producing T Helper Cells and Regulatory T Cells Infiltration in Annular Erythema Associated with Sjögren’s Syndrome Saori Itoi, Atsushi Tanemura, Mamori Tani, Shun Kitaba, Mika Terao, Hiroyuki Murota, Naoki Oiso1,  Ichiro Katayama Department of Dermatology Integrated Medicine, Graduate School of Medicine, Osaka University,  1Department of Dermatology, Kinki University Faculty of Medicine, Osaka, Japan Background:  Peculiar erythema known as annular erythema  associated with Sjögren’s syndr ome (AESS) can be differen- tiated from autoimmune annular erythema and subacute cutaneous lupus erythematosus, both clinically and histolo- gically.",Non-OADS,/arxiv_data1/oa_pdf/ae/ac/ad-26-203.PMC4037673.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.209 ORIGINAL ARTICLE Effect of Adenosine on Melanogenesis in B16 Cells and  Zebrafish Mi Yoon Kim, Hae-Eul Lee, Myung Im, Young Lee, Chang-Deok Kim,  Jeung-Hoon Lee, Young-Joon Seo Department of Dermatology, Research Institute of Medical Sciences, Chungnam National University School of Medicine, Daejeon, Ko rea Background:  Adenosine is a nucleoside, in which an adenine  molecule is attached to a ribofuranose sugar moiety.",Non-OADS,/arxiv_data1/oa_pdf/92/ff/ad-26-209.PMC4037674.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.214 ORIGINAL ARTICLE Dermoscopic Approach to a Small Round to  Oval Hairless Patch on the Scalp Woo-Haing Shim1, Seung-Wook Jwa1, Margie Song1, Hoon-Soo Kim1,  Hyun-Chang Ko1,2, Byung-Soo Kim1,2, Moon-Bum Kim1,2 1Department of Dermatology, 2Medical Research Institute, Pusan National University School of Medicine, Busan, Korea Background:  Various kinds of alopecia can show small  round or oval hairless patch.",Non-OADS,/arxiv_data1/oa_pdf/a2/d1/ad-26-214.PMC4037675.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.221 ORIGINAL ARTICLE Immunomodulatory Effects of Balneotherapy with  Hae-Un-Dae Thermal Water on Imiquimod-Induced Psoriasis-Like Murine Model Young Bok Lee, Jun Young Lee, Hye Jin Lee1, Seong Taek Yun2, Jong Tae Lee3, Hong Jig Kim4,  Dong Soo Yu, So Youn Woo1,*, Jin-Wou Kim* Department of Dermatology, School of Medicine, The Catholic University of Korea,  1Department of Microbiology, Ewha Womans University School of Medicine,  2Department of Earth and Environm ental Sciences, Korea University,  3The Korea Central Institute of Hot Springs, 4Oh&Kim’s Aesthetic Clinic, Seoul, Korea Background:  Balneotherapy, although not a well-established  dermatological treatment, is  thought to have therapeutic  properties for psoriasis and is us ed as an alternative treatment  modality throughout the world.",Non-OADS,/arxiv_data1/oa_pdf/7a/28/ad-26-221.PMC4037676.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.231 CASE REPORT A Recurrent Angiosarcoma Isolated to the Eyelid without  the Recurrence on the Primary Lesion of the Forehead Jung Eun Kim, Byung Jik Kim, Hoon Kang Department of Dermatology, School of Medicine, The Catholic University of Korea, Seoul, Korea Angiosarcoma is a highly malignant vascular tumor of endo- thelial origin.",Non-OADS,/arxiv_data1/oa_pdf/62/ef/ad-26-231.PMC4037677.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.236 CASE REPORT Soft Tissue Infection Caused by Rapid Growing  Mycobacterium following Medical Procedures: T wo Case Reports and Literature Review  Shih-Sen Lin1, Chin-Cheng Lee2, Tsrang-Neng Jang3,4  Departments of 1Internal Medicine, 2Pathology and Laboratory Medicine, 3Division of Infectious Diseases, Departme nt of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei City,  4School of Medicine, Catholic Fu-Jen University, New Taipei City, Taiwan Non-tubecrulosis mycobacteriu m infections were increa- singly reported either pulmona ry or extrapulmonary in the  past decades.",Non-OADS,/arxiv_data1/oa_pdf/1a/c3/ad-26-236.PMC4037678.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.241 CASE REPORT Photodynamic Therapy for Bowen’s Disease  of the Vulva Area Hong-Kyu Kang, Jeong-Hwan Yun, Young- Min Son, Joo-Young Roh, Jong-Rok Lee Department of Dermatology, Gachon University Gil Medical Center, Incheon, Korea Bowen’s disease is a squamous cell carcinoma in situ  and has  the potential to progress to a squamous cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/15/e8/ad-26-241.PMC4037679.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.246 CASE REPORT Acute Generalized Exanthematous Pustulosis Associated  with Tigecycline Savas Ozturk, Cemal Ustun1, Sultan Pehlivan2, Haydar Ucak3  1Department of Dermatology, Balikesir University Medical Faculty, Balikesir,  Departments of 2Infectious Diseases and Clinical Microbiology, 3Pathology, Ministry of Health Elazig Education and  Research Hospital, Elazig, 4Department of Dermatology, Dicle University Medical Faculty, Diyarbakir, Turkey Acute generalized exanthematous pustulosis (AGEP) is a  severe and rare eruption that develops mostly from factors  related to drugs.",Non-OADS,/arxiv_data1/oa_pdf/fd/d9/ad-26-246.PMC4037680.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.250 CASE REPORT Solitary Congenital Erosion in a Newborn: Report of  a Solitary Congenital Self-Healing Reticulohistiocytosis Jung Eun Kim, Byung Jik Kim, Hoon Kang Department of Dermatology, St. Paul’s Hospital, School of Medicine, The Catholic University of Korea, Seoul, Korea Congenital self-healing reticulohistiocytosis (CSHRH) is a  rare, cutaneous, self-limited form of Langerhans cell his- tiocytosis.",Non-OADS,/arxiv_data1/oa_pdf/67/75/ad-26-250.PMC4037681.pdf
"2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.254 LETTER TO THE EDITOR Received February 5, 2013, Revised March 30, 2013, Accepted for  publication April 15, 2013 Corresponding author:  Young Min Park, Department of Dermatology,  Seoul St. Mary’s Hospital, College of Medicine, The Catholic  University of Korea, 222 Banpo-daero, Banpo 4 dong, Seochogu,  Seoul 137-701, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f0/74/ad-26-254.PMC4037682.pdf
"Cold-inducible RNA-binding protein (CIRP) expression is  evident in the nuclei of epidermal keratinocytes in normal skin from back (CIRP immunohistochemical stain, ×200).http://dx.doi.org/10.5021/ad.2014.26.2.256 Expression of Cold-Inducible RNA-Binding Protein in  Normal Skin, Actinic Keratosis and Squamous Cell Carcinoma Bo Mi Park, Jae Hyuk Lee1, Seong Jin Kim Departments of Dermatology and 1Pathology, Chonnam National University Medical School, Gwangju, Korea Dear Editor: Cold-inducible RNA-binding prot eins (CIRP) are a kind of  RNA binding protein associated with diverse cellular res- ponses including cell growth , proliferation, and apop- tosis1.",Non-OADS,/arxiv_data1/oa_pdf/07/97/ad-26-256.PMC4037683.pdf
"Mol Cell Biol 2009;29:1855-1868. http://dx.doi.org/10.5021/ad.2014.26.2.258 Pemphigus Vulgaris in Pregnancy Associated  with Herpes Virus T ype 1 Infection Jiwon Gye, Chan Hee Nam, Ji Seok Kim, Jee Young Kim, Byung Cheol Park,  Myung Hwa Kim, Seung Phil Hong Department of Dermatology, Dankook University Hospital, Cheonan, Korea Dear Editor: Pemphigus vulgaris (PV) rarely  occurs during pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/07/97/ad-26-256.PMC4037683.pdf
"Mol Cell Biol 2009;29:1855-1868. http://dx.doi.org/10.5021/ad.2014.26.2.258 Pemphigus Vulgaris in Pregnancy Associated  with Herpes Virus T ype 1 Infection Jiwon Gye, Chan Hee Nam, Ji Seok Kim, Jee Young Kim, Byung Cheol Park,  Myung Hwa Kim, Seung Phil Hong Department of Dermatology, Dankook University Hospital, Cheonan, Korea Dear Editor: Pemphigus vulgaris (PV) rarely  occurs during pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/6a/7f/ad-26-258.PMC4037684.pdf
"Rev Inst Med Trop Sao Paulo 2011;53:113-117. http://dx.doi.org/10.5021/ad.2014.26.2.260 A Rare Case of Annular Pustular Psoriasis Associated  with Pemphigus Foliaceus Kenichi Kato1,2,*, Takaaki Hanafusa1,*, Ken Igawa1, Motohiro Tatsumi2,  Yuji Takahashi2, Takashi Yamanaka2, Ichiro Katayama1 1Department of Dermatology, Osaka University Graduate School of Medicine, Osaka,  2Department of Dermatology, Kansai Rosai Hospital, Hyogo, Japan Dear Editor: A 56-year-old Japanese woman suffered from multiple,  scaly erythemas on the trunk for approximately 30 years.",Non-OADS,/arxiv_data1/oa_pdf/6a/7f/ad-26-258.PMC4037684.pdf
"Rev Inst Med Trop Sao Paulo 2011;53:113-117. http://dx.doi.org/10.5021/ad.2014.26.2.260 A Rare Case of Annular Pustular Psoriasis Associated  with Pemphigus Foliaceus Kenichi Kato1,2,*, Takaaki Hanafusa1,*, Ken Igawa1, Motohiro Tatsumi2,  Yuji Takahashi2, Takashi Yamanaka2, Ichiro Katayama1 1Department of Dermatology, Osaka University Graduate School of Medicine, Osaka,  2Department of Dermatology, Kansai Rosai Hospital, Hyogo, Japan Dear Editor: A 56-year-old Japanese woman suffered from multiple,  scaly erythemas on the trunk for approximately 30 years.",Non-OADS,/arxiv_data1/oa_pdf/43/c9/ad-26-260.PMC4037685.pdf
"All toenails showed chalky white and opaque nail plates characteristic of leukonychia.http://dx.doi.org/10.5021/ad.2014.26.2.262 Idiopathic Acquired T rue Leukonychia T otalis  and Partialis Seo Wan Kim, Mi Sun Kim, Tae Young Ha n, June Hyunkyung Lee, Sook-Ja Son Department of Dermatology, Eulji General Hospital, Eulji University, Seoul, Korea  Dear Editor: A 19-year-old male patient  presented with one-month  history of progressive whitening of his toenails.",Non-OADS,/arxiv_data1/oa_pdf/0e/fc/ad-26-262.PMC4037686.pdf
"The arrow indicates  the café-au-lait macules, while the dot ted lines indicate the freckling.http://dx.doi.org/10.5021/ad.2014.26.2.264 Piebaldism with Neurofibromatosis T ype I:  A Familial Case Sang-Yeon Park, Hyun Jung Kim1, Sung Ku Ahn Department of Dermatology, Yonsei Univ ersity Wonju College of Medicine, Wonju, 1Department of Dermatology, Atopy and Asthma Center, Seoul Medical Center, Seoul, Korea Dear Editor: Piebaldism is characterized by the congenital absence of melanocytes in affected areas of the skin and hair due to a  mutation of the c-kit proto-oncogene, which affects mela- noblast differentiation and migration 1.",Non-OADS,/arxiv_data1/oa_pdf/1d/f8/ad-26-264.PMC4037687.pdf
"Tel: 82-2-870-2381, Fax: 82-2-870-3866,E-mail: sycho@snu.ac.kr This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:/ /  creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.http://dx.doi.org/10.5021/ad.2014.26.2.267 Tinea Incognito Simulating Herpes Simplex  Virus Infection Young Woon Park1,2,3, Jae Woo Choi1, Seung Hwan Paik1, Dong Young Kim1,2,3,  Seon-Pil Jin2,3, Hyun Sun Park1, Hyun-Sun Yoon1,2,3, Soyun Cho1,2,3 1Department of Dermatology, SMG-SNU Boramae Medical Center,  2Laboratory of Cutaneous Aging and Hair Research, Biomedical  Research Institute, Seoul National University Hospital,  3Institute of Human-Environment Interface Biology, Medical Research  Center, Seoul National University College of Medicine, Seoul , Korea Dear Editor: A 30-year-old-man presented with a 2-month history of a facial lesion.",Non-OADS,/arxiv_data1/oa_pdf/f2/41/ad-26-267.PMC4037688.pdf
"J Der-matol 1998;25:362-366. http://dx.doi.org/10.5021/ad.2014.26.2.269 Allergic Contact Dermatitis Caused by T opical Eye  Drops Containing Latanoprost Ji Hye Lee, Tae Hyung Kim, Soo-Chan Kim Department of Dermatology, Gangnam Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medic ine,  Seoul, Korea  Dear Editor: Prostaglandin analogues are increasingly used as the first choice of drug for an open angle glaucoma 1.",Non-OADS,/arxiv_data1/oa_pdf/f2/41/ad-26-267.PMC4037688.pdf
"J Der-matol 1998;25:362-366. http://dx.doi.org/10.5021/ad.2014.26.2.269 Allergic Contact Dermatitis Caused by T opical Eye  Drops Containing Latanoprost Ji Hye Lee, Tae Hyung Kim, Soo-Chan Kim Department of Dermatology, Gangnam Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medic ine,  Seoul, Korea  Dear Editor: Prostaglandin analogues are increasingly used as the first choice of drug for an open angle glaucoma 1.",Non-OADS,/arxiv_data1/oa_pdf/71/a0/ad-26-269.PMC4037689.pdf
"Dermatological examination  revealed most nails of the involved  fingers were lost (A), and the pro- ximal and lateral nail folds were obviously swollen, and developed a  pseudo-clubbing or ‘chicken drum- stick’ appearance (B).http://dx.doi.org/10.5021/ad.2014.26.2.271 Pseudo-Clubbing Complicated by Dermatophyte  Onychomycosis Fan Wu, Jiao Feng, Hong Sang Department of Dermatology, Jinling Hospital, Nanjin g University School of Medicine, Nanjing, China Dear Editor: The frequent presence of Candida albicans in chronic  paronychia is well known.",Non-OADS,/arxiv_data1/oa_pdf/5f/2b/ad-26-271.PMC4037690.pdf
"Br J Dermatol 1988;118:47-58. http://dx.doi.org/10.5021/ad.2014.26.2.273 Disseminated Cryptococcosis with Widespread  Necrotizing Fasciitis and Cryptococcemia Occurring in an Immunosuppressed Patient Feng Li, Hong-Ming Yang, Hong-Wei Wang Department of Burns and Plastic Surgery, the First Affiliated Hosp ital of the General Hospital of People’s Liberation Army of C hina,  Beijing, China Dear Editor: Cryptococcosis is an unusual opportunistic infection, and  is characterized by a high mortality rate, especially among  those with cryptococcaemia1.",Non-OADS,/arxiv_data1/oa_pdf/5f/2b/ad-26-271.PMC4037690.pdf
"Br J Dermatol 1988;118:47-58. http://dx.doi.org/10.5021/ad.2014.26.2.273 Disseminated Cryptococcosis with Widespread  Necrotizing Fasciitis and Cryptococcemia Occurring in an Immunosuppressed Patient Feng Li, Hong-Ming Yang, Hong-Wei Wang Department of Burns and Plastic Surgery, the First Affiliated Hosp ital of the General Hospital of People’s Liberation Army of C hina,  Beijing, China Dear Editor: Cryptococcosis is an unusual opportunistic infection, and  is characterized by a high mortality rate, especially among  those with cryptococcaemia1.",Non-OADS,/arxiv_data1/oa_pdf/6a/94/ad-26-273.PMC4037691.pdf
"Rev Iberoam Micol 2004;21:143-146. http://dx.doi.org/10.5021/ad.2014.26.2.275 Levels of Serum Soluble P-Selectin and E-Selectin  in Psoriat ıc Patients  Arzu Ataseven, Huseyin Ataseven1, Perihan Ozturk2, Mehmet Ozdemir3, Recep Kesli4,* Department of Dermatology, Konya Tr aining and Research Hospital, Konya, 1Department of Gastroenterology, Necmettin Er bakan University Faculty of Medicine, Konya, 2Department of Dermatology, Sutcu Imam University Faculty of Medicine, Kahramanmaras,  3Department of Microbiology, Necmettin Erbaka n University Faculty of Medicine, Konya,   4Department of Microbiology, Konya Traini ng and Research Hospital, Konya, Turkey Dear Editor: Psoriasis is an immune-mediated, chronic inflammatory  disease1.",Non-OADS,/arxiv_data1/oa_pdf/6a/94/ad-26-273.PMC4037691.pdf
"Rev Iberoam Micol 2004;21:143-146. http://dx.doi.org/10.5021/ad.2014.26.2.275 Levels of Serum Soluble P-Selectin and E-Selectin  in Psoriat ıc Patients  Arzu Ataseven, Huseyin Ataseven1, Perihan Ozturk2, Mehmet Ozdemir3, Recep Kesli4,* Department of Dermatology, Konya Tr aining and Research Hospital, Konya, 1Department of Gastroenterology, Necmettin Er bakan University Faculty of Medicine, Konya, 2Department of Dermatology, Sutcu Imam University Faculty of Medicine, Kahramanmaras,  3Department of Microbiology, Necmettin Erbaka n University Faculty of Medicine, Konya,   4Department of Microbiology, Konya Traini ng and Research Hospital, Konya, Turkey Dear Editor: Psoriasis is an immune-mediated, chronic inflammatory  disease1.",Non-OADS,/arxiv_data1/oa_pdf/a8/34/ad-26-275.PMC4037692.pdf
"Solitary skin-colored soft papule is noted on the anterior  part of the anus.http://dx.doi.org/10.5021/ad.2014.26.2.278 Infantile Perianal Pyramidal Protrusion  Hyo Sang Song, You Chan Kim  Department of Dermatology, Ajou University School of Medicine, Suwon, Korea Dear Editor: Infantile perianal pyramidal protrusion (IPPP) is a rare  benign cutaneous disorder, firs t reported by Kayashima et  al.",Non-OADS,/arxiv_data1/oa_pdf/d2/3f/ad-26-278.PMC4037693.pdf
"(C) Beau’s lines on the right  great toenail following HFMD (pa-tient 1).http://dx.doi.org/10.5021/ad.2014.26.2.280 A Clinical Study of Nail Changes Occurring Secondary to  Hand-Foot-Mouth Disease: Onychomadesis and Beau’s Lines  Ji Yeon Shin, Baik Kee Cho, Hyun Jeong Park Department of Dermatology, School of Medicine, The Catholic University of Korea, Seoul, Korea Dear Editor: Hand-foot-mouth disease (HFMD) is a common viral in-fection that often occurs in small epidemics during the spring or autumn 1.",Non-OADS,/arxiv_data1/oa_pdf/7f/ee/ad-26-280.PMC4037694.pdf
"Euro Surveill 2010;15: pil: 19663.  http://dx.doi.org/10.5021/ad.2014.26.2.283 Anetoderma Developing in Generalized Granuloma  Annulare in an Infant Ho Song Kang, Jun Oh Paek, Min Won Lee, Hee Joon Yu, Joung Soo Kim Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea Dear Editor: Anetoderma is a rare cutaneou s disorder characterized by  localized depressions or the outpouchings of the skin  caused by laxity and the we akening of the dermal con-nective tissue as a result of the focal loss of elastic fibers1.",Non-OADS,/arxiv_data1/oa_pdf/7f/ee/ad-26-280.PMC4037694.pdf
"Euro Surveill 2010;15: pil: 19663.  http://dx.doi.org/10.5021/ad.2014.26.2.283 Anetoderma Developing in Generalized Granuloma  Annulare in an Infant Ho Song Kang, Jun Oh Paek, Min Won Lee, Hee Joon Yu, Joung Soo Kim Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea Dear Editor: Anetoderma is a rare cutaneou s disorder characterized by  localized depressions or the outpouchings of the skin  caused by laxity and the we akening of the dermal con-nective tissue as a result of the focal loss of elastic fibers1.",Non-OADS,/arxiv_data1/oa_pdf/40/a6/ad-26-283.PMC4037695.pdf
Histopathologic features of periodic acid-Schiff-positiv e tinea cases Variable Value Variable host inflammatory response 18 (100) Parakeratosis 13 (72)Basket weave keratin layer 12 (67)Neutrophils in stratum malpighii 10 (56)Spongiotic changes 8 (44)Papillary dermal edema 6 (33)Hyphae on H&E 6 (33)Neutrophils in stratum corneum 5 (28)Eosinophils in dermis 5 (28)Compact orthokeratosis 4 (22)Sandwich sign 4 (22)Subcorneal pustules 4 (22)Folliculitis and/or folliculocentric inflammation 4 (22)Hemorrhage 4 (22)Interface and/or lichenoid changes 3 (17)Dermal fibrosis 3 (17)Psoriasiform changes 2 (11) Values are presented as number (%).http://dx.doi.org/10.5021/ad.2014.26.2.286 ‘Clues’ for the Histological Diagnosis of Tinea:  How Reliable Are They?,Non-OADS,/arxiv_data1/oa_pdf/2c/51/ad-26-286.PMC4037696.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b0/c4/srep05106.PMC4037705.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5106 | DOI: 10.1038/srep05106 10",Non-OADS,/arxiv_data1/oa_pdf/b0/c4/srep05106.PMC4037705.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5114 | DOI: 10.1038/srep05114 7",Non-OADS,/arxiv_data1/oa_pdf/fc/ec/srep05114.PMC4037706.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3f/5d/srep05102.PMC4037708.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5102 | DOI: 10.1038/srep05102 5",Non-OADS,/arxiv_data1/oa_pdf/3f/5d/srep05102.PMC4037708.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5108 | DOI: 10.1038/srep05108 6",Non-OADS,/arxiv_data1/oa_pdf/28/37/srep05108.PMC4037710.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/86/2f/srep05103.PMC4037711.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5103 | DOI: 10.1038/srep05103 10",Non-OADS,/arxiv_data1/oa_pdf/86/2f/srep05103.PMC4037711.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/95/9a/srep05105.PMC4037712.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5105 | DOI: 10.1038/srep05105 11",Non-OADS,/arxiv_data1/oa_pdf/95/9a/srep05105.PMC4037712.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/26/73/srep05104.PMC4037714.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5104 | DOI: 10.1038/srep05104 4",Non-OADS,/arxiv_data1/oa_pdf/26/73/srep05104.PMC4037714.pdf
"101, 267203; DOI http://dx.doi.org/10.1103/PhysRevLett.101.267203 (2008).",Non-OADS,/arxiv_data1/oa_pdf/a9/ac/srep05111.PMC4037716.pdf
"J Chem Phys 126, 267203; DOI http://dx.doi.org/10.1063/1.2734550 (2007).",Non-OADS,/arxiv_data1/oa_pdf/a9/ac/srep05111.PMC4037716.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a9/ac/srep05111.PMC4037716.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5111 | DOI: 10.1038/srep05111 7",Non-OADS,/arxiv_data1/oa_pdf/a9/ac/srep05111.PMC4037716.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5101 | DOI: 10.1038/srep05101 6",Non-OADS,/arxiv_data1/oa_pdf/3a/44/srep05101.PMC4037748.pdf
"199Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/8e/aps-41-199.PMC4037762.pdf
This  document reports statistics complied monthly on the papers  of each journal accessed through the digital object identifier  (DOI) proxy server (http://dx.doi.org/).,OADS,/arxiv_data1/oa_pdf/71/8e/aps-41-199.PMC4037762.pdf
"201Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/c0/aps-41-201.PMC4037763.pdf
"209Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/93/aps-41-209.PMC4037764.pdf
"213Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/6a/aps-41-213.PMC4037765.pdf
"218Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/ec/aps-41-218.PMC4037766.pdf
Available from: http://journals.lww.,Non-OADS,/arxiv_data1/oa_pdf/c7/ec/aps-41-218.PMC4037766.pdf
"225Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/e5/aps-41-225.PMC4037767.pdf
"231Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/f6/aps-41-231.PMC4037768.pdf
"241Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/d3/aps-41-241.PMC4037769.pdf
"248Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/aps-41-248.PMC4037770.pdf
KAI1 (National Center for Biotechnology  Information accession number AI231213) was increased  eightfold at 12 hours (This finding is provided in an online Data  Supplement available at http://diabetes.diabetesjournals.org/ content/52/11/2701/suppl/DC1).Normal skin 46 kd-Diabetic skin KAI 1 ß-actin Fig.,Non-OADS,/arxiv_data1/oa_pdf/ac/4e/aps-41-248.PMC4037770.pdf
"253Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/cf/aps-41-253.PMC4037771.pdf
"258Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/c1/aps-41-258.PMC4037772.pdf
"264Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/aps-41-264.PMC4037773.pdf
"271Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/6a/aps-41-271.PMC4037774.pdf
Available from: http://www.plasticsurgery.org/Documents/news-resources/statistics/2012-Plastic-Surgery-Statistics/ Cosmetic-Procedure-T rends-2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/6a/aps-41-271.PMC4037774.pdf
"277Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/48/aps-41-277.PMC4037775.pdf
"285Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/4b/aps-41-285.PMC4037776.pdf
"Received: 1 Sep 2013 • Revised: 10 Oct 2013 • Accepted: 10 Oct 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/10.5999/aps.2014.41.3.290 • Arch Plast Surg 2014;41:290-291 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.weeks of gestational age by cesarean section.",Non-OADS,/arxiv_data1/oa_pdf/3a/1f/aps-41-290.PMC4037777.pdf
"Received: 30 Jul 2013 • Revised: 2 Sep 2013 • Accepted: 2 Sep 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.3.292 • Arch Plast Surg 2014;41:292-293 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/91/aps-41-292.PMC4037778.pdf
"Received: 24 Jul 2013 • Revised: 30 Sep 2013 • Accepted: 2 Oct 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.3.294 • Arch Plast Surg 2014;41:294-296 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/0c/aps-41-294.PMC4037779.pdf
"Received: 21 Jul 2013 • Revised: 11 Sep 2013 • Accepted: 27 Sep 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.3.296 • Arch Plast Surg 2014;41:296-299 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/0c/aps-41-294.PMC4037779.pdf
"Received: 21 Jul 2013 • Revised: 11 Sep 2013 • Accepted: 27 Sep 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.3.296 • Arch Plast Surg 2014;41:296-299 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/1f/aps-41-296.PMC4037780.pdf
"Received: 28 Jan 2014 • Revised: 4 Mar 2014 • Accepted: 4 Mar 2014   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.3.299 • Arch Plast Surg 2014;41:299-301 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Ecthyma gangrenosum (EG) is an aggressive  cutaneous disease caused by local or systemic  Pseudomonas aeruginosa infection characterized by  cutaneous manifestations ranging from maculopapular  lesions and hemorrhagic bullae to necrotic tissue  ulceration with surrounding erythema [1-5].",Non-OADS,/arxiv_data1/oa_pdf/c6/1f/aps-41-296.PMC4037780.pdf
"Received: 28 Jan 2014 • Revised: 4 Mar 2014 • Accepted: 4 Mar 2014   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.3.299 • Arch Plast Surg 2014;41:299-301 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Ecthyma gangrenosum (EG) is an aggressive  cutaneous disease caused by local or systemic  Pseudomonas aeruginosa infection characterized by  cutaneous manifestations ranging from maculopapular  lesions and hemorrhagic bullae to necrotic tissue  ulceration with surrounding erythema [1-5].",Non-OADS,/arxiv_data1/oa_pdf/44/3c/aps-41-299.PMC4037781.pdf
"Received: 24 Jul 2013 • Revised: 13 Aug 2013 • Accepted: 13 Aug 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.3.302 • Arch Plast Surg 2014;41:302-304 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.lesion was a mass with an ovoid shape and was parallel  to the long axis of the bone; it had a slightly marginal  sclerotic border.",Non-OADS,/arxiv_data1/oa_pdf/47/6a/aps-41-302.PMC4037782.pdf
"After discarding reads without adaptor sequence and being shorter than 15 bp (trimming), reads were assigned to known miRNAs (Sanger miRBase release 18; http://www.mirbase.org/) and known non-coding RNAs (ensembl database Homo_sa- piens.GRCh37.67.ncrna.fa; http://www.ensembl.org).",OADS,/arxiv_data1/oa_pdf/5b/f2/bjc2014134a.PMC4037819.pdf
"A systematic search for articles up to the end of 2013 was conducted through four databases: PubMed, Embase, Chinese National Knowledge Infrastructure (CNKI, http://www.cnki.net), and VIP Journal integration platform (VJIP, http://en.cqvip.com).",OADS,/arxiv_data1/oa_pdf/78/2a/bjc2014172a.PMC4037820.pdf
"The Cochrane Collaboration, available from http://www.cochrane-handbook.org.",OADS,/arxiv_data1/oa_pdf/78/2a/bjc2014172a.PMC4037820.pdf
"APPENDIX 1 Table A1 .Electronic search strategy PubMed/Embase search CNKI/VJIP search Where treated (English database) (Chinese database) 1 Oesophageal cancer Title/abstract 2 Oesophageal squamous cell carcinomaTitle/abstract 3 Oesophageal neoplasm Title/abstract 4 Dietary pattern Title/abstract 5 Nutrients pattern Title/abstract 6 Food pattern Title/abstract 7 Eating pattern Title/abstract 8 Dietary habits Title/abstract 9 Diet Title/abstract 10 Dietary Title/abstract 11 Nutrients Title/abstract 12 1 OR 2 OR 313 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR1114 12 and 13 15 Limited to English or Chinese language 16 Limited to humans study17 Limited to factor analysis/principle component factor analysis/ cluster analysis 18 Limited 14 to (15 and 16 and 17) Databases searched, PubMed (http://www.ncbi.nlm.nih.gov/pubmed/), Embase (http:// www.embase.com), CNKI (http://www.cnki.net/), VJIP (http://en.cqvip.com/), Citation track- ing, ISI Web of Science (http://apps.isiknowledge.com), Scopus (http://www.scopus.com).BRITISH JOURNAL OF CANCER Meta-analysis of dietary patterns and ESCC 2792 www.bjcancer.com | DOI:10.1038/bjc.2014.172",Non-OADS,/arxiv_data1/oa_pdf/78/2a/bjc2014172a.PMC4037820.pdf
Available at http://ctep.cancer.gov/ protocolDevelopment/electronic_applications/docs/ctcaev3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/99/b0/bjc2014174a.PMC4037822.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Long-term survivors in HER2-positive MBC 2764 www.bjcancer.com | DOI:10.1038/bjc.2014.174,Non-OADS,/arxiv_data1/oa_pdf/99/b0/bjc2014174a.PMC4037822.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Vitamin D and breast cancer risk or mortality 2784 www.bjcancer.com | DOI:10.1038/bjc.2014.175,Non-OADS,/arxiv_data1/oa_pdf/87/5b/bjc2014175a.PMC4037823.pdf
http://www.scotlandscensus.gov.uk/documents/censusresults/release1a/rel1asb.pdf (accessed 04/07/13).,Non-OADS,/arxiv_data1/oa_pdf/7f/74/bjc2014198a.PMC4037824.pdf
National Services Scotland ISD (2013) Scottish Cervical Screening Programme Statistics 2012-13 https://isdscotland.scot.nhs.uk/Health-Topics/Cancer/Publications/2013-08-27/2013-08-27-Cervical-Screening-report.pdf?65131777525[accessed 05/02/14].,Non-OADS,/arxiv_data1/oa_pdf/7f/74/bjc2014198a.PMC4037824.pdf
Proc EuroGINhttp://www.eurogin.com/2013/ images/pdf/EUROGIN-2013-Abstracts-Part-2.pdf[accessed 05/01/14].,Non-OADS,/arxiv_data1/oa_pdf/7f/74/bjc2014198a.PMC4037824.pdf
Epidermal Growth Factor Receptor Database http://www.somatic- mutations-egfr.info/overall_mutation_frequency.html).,OADS,/arxiv_data1/oa_pdf/da/3a/bjc2014210a.PMC4037826.pdf
REFERENCES Age Group of Lung Cancer Diagnosed (2000–2007) http://www.aboutcancer.,Non-OADS,/arxiv_data1/oa_pdf/da/3a/bjc2014210a.PMC4037826.pdf
w2-tests for Hardy–Weinberg equilibrium (bi-allelic genotypes) were performed on http://www.oege.org/software/ hwe-mr-calc.shtml.,OADS,/arxiv_data1/oa_pdf/e6/54/bjc2014213a.PMC4037827.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Colorectal cancer characteristics and MMR status BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.213 2737,Non-OADS,/arxiv_data1/oa_pdf/e6/54/bjc2014213a.PMC4037827.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)c-MYC gain in Lung Adenocarcinoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.218 2699,Non-OADS,/arxiv_data1/oa_pdf/37/e9/bjc2014218a.PMC4037828.pdf
R package version 2.10.1 edn http://bioinformatics.mdanderson.org/Software/OOMPA.,Non-OADS,/arxiv_data1/oa_pdf/99/6f/bjc2014219a.PMC4037829.pdf
"(Vienna, Austria: R Foundation for Statistical Computing) http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/99/6f/bjc2014219a.PMC4037829.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Loss of FAK reduces the incidence of mammary tumours BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.219 2755,Non-OADS,/arxiv_data1/oa_pdf/99/6f/bjc2014219a.PMC4037829.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Rac1 and treatment resistance of HNSCC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.221 2687,Non-OADS,/arxiv_data1/oa_pdf/3a/cd/bjc2014221a.PMC4037830.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Elacridar and ritonavir boost oral taxanes 2676 www.bjcancer.com | DOI:10.1038/bjc.2014.222,Non-OADS,/arxiv_data1/oa_pdf/52/9c/bjc2014222a.PMC4037831.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Global hypomethylation and breast cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.223 2771,Non-OADS,/arxiv_data1/oa_pdf/2a/ad/bjc2014223a.PMC4037832.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Serum levels of HGF and EREG in mCRC patients BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.230 2727,Non-OADS,/arxiv_data1/oa_pdf/6a/dc/bjc2014230a.PMC4037834.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/fa/mdu116.PMC4037858.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/c7/mdu133.PMC4037862.pdf
Available  from: http://hbr.org/2007/09/performing-a-project-premortem/ar/1 [Last accessed on  2013 Mar 31].,Non-OADS,/arxiv_data1/oa_pdf/0b/0d/MSM-12-153.PMC4037894.pdf
Available from:  http://www.online-literature.com/shakespeare/hamlet/4/ [Last accessed on 2013 Mar 31].,Non-OADS,/arxiv_data1/oa_pdf/0b/0d/MSM-12-153.PMC4037894.pdf
Available from:  http://www.iep.utm.edu/person-i/ [Last accessed on 2010 Dec 19].,Non-OADS,/arxiv_data1/oa_pdf/b7/66/MSM-12-168.PMC4037897.pdf
Available from:  http://www.iep.utm.edu/person-i/ [Last accessed on 2010 Dec 19].,Non-OADS,/arxiv_data1/oa_pdf/0c/49/MSM-12-169.PMC4037898.pdf
"It is based on, but replaces, Template for MSM Submissions  (Singh, 2011b2) at http://www.msmonographs.org/article.asp?issn=0973-1229;year=2011;vol ume=9;issue=1;spage=320;epage=323;aulast=Singh  .",Non-OADS,/arxiv_data1/oa_pdf/99/14/MSM-12-194.PMC4037899.pdf
"msmonographs.org/contributors.asp, and detailed article on MSM  Referencing (Singh, 2012),  which appears on p184-8 of MSM 2012, and at http://www.msmonographs.org/article.",Non-OADS,/arxiv_data1/oa_pdf/99/14/MSM-12-194.PMC4037899.pdf
More  details are also available at About Us  at http://msmonographs.org/aboutus.asp Template 1.,Non-OADS,/arxiv_data1/oa_pdf/99/14/MSM-12-194.PMC4037899.pdf
Available at http://www.iep.utm.edu/brainvat  [Last  accessed on 2011 Dec 26] vi.,Non-OADS,/arxiv_data1/oa_pdf/99/14/MSM-12-194.PMC4037899.pdf
Available at: http://www.hindustantimes.com/Don-t-blame- superbug-on-Indiait-s-everywhere/Article1-585926.aspx [Last accessed on 2011  Jan 13].,Non-OADS,/arxiv_data1/oa_pdf/99/14/MSM-12-194.PMC4037899.pdf
Available at: http://www.bbc.co.uk/news/world-south- asia-10954890  .,Non-OADS,/arxiv_data1/oa_pdf/99/14/MSM-12-194.PMC4037899.pdf
"Typical Paper, Editorial, and other submissions   For a typical review article, see  http://msmonographs.org/article.asp?issn=0973-1229;year=2012;volume=10;issue=1;spa ge=20;epage=32;aulast=Englisch  And/or  http://msmonographs.org/article.asp?issn=0973-1229;year=2012;volume=10;issue=1;sp age=122;epage=133;aulast=Maturo   For a typical editorial, see   http://msmonographs.org/article.asp?issn=0973-1229;year=2012;volume=10;issue=1;sp age=4;epage=12;aulast=Andrade  Or  http://msmonographs.org/article.asp?issn=0973-1229;year=2012;volume=10;issue=1;spa ge=13;epage=19;aulast=Carpenter  For a typical Book review, see  http://msmonographs.org/article.asp?issn=0973-1229;year=2007;volume=5;issue=1;spag e=228;epage=232;aulast=McHenry  or  http://www.msmonographs.org/article.asp?issn=0973-1229;year=2010;volume=8;issue= 1;spage=146;epage=150;aulast=Andrade   For typical MSM  Poem, see  http://www.msmonographs.org/article.asp?issn=0973-1229;year=2008;volume=6;issue= 1;spage=277;epage=278;aulast=Brenner  For a typical Journalology article, see  http://msmonographs.org/article.asp?issn=0973-1229;year=2012;volume=10;issue=1;sp age=158;epage=180;aulast=Tharyan  For a typical article in the Looking Glass, see   http://www.msmonographs.org/article.asp?issn=0973-1229;year=2008;volume=6;issue",Non-OADS,/arxiv_data1/oa_pdf/99/14/MSM-12-194.PMC4037899.pdf
"MSM : www.msmonographs.org199 A. R. Singh, (2014), Template for MSM submissions 2014 =1;spage=41;epage=47;aulast=Gilman  For a typical article in Reflections, see   http://www.msmonographs.org/article.asp?issn=0973-1229;year=2008;volume=6;issue =1;spage=135;epage=145;aulast=Narlikar  For a typical article in Musings, see   http://www.msmonographs.org/article.asp?issn=0973-1229;year=2008;volume=6;issue =1;spage=131;epage=134;aulast=Arnold  For typical obituary, see   http://www.msmonographs.org/article.asp?issn=0973-1229;year=2008;volume=6;issue =1;spage=281;epage=284;aulast=Raveh26.",Non-OADS,/arxiv_data1/oa_pdf/99/14/MSM-12-194.PMC4037899.pdf
Available from: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.,OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.psychiatry.org/mental- health/lets-talk-facts-brochures [Last accessed on 2013 Dec 20].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://bombaypsych.org/faqs/faqs.html [Last accessed  on 2013 Dec 29].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.theguardian.com/commentisfree/2010/may/10/ mental-illness-developing-world [Last accessed on 2013 Dec 30].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from:  http://edition.cnn.com/2006/WORLD/europe/10/04/shortcuts.nobelprize/index.html  [Last accessed on 2013 Dec 29].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.kevinmd.com/blog/2013/11/psychiatry-handicapped- today.html [Last accessed on 2013 30 Dec].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.ips-online.org/page.php?p=58  [Last accessed on 2013 Dec 28].,OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.rcpsych.,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.time-to-change.org.uk/blog/academic-life-mental-illness  [Last accessed on 2013 Dec 20].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.mayoclinic.org/diseases- conditions/mental-illness/basics/definition/con-20033813 [Last accessed on 2013 Dec 28].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.nlm.nih.gov/ medlineplus/mentaldisorders.html [Last accessed on 2013 Dec 26].,OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.nimh.nih.gov/health/ publications/publications-in-english.shtml [Last accessed on 2013 Dec 30].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://dx.doi.org/10.1787/health_glance- 2013-26-en [Last accessed on 2013 Dec 28].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.oecd.org/about/ membersandpartners/ [Last accessed on 2013 Dec 29].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.scidev.net/global/health/opinion/mental-health-in- the-developing-world-time-for-inn.html [Last accessed on 2013 Dec 29].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.rcpsych.,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://psychiatry.stanford.edu [Last accessed  on 2013 Dec 29].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.census2011.co.in/states.php [Last accessed  on 2013 Dec 29].,OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.who.int/mental_ health/mhgap_final_english.pdf [Last accessed on 2013 Dec 30].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.who.int/mental_health/policy/legislation/ en/index.html [Last accessed on 2013 Dec 29].,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from:  http://www.who.int/features/factfiles/mental_health/mental_health_facts/en/index6.,OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.who.int/features/factfiles/ mental_health/mental_health_facts/en/index8.html [Last accessed on 2013 Dec 29].,OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.who.int/features/factfiles/mental_health/ mental_health_facts/en/index9.html [Last accessed on 2013 Dec 29].,OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
"About the Author Ajai R. Singh, MD, is a Psychiatrist and Editor, Mens Sana  Monographs (http://www.msmonographs.org ).",Non-OADS,/arxiv_data1/oa_pdf/d9/3c/MSM-12-35.PMC4037900.pdf
Available from: http://www.nimh.nih.,Non-OADS,/arxiv_data1/oa_pdf/49/88/MSM-12-92.PMC4037905.pdf
Available from: http://www.madinamerica.,Non-OADS,/arxiv_data1/oa_pdf/49/88/MSM-12-92.PMC4037905.pdf
Available from:  http://www.nimh.nih.gov/about/strategic-planning-reports/index.shtml#strategic- objective1 [Last accessed on 2013 Dec 20].,Non-OADS,/arxiv_data1/oa_pdf/49/88/MSM-12-92.PMC4037905.pdf
"MSM : www.msmonographs.org103 A. R. Singh, (2014), Search commonalities in psychiatric phenomena About the Author Ajai R. Singh, MD, is a Psychiatrist and Editor, Mens Sana Monographs  (http://www.msmonographs.org ).",Non-OADS,/arxiv_data1/oa_pdf/49/88/MSM-12-92.PMC4037905.pdf
"NDA 202,714, Onyx Pharmaceuticals, Inc., Proposed Trade Name: Kyprolis (Carfilzomib for Injection), Briefing Document, ODAC Meeting Date: 20 June 2012, Submission Date: 17 May 2012,   Available from URL: http://www.fda.gov/downloads/AdvisoryCom-mittees/CommitteesMeetingMaterials/Drugs/OncologicDrugs-AdvisoryCommittee/UCM308565.pdf.",Non-OADS,/arxiv_data1/oa_pdf/98/02/WO-18-22138.PMC4037992.pdf
Available from URL: http://www.accessdata.fda.gov/drugsatfda_docs/ la- bel/2012/202714lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/02/WO-18-22138.PMC4037992.pdf
http://www.epid.coi.waw.pl/krn/.,Non-OADS,/arxiv_data1/oa_pdf/d7/0e/WO-18-21643.PMC4037996.pdf
http://www.nfz.gov.pl/new   8.,Non-OADS,/arxiv_data1/oa_pdf/d7/0e/WO-18-21643.PMC4037996.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d6/ba/srep05058.PMC4038025.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5058 | DOI: 10.1038/srep05058 5",Non-OADS,/arxiv_data1/oa_pdf/d6/ba/srep05058.PMC4038025.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5068 | DOI: 10.1038/srep05068 7",Non-OADS,/arxiv_data1/oa_pdf/88/53/srep05068.PMC4038026.pdf
"This is an Open Access article distributed under the terms of the Creative Commons A ttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercialreproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/c1/jit839.PMC4038137.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/3.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/ce/gfu098.PMC4038250.pdf
"Individual BP responses were highly variable, with more than one-third of patients showing BP increases after the procedure[16] (Figure 1).‘Belgian Study rains on Renal Denervation Parade ’wrote an editorialist ( http://www.medlatest.com/2013/ 06/18/belgian-study-rains-renal-denervation-parade/ ).",Non-OADS,/arxiv_data1/oa_pdf/99/ce/gfu098.PMC4038250.pdf
"Notwith- standing some other, more critical assessments of the ef ﬁcacy and safety of the technique [ 17,18], the parade went on apparently undisturbed until the debacle caused by the an-nouncement that Symplicity HTN-3 [ 8] had failed to reach itsprimary ef ﬁcacy endpoint ( http://www.tctmd.com/show.aspx?",Non-OADS,/arxiv_data1/oa_pdf/99/ce/gfu098.PMC4038250.pdf
"This news had a devastating impact on the device industry, leading to de ﬁnitive or temporary stopping of large ongoing research programmes ( http://www.reuters.com/article/ 2014/01/24/us-covidien-divestment-idUSBREA0N18B20140124 ).",Non-OADS,/arxiv_data1/oa_pdf/99/ce/gfu098.PMC4038250.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/81/e5/tcrm-10-367.PMC4038347.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 367–372Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  367ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5948 3Radiation dose to the nodal regions   during prone versus supine breast irradiation Melinda Csenki Dóra Újhidy adrienn Cserháti Zsuzsanna Kahán Zoltán Varga Department of Oncotherapy,   University of szeged, szeged, hungary Correspondence: Zoltán Varga   Department of Oncotherapy,   University of szeged, 12 Korányi Fasor,   szeged 6720, hungary   Tel +36 62 545 404   Fax +36 62 545 922   email varga.zoltan@med.u-szeged.h uBackground:  Prone positioning for breast radiotherapy is preferable when the aim is a   reduction of the dose to the ipsilateral lung or the heart in certain left-sided cases.",Non-OADS,/arxiv_data1/oa_pdf/81/e5/tcrm-10-367.PMC4038347.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/81/e5/tcrm-10-367.PMC4038347.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/81/e5/tcrm-10-367.PMC4038347.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis)Lamin B2 prevents chromosome instability T Kuga et al 12 Oncogenesis (2014), 1 – 12 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/1c/be/oncsis20146a.PMC4038388.pdf
"Genomic and transcriptome proﬁling Genomic proﬁling of the tumor specimens was performed using whole- genome tiling 38K array-comparative genomic hybridization microarrays, as previously described.23,24Data preprocessing, normalization and data analysis were performed as previously described using log 2ratio thresholds set at þ0.2,Xþ0.5,/C00.2 and p/C01.0 for low-level gain, high-level gain/ampliﬁcation, heterozygous loss and homozygous deletion(henceforth referred to as gain, ampliﬁcation, loss and deletion), respectively.24Total RNA samples from 150/229 tumor specimens were isolated and proﬁled using Illumina HumanHT-12 Beadchips (Illumina Inc.)as previously described.24Enriched gene ontology terms associated with differentially regulated genes were set to Po0.05, analyzed further using the gene ontology database (http://www.geneontology.org).",OADS,/arxiv_data1/oa_pdf/7c/d0/oncsis20148a.PMC4038389.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Genetic and epigenetic changes in 8p11-p12-ampliﬁed breast tumors TZ Parris et al 8 Oncogenesis (2014), 1 – 8 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/7c/d0/oncsis20148a.PMC4038389.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis)COL1A1, IFITM1 in gliomas A Balbous et al 10 Oncogenesis (2014), 1 – 10 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/38/db/oncsis20145a.PMC4038390.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/S100P antibodies for pancreatic cancer treatment S Dakhel et al 10 Oncogenesis (2014), 1 – 10 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/5f/3d/oncsis20147a.PMC4038391.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).Activated Shh signaling promotes zebraﬁsh glioma BJ u et al 10 Oncogenesis (2014), 1 – 10 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/ac/ad/oncsis201410a.PMC4038393.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/e0/opth-8-1011.PMC4038418.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1011–1015Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1011Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6398 2Journal name: Clinical Ophthalmology Journal Designation: Case Series Y ear: 2014 Volume: 8 Running head verso: Lee and Hardten Running head recto: PTK after Descemet’s stripping endothelial keratoplasty DOI: http://dx.doi.org/10.2147/OPTH.S63982 Visual and subjective outcomes of  phototherapeutic keratectomy after Descemet’s  stripping endothelial keratoplasty Bryan s Lee1,2 David r Hardten2 1Department of Ophthalmology,   University of Washington, seattle,   Wa, 2Minnesota eye Consultants,   Minneapolis, MN, UsaBackground:  Patients with endothelial disease also often have scarring or surface corneal  disease.",Non-OADS,/arxiv_data1/oa_pdf/d6/e0/opth-8-1011.PMC4038418.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d6/e0/opth-8-1011.PMC4038418.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1015PTK after Descemet’s stripping endothelial keratoplasty in our case series did not achieve such a high visual acuity  after DSEK.,Non-OADS,/arxiv_data1/oa_pdf/d6/e0/opth-8-1011.PMC4038418.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/f4/ndt-10-897.PMC4038419.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 897–906Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  897OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6149 2Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Shaygan et al Running head recto: Neuropathic sensory symptoms DOI: http://dx.doi.org/10.2147/NDT.S61492 Neuropathic sensory symptoms: association   with pain and psychological factors Maryam shaygan1 andreas Böger2 Birgit Kröner-herwig1 1Department of clinical Psychology  and Psychotherapy, University  of göttingen, germany; 2Pain  Management clinic at the red cross  hospital, Kassel, germanyBackground:  A large number of population-based studies of chronic pain have considered  neuropathic sensory symptoms to be associated with a high level of pain intensity and negative  affectivity.",Non-OADS,/arxiv_data1/oa_pdf/99/f4/ndt-10-897.PMC4038419.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/99/f4/ndt-10-897.PMC4038419.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 906shaygan et al  11.,Non-OADS,/arxiv_data1/oa_pdf/99/f4/ndt-10-897.PMC4038419.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/e2/ndt-10-887.PMC4038420.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 887–895Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  887OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5522 0Psychometric evaluation of the sheehan   Disability scale in adult patients with attention-   deficit/hyperactivity disorder Theresa coles1 cheryl coon1 carla DeMuro1 lori Mcleod1 ari gnanasakthy2 1Patient- reported Outcomes, rTi  health solutions, research Triangle  Park, N c, 2Novartis Pharmaceuticals,   east hanover, NJ, Usa correspondence: carla DeMuro   rTi health solutions, 3040 cornwallis   Road, Post Office Box 12194, Research   Triangle Park, Nc 27709-2194, Usa   Tel +1 484 597 0159   Fax +1 919 541 7222   email demuromercon@rti.or gAbstract:  Inattention and impulsivity symptoms are common among adults with attention- deficit/hyperactivity disorder (ADHD), which can lead to difficulty concentrating, restlessness,  difficulty completing tasks, disorganization, impatience, and impulsiveness.",Non-OADS,/arxiv_data1/oa_pdf/d9/e2/ndt-10-887.PMC4038420.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d9/e2/ndt-10-887.PMC4038420.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/e2/ndt-10-887.PMC4038420.pdf
Available from: http://www.med.nyu.edu/Psych/training/adhd.,Non-OADS,/arxiv_data1/oa_pdf/d9/e2/ndt-10-887.PMC4038420.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/df/8d/ndt-10-817.PMC4038421.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 817–828Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  817OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5929 3latent class analysis on internet and smartphone  addiction in college students Jung-Yeon Mok1 sam-Wook choi1,2 Dai-Jin Kim³ Jung-seok choi4 Jaewon lee2 heejune ahn5 eun-Jeung choi6 Won-Y oung song7 1eulji addiction institute, eulji  University, seoul, south Korea;   2Department of Psychiatry, gangnam  eulji hospital, eulji University,   seoul, south Korea; 3Department of  Psychiatry, seoul st Mary’s hospital,   college of Medicine, catholic  University of Korea, seoul, south  Korea; 4Department of Psychiatry,   sMg-sNU Boramae Medical center,   seoul, south Korea; 5Department  of electrical and information  engineering, seoulT ech, seoul, south  Korea; 6Department of social Welfare,   Dongshin University, Naju, south  Korea; 7Department of counseling  and Psychotherapy, Konyang  University, Nonsan, south Korea correspondence: sam-Wook choi   gangnam eulji hospital, eulji University,  202 Dosan-daero, gangnam-gu, seoul,   135-816, south Korea   Tel +82 2 3438 1121   Fax +82 2 3438 1001   email peaceinu@hanmail.ne tPurpose:  This study aimed to classify distinct subgroups of people who use both smartphone  and the  internet based on addiction severity levels.",Non-OADS,/arxiv_data1/oa_pdf/df/8d/ndt-10-817.PMC4038421.pdf
Available from:  http://dx.doi.org/10.4135/9781412986311.n1 0.,Non-OADS,/arxiv_data1/oa_pdf/df/8d/ndt-10-817.PMC4038421.pdf
Available from: http://tech2.in.com/news/general/japan- plans-fasting-camps-for-webaddicted-children/91228 4.,Non-OADS,/arxiv_data1/oa_pdf/df/8d/ndt-10-817.PMC4038421.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/df/8d/ndt-10-817.PMC4038421.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/8d/ndt-10-817.PMC4038421.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNanotechnology, Science and Applications 2014:7 31–53Nanotechnology, Science and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  31Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSA.S3940 6Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
"Or use: http://dvpr.es/1tEDr2 zNanotechnology in agri-food production:   an overview Bhupinder Singh Sekhon institute of Pharmaceutical Sciences,   PCTe Group of institutes, Ludhiana,   india Correspondence: Bhupinder Singh  Sekhon   institute of Pharmaceutical Sciences,  PCTe Group of institutes, near Baddowal  Cantt, Ludhiana  142021, india   Tel +91 16 1288 8550  email sekhon224@yahoo.co mAbstract:  Nanotechnology is one of the most important tools in modern agriculture, and  agri-food nanotechnology is anticipated to become a driving economic force in the near future.",Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://nap.sumdu.edu.ua/index.php/nap/nap2013/paper/ view/1097/50 4.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
"Available from http://www.ifpri.org/sites/default/files/ publications /bp019.pd f. Accessed May 6, 2014.",Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
"Available from: http://www.ungs.edu.ar/globelics/wp-content/ uploads/2011/12/ID-15-Cortes-Learning-and-innovation-lessons-from- sectorial-studies.pd f. Accessed April  18, 2014.",Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://nano.gov/sites/default/files/ pub_resource/2014_nni_strategic_pla n.pdf.,OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available  from: http://www.sciencedaily.com/releases/2007/06/070619083554.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
"Available from: http://www.nseresearch.org/2007/ overviews/Day3_Scott.pd f. Accessed April  19, 2014.",OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: ftp://ftp.cordis.europa.eu/pub/nanotechnology/docs/ nanotechnology_in_agriculture_and_food .pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
"Available from:  http://www.iranreview.org/content/Documents/Iranians_Researchers_  Produce_Nano_Organic_Fertilizer.ht m. Accessed April  11, 2014.",Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from:  http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZNYK200608011.,OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.azonano.com/article.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
"Available from: http://www.etcgroup.org/ sites/www.etcgroup.org/files/report/etcannual-report0607_sm.pd f.  Accessed April  19, 2014.",Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
"Available from: http://www.isb.vt.edu/articles/jun0605.ht m.  Accessed April  19, 2014.",Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://nano.gov/sites/default/files/pub_resource/ nsi_nanosensors_resources_for_web.pdf.,OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.soci.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.soci.org/ Chemistry-and-Industry/CnI-Data/2011/6/Soil-free-farming.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.wipro.com/blog/Green- nanotechnology - Making-way-for-a-sustainable-future.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.ifoam.org/pt/ifoam-position-paper-use- nanotechnologies-and-nanomaterials-organic-agriculture.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
"Available  from: http://www.non-gmoreport.com/articles/oct09/us_organic_  standards_ban_nanotechnology.php#sthash.y2BGmFJB.dpu f.  Accessed April  19, 2014.",OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
"Available from: http://www.nanowerk.com/news/ newsid=25380.php#ixzz2t6GMqdk j. Accessed April  19, 2014.",Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
"Available from: http://www.nanowerk.com/ nanotechnology -in-food.php#ixzz2rx2SfZw v. Accessed April  19, 2014.",Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.hkc22.com/nanofood2040.html.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.nanowerk.com/products/product.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.nanowerk.com/products/product.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.nanowerk.com/products/product.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
"Available from: http://www.oilfresh.com/pdf/ OilFresh_WingZone%2020080513%20Final.pd f. Accessed April  19,  2014.",Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.miami.edu/index.php/ news/releases/tiny_gold_particles_help_researchers_find_protein_  impostor_ /.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.popularmechan - ics.com/science/research/4270075.html.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://referat.znate.ru/text/ index-42879.html?page =44.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.highbeam.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.allaboutfeed.net/Nutrition/Feed-  Additives/2013/3/Nano-technology-in-animal-feed-1194836W /.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.nanowerk.com/nanotechnology/reports/ reportpdf/report10.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available  from: http://www.scidev.net/global/news/nanotech-filter-may-protect- farmed-fish-from-fungus.html.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
"Nanotechnology, Science and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nanotechnology-science-and-applications-journa lNanotechnology, Science and Applications is an international, peer- reviewed, open access journal that focuses on the science of nanotech - nology in a wide range of industrial and academic applications.",Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.etcgroup.org/content/down- farm-impact-nano-scale-technologies-food-and-agriculture.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.iatp.org/files/2013_04_23_Nanotech_ SS.pdf.,OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.europarl.europa.eu/meetdocs/2009_2014/ documents/envi/dv/envi20140212_dea_nano_/envi20140212_dea_ nano_en.pdf.,OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
Available from: http://www.europarl.europa.eu/ meetdocs/2009_2014/documents/envi/re/1015/1015222/1015222en.,Non-OADS,/arxiv_data1/oa_pdf/00/a8/nsa-7-031.PMC4038422.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/ea/ndt-10-907.PMC4038423.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 907–914Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  907OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6345 9Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Fornaro et al Running head recto: Agomelatine ERG DOI: http://dx.doi.org/10.2147/NDT.S63459 Michele Fornaro1 Fabio Bandini2 luca cestari3 christian cordano4 carla Ogliastro4 claudio albano4 Domenico De Berardis5 Matteo Martino6 andrea escelsior6 giulio rocchi6 Pantaleo Fornaro6 concetta De Pasquale1 1Department of educative science,   University of catania, catania, italy;   2Department of Neurology, san Paolo  hospital, savona, italy; 3Department  of Ophthalmology, University of  Pisa, Pisa, italy; 4Department of  Neurosciences, Ophthalmology   and genetics – section of Neurology,   University of genoa, genoa, italy;  5National health service, Department  of Mental health, Psychiatric service  of Diagnosis and Treatment, hospital  g. Mazzini, asl 4, T eramo, italy;   6Department of Neurosciences,   Ophthalmology and genetics –  section of Psychiatry, University   of genoa, genoa, italy correspondence: Michele Fornaro Department of educative science,  University of catania, Via T eatro greco, 84, ZiP 95125,   catania, italy T el +39 347 414 0003 Fax +39 010 353 7669 email dott.fornaro@gmail.co mElectroretinographic modifications induced by  agomelatine: a novel avenue to the understanding  of the claimed antidepressant effect of the drug?",Non-OADS,/arxiv_data1/oa_pdf/c3/ea/ndt-10-907.PMC4038423.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c3/ea/ndt-10-907.PMC4038423.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 914Fornaro et al  65.,Non-OADS,/arxiv_data1/oa_pdf/c3/ea/ndt-10-907.PMC4038423.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/81/5a/opth-8-989.PMC4038424.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 989–992Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  989Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/ 10.2147/OPTH.S6408 2Journal name: Clinical Ophthalmology Journal Designation: Case report Y ear: 2014 Volume: 8 Running head verso: Oladiwura et al Running head recto: Macular OCT findings following blunt ocular trauma DOI: http://dx.doi.org/10.2147/OPTH.S64082 Macular optical coherence tomography   findings following blunt ocular trauma Correspondence: elliott Yann ah-kee University of Glasgow School   of Medicine, University Avenue,   Glasgow, G12 8QQ, UK email elliottahkee@gmail.co mDilys Oladiwura1 Lik thai Lim1 elliott Yann ah-kee2 James angus scott3 1T ennent Institute of Ophthalmology,   Gartnavel General Hospital (NHS  Greater Glasgow and Clyde Trust),   Glasgow, UK; 2University of Glasgow,   Glasgow, UK; 3Falkirk Community  Hospital (Forth Valley NHS Trust),   Falkirk, UKAbstract:  This case report describes the optical coherence tomography (OCT) results of Ber - lin’s edema in a male subject following blunt ocular trauma from a soccer ball.",Non-OADS,/arxiv_data1/oa_pdf/81/5a/opth-8-989.PMC4038424.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/81/5a/opth-8-989.PMC4038424.pdf
"Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 992Oladiwura et al inner segment foveal disruption, and intra-retinal edema  in the outer nuclear layer.",Non-OADS,/arxiv_data1/oa_pdf/81/5a/opth-8-989.PMC4038424.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8f/7a/opth-8-981.PMC4038425.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 981–988Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  981Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6187 1Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Gungel et al Running head recto: Effects of ranibizumab on fluorescein angiography findings and VA in AMD DOI: http://dx.doi.org/10.2147/OPTH.S61871 The effects of ranibizumab injections on  fluorescein angiographic findings and visual acuity  recovery in age-related macular degeneration Correspondence: hulya gungel istanbul education and research  hospital, eye Clinic, Kasap ˙ilyas Mh Org  Abdurrahman Nafiz Gürman Cd PK:  34098, Fatih, istanbul, T urkey T el +90 532 548 20 88 Fax +90 212 632 00 60 email hulyagungel@msn.comhulya gungel1 Ozen ayranci  Osmanbasoglu1 Cigdem altan2 Deniz Oygar Baylancicek3 Isil Basgil Pasaoglu2 1istanbul education and research  hospital, eye Clinic, 2Beyoglu eye  education and research hospital,   3Kudret eye hospital, istanbul, T urkeyAim:  The objective of the study reported here was to evaluate the effect of ranibizumab on  retinal circulation times and vessel caliber and to analyze the correlation of these factors with  visual acuity (VA) prognosis in patients with age-related macular degeneration (AMD).",Non-OADS,/arxiv_data1/oa_pdf/8f/7a/opth-8-981.PMC4038425.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/8f/7a/opth-8-981.PMC4038425.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 988gungel et al  5.,Non-OADS,/arxiv_data1/oa_pdf/8f/7a/opth-8-981.PMC4038425.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/02/opth-8-999.PMC4038426.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 999–1002Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  999Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6226 7Journal name: Clinical Ophthalmology Journal Designation: Case Series Y ear: 2014 Volume: 8 Running head verso: Dirani et al Running head recto: Resolution of SFD in DSM after treatment by spironolactone DOI: http://dx.doi.org/10.2147/OPTH.S62267 resolution of foveal detachment in dome-shaped  macula after treatment by spironolactone: report   of two cases and mini-review of the literature ali Dirani1 alexandre Matet1 Talal Beydoun2 irmela Mantel1 Francine Behar-Cohen1–3 1Department of Ophthalmology,   University of Lausanne, Jules Gonin  eye Hospital, Lausanne, switzerland;  2Department of Ophthalmology,   Hôtel-Dieu de Paris Hospital,   assistance Publique – Hôpitaux de  Paris, Paris, France; 3inserm UM rs872,   Physiopathology of Ocular Diseases:   Therapeutic innovations, Centre  de recherche des Cordeliers, Paris,   FranceAbstract:  Dome-shaped macula (DSM) was recently described in myopic patients as a convex  protrusion of the macula within a posterior pole staphyloma.",Non-OADS,/arxiv_data1/oa_pdf/52/02/opth-8-999.PMC4038426.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/52/02/opth-8-999.PMC4038426.pdf
"Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1002Dirani et al chorioretinopathy.10,11 In the rat choroid, a potassium  channel  (SK3) that belongs to the endothelial-derived relaxing factors,  has been identified as a mineralocorticoid target involved in  choroidal vasodilation.10 However, other mineralocorticoid  molecular targets may contribute to the effect of spironolac - tone, particularly in the retinal pigment epithelial cells, which  express the MR.12 We therefore hypothesized that in addition  to compressive and obstructive forces,  previously proposed  as primum movens for the development of SFD, other  mechanisms involving the mineralocorticoid pathway could  be involved.",Non-OADS,/arxiv_data1/oa_pdf/52/02/opth-8-999.PMC4038426.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/a2/ijn-9-2479.PMC4038451.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2479–2488International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2479OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S5966 1Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Namvar et al Running head recto: Fe3O4 MNPs synthesized via seaweed aqueous extract DOI: http://dx.doi.org/10.2147/IJN.S59661 cytotoxic effect of magnetic iron oxide  nanoparticles synthesized via seaweed   aqueous extract Farideh Namvar1,2 heshu sulaiman rahman3,4 rosfarizan Mohamad1,5 Javad Baharara2 Mahnaz Mahdavi6 elaheh amini7 Max stanley chartrand8 swee Keong Yeap3 1Institute of Tropical Forestry and  Forest Products, Universiti Putra  Malaysia, selangor, Malaysia; 2research  center for animal Development  applied Biology, Mashhad Branch,   Islamic azad University, Mashhad, Iran;   3Institute of Bioscience, 4Department  of Microbiology and Pathology,    Faculty of Veterinary Medicine,   5Department of Bioprocess  Technology, Faculty of Biotechnology  and Biomolecular sciences, Universiti  Putra Malaysia, selangor, Malaysia;   6Department of chemistry, Faculty  of science, Islamic azad University,   shiraz Branch, shiraz, 7Kharazmi  University, T ehran, Iran; 8Digicare  Behavioral research, casa grande,   aZ, Usa correspondence: Farideh Namvar   Institute of Tropical Forestry and Forest  Products, Universiti Putra Malaysia,   43400 UPM serdang, selangor, Darul  ehsan, Malaysia   email farideh.namvar@putra.upm.edu.m y    heshu sulaiman rahman   Department of Microbiology and  Pathology, Faculty of Veterinary Medicine,  Universiti Putra Malaysia, 43400 UPM  serdang, selangor, Malaysia   T el +60 3 8946 3455   Fax +60 3 8946 1071   email heshusr77@gmail.comAbstract:  Magnetic iron oxide nanoparticles (Fe3O4 MNPs) are among the most useful metal  nanoparticles for multiple applications across a broad spectrum in the biomedical field, includ - ing the diagnosis and treatment of cancer.",Non-OADS,/arxiv_data1/oa_pdf/d9/a2/ijn-9-2479.PMC4038451.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d9/a2/ijn-9-2479.PMC4038451.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 2488Namvar et al  31.,Non-OADS,/arxiv_data1/oa_pdf/d9/a2/ijn-9-2479.PMC4038451.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 209–215Journal of Multidisciplinary Healthcare Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
"Or use: http://dvpr.es/1kVdxD 5Dove press submit your manuscript | www.dovepress.co m Dove press  209Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S5907 1Nutrition in medical education: reflections from  an initiative at the University of cambridge lauren Ball1 Jennifer crowley2 celia laur3 Minha rajput-ray3 stephen gillam4 sumantra ray3 1nutrition and Dietetics, school of allied  Health sciences, centre for Health  Practice innovation, griffith University,   Queensland, Brisbane, australia;  2Faculty  of Medical and Health sciences, University  of auckland, auckland, new Zealand;   3need for nutrition education/ innovation  Programme, Medical research council  Human n utrition research, cambridge,   UK; 4Department of Public Health and  Primary care, institute of Public Health,   University of cambridge, cambridge, UK correspondence: sumantra ray   need for nutrition education/innovation  Programme, c/o Mrc Human nutrition  research, elsie Widdowson laboratory,   120 Fulbourn road, cambridge   cB1 9nl, UK   Tel +44 1223 426 356  Fax +44 1223 437 515  email sumantra.ray@mrc-hnr.cam.ac.u kAbstract:  Landmark reports have confirmed that it is within the core responsibilities of doctors  to address nutrition in patient care.",Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
Available  from: http://www.healthypeople.gov/2020/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
Available from: http://www.gmc-uk.org/TomorrowsDoc - tors_2009.pdf_3926097 1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
"Available from: http://www.thenacc.co.uk/assets/ downloads/139/10%20key%20Characteritstics%20of%20Good%20 Nutritional%20Care%20poster.pd f. Accessed April 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
Available from: http://www.gpo.gov/fdsys/pkg/ STATUTE-104/pdf/STATUTE-104-Pg1034.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
Available from: http://www.nnedpro.org.uk/wordpress/wp-content/ uploads/2013/08/PlanningNutritionEducationInterventions.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
"Available from:  http://www.medschl.cam.ac.u k. Accessed December 1, 2013.",Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
Available from: http://www.aomrc.org.,Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
Available from:  http://www.gmc-uk.org/Undergraduate_interprofessional_ education.,Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
Available  from: http://www.nhlbi.nih.gov/meetings/workshops/  nutrition.htm.,Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
Available  from: http://bipartisanpolicy.org/sites/default/files/5023_BPC_Nutri - tionReport_FNL_Web_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/b7/jmdh-7-209.PMC4038452.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c1/15/ijnrd-7-191.PMC4038453.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2014:7 191–201International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  191ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S6515 8Reduction of costs for anemia-management drugs  associated with the use of ferric citrate anila Thomas1 leif e Peterson2 1clinical Pharmacy services, houston   Methodist hospital, houston, TX,    Usa;  2center for Biostatistics,    houston Methodist Research   Institute, houston, TX, Usa correspondence: leif e Peterson   center for Biostatistics, houston  Methodist Research Institute,   6565 Fannin street, suite MgJ6-031,   houston, TX  77030, Usa   email lepeterson@houstonmethodist.or gBackground:  Ferric citrate is a novel phosphate binder which has the potential to reduce  usage of erythropoietin-stimulating agents (ESAs) and intravenous (IV) iron used for anemia  management during hemodialysis (HD) among patients with end-stage renal disease (ESRD).",Non-OADS,/arxiv_data1/oa_pdf/c1/15/ijnrd-7-191.PMC4038453.pdf
"At  present, however, FDA approval of ferric citrate is pend - ing (target date June  7, 2014, http://www.keryx.co m), and  therefore, there are no Phase IV post-marketing data to  confirm cost-savings of ESAs and IV iron during ESRD  anemia management as a result of using ferric citrate.",Non-OADS,/arxiv_data1/oa_pdf/c1/15/ijnrd-7-191.PMC4038453.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/c1/15/ijnrd-7-191.PMC4038453.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/15/ijnrd-7-191.PMC4038453.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/ef/ijn-9-2459.PMC4038454.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2459–2467International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2459OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5947 1Optimal energy for cell radiosensitivity  enhancement by gold nanoparticles using  synchrotron-based monoenergetic photon beams Wan Nordiana rahman1,2 stéphanie corde3,4 Naoto Yagi5 siti aishah abdul aziz1 Nathan annabell2 Moshi geso2 1school of health sciences, Universiti  sains Malaysia, Kelantan, Malaysia;   2Division of Medical radiation, school  of Medical sciences, royal Melbourne  Institute of T echnology, Bundoora, VIc ,  3radiation Oncology, Prince of Wales  hospital, high street, randwick,   4centre for Medical radiation Physics,   University of Wollongong, Wollongong,   NsW, australia;  5Japanese synchrotron  radiation research Institute, sayo-gun,   hyogo, Japan correspondence: Wan Nordiana rahman   school of health sciences, Universiti  sains Malaysia, health campus,  16150  Kota Bharu, Kelantan, Malaysia   Tel +60 9767 7811  Fax +60 9767 7515  email wandiana@usm.m y    Moshi geso   Division of Medical radiation, school  of Medical sciences, rMIT University,  Bundoora, VIc, australia   Tel +61 3 9925 7991  email moshi.geso@rmit.ed u.auAbstract:  Gold nanoparticles have been shown to enhance radiation doses delivered to  biological targets due to the high absorption coefficient of gold atoms, stemming from their  high atomic number (Z) and physical density.",Non-OADS,/arxiv_data1/oa_pdf/bb/ef/ijn-9-2459.PMC4038454.pdf
Available  from: http://physics.nist.gov/PhysRefData/Xcom/Text/XCOM.html .,OADS,/arxiv_data1/oa_pdf/bb/ef/ijn-9-2459.PMC4038454.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/bb/ef/ijn-9-2459.PMC4038454.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/ef/ijn-9-2459.PMC4038454.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/81/jpr-7-269.PMC4038455.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 269–276Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  269ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S6119 3cingulate metabolites during pain   and morphine treatment as assessed   by magnetic resonance spectroscopy Tine Maria hansen1 anne estrup Olesen2 carsten Wiberg simonsen1 asbjørn Mohr Drewes2,3 Jens Brøndum Frøkjær1 1Mech- sense, Department of  Radiology,  2Mech-sense, Department  of gastroenterology,  3center  for sensory-Motor interaction,   Department of health science and  T echnology, aalborg University,   aalborg, Denmark correspondence: Jens Brøndum Frøkjær   Mech-sense, Department of Radiology,   aalborg University hospital, hobrovej   18-22, 9000 aalborg, Denmark   Tel +45 9932 6825  Fax +45 9932 6507  email jf@mech-sense.co mBackground:  Experimental investigation of cerebral mechanisms underlying pain and  analgesia  are important in the development of methods for diagnosis and treatment of pain.",Non-OADS,/arxiv_data1/oa_pdf/47/81/jpr-7-269.PMC4038455.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/47/81/jpr-7-269.PMC4038455.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/81/jpr-7-269.PMC4038455.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/88/ea/1699.PMC4038497.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/45/60/1704.PMC4038498.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/bc/f8/1715.PMC4038499.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c2/78/1730.PMC4038500.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9e/eb/1744.PMC4038501.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/2e/77/1755.PMC4038502.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/28/2b/1769.PMC4038503.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6d/29/1782.PMC4038504.pdf
aMany more in COSMIC database (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/).,Non-OADS,/arxiv_data1/oa_pdf/6d/29/1782.PMC4038504.pdf
These were purchased by UT  Southwestern as a library (TRC-Hs1.0 [Human]) from Open Biosys - tems (sequences are available online at the Open Biosystems  website http://dharmacon.gelifesciences.com/rnai-and-custom-rna   -synthesis/shrna/gipz-lentiviral-shrna/libraries /).,OADS,/arxiv_data1/oa_pdf/6d/29/1782.PMC4038504.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org   /licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/68/a7/1793.PMC4038505.pdf
"Sixty-two percent of ANO1- interacting proteins are represented in the Ciliary Proteome Data - base (http://v3.ciliaproteome.org/cgi-bin/index.php; Albertson,  2006), and the highest-ranking ANO1-interacting proteins have  experimentally verified functions of organization of the cytoskele - ton, membrane–cytoskeletal interactions, and membrane traffick - ing.",OADS,/arxiv_data1/oa_pdf/68/a7/1793.PMC4038505.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/99/56/1808.PMC4038506.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/be/ijgm-7-253.PMC4038523.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 253–257International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  253Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJGM.S6374 4Community-acquired pneumonia caused by  carbapenem-resistant Streptococcus pneumoniae :  re-examining its prevention and treatment asako Doi1,2 Kentaro Iwata3 Hiroshi takegawa4 Kanji Miki5 Yumi sono1,2 Hiroaki Nishioka2 Jumpei takeshita6 Keisuke tomii7 tsunekazu Haruta1 1Department of Infectious Diseases,   2Department of General Internal  Medicine, Kobe City Medical Center  General Hospital,  3Division of  Infectious Diseases, Kobe University  Hospital, Japan;  4Department of  Laboratory Medicine, Kobe City  Medical Center General Hospital,   Japan;  5Hyogo Health service  association, Hyogo,  6Foundation of  Biochemical Research and Innovation,   osaka,  7Department of p ulmonary  Medicine, Kobe City Medical Center  General Hospital, Hyogo, Japan Correspondence: asako Doi   Department of Infectious Diseases,   Kobe City Medical Center General   Hospital, Kobe City, Hyogo, Japan   tel +817 8302 4321  Fax +817 8302 7537  email asakodoi@gmail.co mAbstract:  A 73-year-old man with no significant past medical history or any history of health  care visits was hospitalized for pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/62/be/ijgm-7-253.PMC4038523.pdf
"Available from: http://www.nih-janis.jp/report/open_ report/2013/2/1/ken_Open_Report_201303.pd f. Accessed April  21,  2014.",OADS,/arxiv_data1/oa_pdf/62/be/ijgm-7-253.PMC4038523.pdf
"Available  from: http://news.idsociety.org/idsa/issues/2008-04-01/11.htm l.  Accessed April  21, 2014.",OADS,/arxiv_data1/oa_pdf/62/be/ijgm-7-253.PMC4038523.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/62/be/ijgm-7-253.PMC4038523.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/be/ijgm-7-253.PMC4038523.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/a0/ceg-7-163.PMC4038524.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2014:7 163–172Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  163REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S4526 1is there a role for vedolizumab in the treatment  of ulcerative colitis and Crohn’s disease?,Non-OADS,/arxiv_data1/oa_pdf/04/a0/ceg-7-163.PMC4038524.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/04/a0/ceg-7-163.PMC4038524.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/a0/ceg-7-163.PMC4038524.pdf
Available from http://publications.nice.org.uk/ulcerative-colitis-cg166.,Non-OADS,/arxiv_data1/oa_pdf/04/a0/ceg-7-163.PMC4038524.pdf
Available from: http://clinicaltrials.gov/show/NCT0079093 3.,Non-OADS,/arxiv_data1/oa_pdf/04/a0/ceg-7-163.PMC4038524.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/b2/ccid-7-145.PMC4038525.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2014:7 145–163Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  145RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S3533 4Current evidence and applications   of photodynamic therapy in dermatology Marilyn T wan1 Jennifer Y Lin2 1Melanoma Program, Dana-Farber  Cancer Institute, 2Department of  Dermatology, Brigham and women’s  Hospital, Harvard Medical School,   Boston, MA, USA Correspondence: Jennifer Y Lin   Department of Dermatology, Brigham   and women’s Hospital, Harvard Medical   School, Boston, MA 02115, USA   Tel +1 617 264 5943   email jylin@partners.or gAbstract:  In photodynamic therapy (PDT) a photosensitizer –  a molecule that is activated by  light – is administered and exposed to a light source.",Non-OADS,/arxiv_data1/oa_pdf/d1/b2/ccid-7-145.PMC4038525.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/d1/b2/ccid-7-145.PMC4038525.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/b2/ccid-7-145.PMC4038525.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/75/2a/dddt-8-571.PMC4038526.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 571–581Drug Design, Development and Therapy Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/75/2a/dddt-8-571.PMC4038526.pdf
"Or use: http://dvpr.es/QTrQx wDove press submit your manuscript | www.dovepress.co m Dove press  571Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6309 6Pharmacoinformatics elucidation of potential   drug targets against migraine to target   ion channel protein KcnK18 sheikh arslan sehgal Mubashir hassan sajid rashid national center for Bioinformatics,   Quaid-i-azam University, islamabad,   Pakistan correspondence: sajid rashid   national center for Bioinformatics,  Quaid-i-azam University,   P.O.",Non-OADS,/arxiv_data1/oa_pdf/75/2a/dddt-8-571.PMC4038526.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/75/2a/dddt-8-571.PMC4038526.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/2a/dddt-8-571.PMC4038526.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/0b/ijgm-7-237.PMC4038527.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 237–251International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  237RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S6254 9Inotropes do not increase mortality in advanced  heart failure Maya Guglin Marc Kaufman University of South Florida,    Tampa, FL, USA Correspondence: Maya Guglin   University of South Florida,   2 Tampa General Circle, Tampa,  FL 33606, FL, USA   Tel +1 248 346 350   email mguglin@gmail.co mAbstract:  Inotrope use is one of the most controversial topics in the management of heart failure.",Non-OADS,/arxiv_data1/oa_pdf/d0/0b/ijgm-7-237.PMC4038527.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/d0/0b/ijgm-7-237.PMC4038527.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/0b/ijgm-7-237.PMC4038527.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e9/fb/ijn-9-2469.PMC4038528.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2469–2478International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2469OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5975 3silver nanoparticles promote osteogenic  differentiation of human urine-derived   stem cells at noncytotoxic concentrations hui Qin1,* chen Zhu2,* Zhiquan an1 Yao Jiang1 Yaochao Zhao1 Jiaxin Wang1 Xin liu1 Bing hui1 Xianlong Zhang1 Yang Wang1 1Department of Orthopedics,   sixth People’s hospital, shanghai  Jiao Tong University school of  Medicine, shanghai, 2Department  of Orthopaedic surgery, Provincial  hospital affiliated to anhui Medical  University, heFei, People’s republic  of china *These authors contributed equally to  this work correspondence: Xianlong Zhang   sixth People’s hospital, shanghai Jiao  Tong University school of Medicine,   600 Yi-shan road, shanghai 200233,  People’s republic of china   Tel +86 21 6436 9181   Fax +86 21 6470 1361   email zhangxianl197826@163.co m    Yang Wang   sixth People’s hospital, shanghai Jiao  Tong University school of Medicine,   600 Yi-shan road, shanghai 200233,  People’s republic of china   Tel +86 21 6436 9183   Fax +86 21 6470 1363   email wangyang197826@163.co mAbstract:  In tissue engineering, urine-derived stem cells are ideal seed cells and silver  nanoparticles (AgNPs) are perfect antimicrobial agents.",Non-OADS,/arxiv_data1/oa_pdf/e9/fb/ijn-9-2469.PMC4038528.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e9/fb/ijn-9-2469.PMC4038528.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/fb/ijn-9-2469.PMC4038528.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/96/idr-7-137.PMC4038529.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2014:7 137–143Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  137RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S5538 0Corticosteroids in the treatment of dengue   shock syndrome Senaka Rajapakse1 Chaturaka Rodrigo1 Sachith Maduranga1 Anoja Chamarie Rajapakse2 1Department of Clinical Medicine,   Faculty of Medicine, University of  Colombo, Colombo, Sri Lanka; 2Kings  Mill Hospital, Sherwood Forest NHS  Foundation Trust, Sutton-in-Ashfield,   Nottinghamshire, UK Correspondence: Senaka Rajapakse   Tropical Medicine Research Unit,   Department of Clinical Medicine,   Faculty of Medicine, University of  Colombo, 25 Kynsey Road,   Colombo 08, Sri Lanka   Tel +94 11 269 5300   Fax +94 11 268 9188   email senaka.ucfm@gmail.co m;   senaka@tropmed.cmb.ac.l kAbstract:  Dengue infection causes significant morbidity and mortality in over 100 countries  worldwide, and its incidence is on the rise.",Non-OADS,/arxiv_data1/oa_pdf/8e/96/idr-7-137.PMC4038529.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/8e/96/idr-7-137.PMC4038529.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/96/idr-7-137.PMC4038529.pdf
17(2):38–44.Special Issue on Fitness to Drive DOI:http://dx.doi.org/10.5770/cgj.17.136EDITORIAL © 2014 Author(s).,Non-OADS,/arxiv_data1/oa_pdf/c4/be/cgj-17-37.PMC4038533.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/be/cgj-17-37.PMC4038533.pdf
"Geriatric Rehabilitation Patients’ Perceptions   of Unit Dining Locations Françoise Baptiste, MSc, Mary Egan, PhD, Claire-Jehanne Dubouloz-Wilner, PhD  School of Rehabilitation Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, ON DOI:http://dx.doi.org/10.5770/cgj.17.54ORIGINAL RESEARCH © 2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/6c/42/cgj-17-38.PMC4038534.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/42/cgj-17-38.PMC4038534.pdf
"(8) Other predictors can include specific medical con - ditions such as frailty,(9) cognitive decline,(10) hospitalization  for acute medical events such as falls(11) or fractures,(12) or Increased Health Service Utilization Costs  in the Year Prior to Institutionalization:  Findings from the Canadian Study of Health  and Aging John A. Naslund, MPH1, Agnes H. Sauter, MA2, Gloria Gutman, PhD3, B. Lynn Beattie, MD, FRCPC4 1The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Hanover, NH, USA; 2University of  British Columbia Okanagan, Kelowna, BC, Canada; 3Gerontology Research Center, Simon Fraser University Vancouver  Campus, Vancouver, BC, Canada; 4Department of Medicine, Division of Geriatric Medicine, University of British Columbia,  Vancouver, BC, Canada DOI:http://dx.doi.org/10.5770/cgj.17.82ORIGINAL RESEARCH © 2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ae/9e/cgj-17-45.PMC4038535.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/9e/cgj-17-45.PMC4038535.pdf
"(11,12) All of these  considerations underscore the importance of the need for, and the important role that, COE physicians play in the delivery of health services to seniors with complex health needs.Geriatric Core Competencies for Family   Medicine Curriculum and Enhanced Skills:  Care of Elderly Lesley Charles, BSc, MBChB, CCFP, COE  (Dip), Jean A.C. Triscott, BSc, BED/AD, MD, CCFP, FAAFP, FCFP ,   Bonnie M. Dobbs, BA, PhD , Rhianne McKay, BA, MA   Division of Care of the Elderly, Department of Family Medicine, University of Alberta, Edmonton, AB DOI:http://dx.doi.org/10.5770/cgj.17.95ORIGINAL RESEARCH © 2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/9f/3a/cgj-17-53.PMC4038536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/3a/cgj-17-53.PMC4038536.pdf
Available from:  http://publications.gc.ca/Collection/Statcan/85F0033M/85F0 033MIE2001008 2.,Non-OADS,/arxiv_data1/oa_pdf/9f/3a/cgj-17-53.PMC4038536.pdf
Available from: http://www.statcan.gc.ca/pub/89-519-x/89-519-x2006001-eng.pdf  4.,OADS,/arxiv_data1/oa_pdf/9f/3a/cgj-17-53.PMC4038536.pdf
"Comparison of the SIMARD MD to Clinical   Impression in Assessing Fitness to Drive in   Patients with Cognitive Impairment  Madelaine Wernham, BNSc1, Pamela G. Jarrett, MD, FRCPC, FACP2, Connie Stewart, PhD3,   Elizabeth MacDonald, MD, FRCPC2, Donna MacNeil, PhD, MD, FRCPC2, Cynthia Hobbs, MD, FRPC2 1Dalhousie University Medical School, Saint John, NB; 2Department Geriatric Medicine, Horizon Health Network,   Saint John, NB; 3Department of Computer Science & Applied Statistics, University of New Brunswick, Saint John, NB DOI:http://dx.doi.org/10.5770/cgj.17.100ORIGINAL RESEARCH © 2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/3a/c4/cgj-17-63.PMC4038537.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/c4/cgj-17-63.PMC4038537.pdf
Available from: http://www.cccdtd.ca/pdfs/ Final_Recommendations_CCCDTD_2007.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/c4/cgj-17-63.PMC4038537.pdf
Available from: http://ccmta.ca/images/ publications/pdf//Determining-Driver-Fitness-In-Canada- Final.pdf  9.,Non-OADS,/arxiv_data1/oa_pdf/3a/c4/cgj-17-63.PMC4038537.pdf
Available from: http://www.aan.,Non-OADS,/arxiv_data1/oa_pdf/3a/c4/cgj-17-63.PMC4038537.pdf
Available from: http://laws.gnb.ca/en/ ShowPdf/cs/M-17.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/c4/cgj-17-63.PMC4038537.pdf
"(8)  Health-care professionals play an important role in en - suring appropriately timed cessation occurs for individuals with dementia; physician advice is one of the most frequently Not If, But When: Impact of a Driving and   Dementia Awareness and Education Campaign  for Primary Care Physicians Paige Moorhouse, MD, MPH1,2, Laura M. Hamilton, BSc1 1Geriatric Medicine Research, Capital District Health Authority & Dalhousie University, Halifax, NS;   2Division of Geriatric Medicine, Capital District Health Authority & Dalhousie University, Halifax, NS, Canada DOI:http://dx.doi.org/10.5770/cgj.17.109ORIGINAL RESEARCH © 2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/66/15/cgj-17-70.PMC4038538.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/15/cgj-17-70.PMC4038538.pdf
Available from:  http://www.alzheimer.ca/~/media/Files/ national/Advocacy/ASC_Rising_Tide_Full_Report_e.pdf,Non-OADS,/arxiv_data1/oa_pdf/66/15/cgj-17-70.PMC4038538.pdf
Available from: http://www.cma.ca/driversguide  17.,Non-OADS,/arxiv_data1/oa_pdf/66/15/cgj-17-70.PMC4038538.pdf
"An effective system for traffic safety entails delineating the roles of various groups including older drivers, health-care providers Consensus Statements on the Assessment   of Older Drivers David B. Hogan MD, FACP, FRCPC1, Charles T. Scialfa, PhD2, Jeff K. Caird, PhD2 1Department of Medicine, Faculty of Medicine; 2Department of Psychology, Faculty of Arts,   University of Calgary, Calgary, AB DOI:http://dx.doi.org/10.5770/cgj.17.111CLINICAL PRACTICE GUIDELINES/CONSENSUS STATEMENTS © 2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/df/1a/cgj-17-76.PMC4038539.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/1a/cgj-17-76.PMC4038539.pdf
Available from: http://pareonline.net/pdf/ v12n10.pdf  20.,Non-OADS,/arxiv_data1/oa_pdf/df/1a/cgj-17-76.PMC4038539.pdf
Available from: https://www.kpmg.com/US/en/Issues   AndInsights/ArticlesPublications/Documents/self-driving-cars-next-revolution.pdf  41.,Non-OADS,/arxiv_data1/oa_pdf/df/1a/cgj-17-76.PMC4038539.pdf
Keywords: Antenatal ultrasound; Umbilical veins; Varicose veins Original  Article Obstet Gynecol Sci 2014;57(3):181-186 http://dx.doi.org/10.5468/ogs.2014.57.3.181 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/5d/b2/ogs-57-181.PMC4038683.pdf
Keywords: Fetal outcome; Intra-operative complications; Multiple cesarean sections; Pregnancy outcome Original  Article Obstet Gynecol Sci 2014;57(3):187-192 http://dx.doi.org/10.5468/ogs.2014.57.3.187 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/65/57/ogs-57-187.PMC4038684.pdf
"Keywords:   Echocardiography; Heart defects, congenital; Heterotaxy syndrome; Prenatal diagnosisOriginal  Article Obstet Gynecol Sci 2014;57(3):193-200 http://dx.doi.org/10.5468/ogs.2014.57.3.193 pISSN 2287-8572  · eISSN 2287-8580",Non-OADS,/arxiv_data1/oa_pdf/23/ee/ogs-57-193.PMC4038685.pdf
Keywords: Dendritic cells; Endometrial neoplasms; S100 Original  Article Obstet Gynecol Sci 2014;57(3):201-207 http://dx.doi.org/10.5468/ogs.2014.57.3.201 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/65/61/ogs-57-201.PMC4038686.pdf
Keywords: Autoimmunity; Natural killer cell; Uterine blood flowOriginal  Article Obstet Gynecol Sci 2014;57(3):208-215 http://dx.doi.org/10.5468/ogs.2014.57.3.208 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/e5/1a/ogs-57-208.PMC4038687.pdf
Keywords: Gonadotrophin-releasing hormone antagonist; In vitro  fertilization; Letrozole; Poor responderOriginal  Article Obstet Gynecol Sci 2014;57(3):216-222 http://dx.doi.org/10.5468/ogs.2014.57.3.216 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/cd/ab/ogs-57-216.PMC4038688.pdf
Keywords: Intracranial sign; Meningocele; Meningocele repair; Maternal serum alpha-fetoproteins; Spinal dysraphismCase Report Obstet Gynecol Sci 2014;57(3):223-227 http://dx.doi.org/10.5468/ogs.2014.57.3.223 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/7e/4a/ogs-57-223.PMC4038689.pdf
Keywords: Ganglioneuroma; Pregnancy; RetroperitoneumCase Report Obstet Gynecol Sci 2014;57(3):228-231 http://dx.doi.org/10.5468/ogs.2014.57.3.228 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/4e/38/ogs-57-228.PMC4038690.pdf
Keywords: Cervical cerclage; Laparoscopy; PregnancyCase Report Obstet Gynecol Sci 2014;57(3):232-235 http://dx.doi.org/10.5468/ogs.2014.57.3.232 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/b8/f6/ogs-57-232.PMC4038691.pdf
Keywords: Adjuvant; Chemoradiotherapy; Operation; Pregnancy; Retroperitoneal liposarcomaCase Report Obstet Gynecol Sci 2014;57(3):236-239 http://dx.doi.org/10.5468/ogs.2014.57.3.236 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/bd/11/ogs-57-236.PMC4038692.pdf
Keywords: Melanoma; Neoplasm metastasis; Peritoneal seedingCase Report Obstet Gynecol Sci 2014;57(3):240-243 http://dx.doi.org/10.5468/ogs.2014.57.3.240 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/31/bc/ogs-57-240.PMC4038693.pdf
Keywords: Citrullinemia; Preimplantation diagnosisCase Report Obstet Gynecol Sci 2014;57(3):244-247 http://dx.doi.org/10.5468/ogs.2014.57.3.244 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/98/10/ogs-57-244.PMC4038694.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):197-206 http://dx.doi.org/10.3341/kjo.2014.28.3.197 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.197 Original ArticleKorean Guidelines for the Diagnosis and Management of Dry Eye:  Development and Validation of Clinical Efficacy Joon Young Hyon1, Hyo-Myung Kim2, Doh Lee3, Eui-Sang Chung4, Jong-Suk Song2, Chul Young Choi4,   Jungbok Lee5; the Korean Corneal Disease Study Group 1Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea 2Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea 3Department of Ophthalmology, Inje University College of Medicine, Goyang, Korea 4Department of Ophthalmology, Sungkyunkwan University College of Medicine, Seoul, Korea 5Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Purpose:  To evaluate the clinical efficacy of newly developed guidelines for the diagnosis and management of  dry eye.",Non-OADS,/arxiv_data1/oa_pdf/62/11/kjo-28-197.PMC4038724.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):207-212 http://dx.doi.org/10.3341/kjo.2014.28.3.207 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.207 Original ArticleIsolation of IgG Antibodies to Toxocara in Ankylosing Spondylitis  Patients with Acute Anterior Uveitis Francisco-Javier Jiménez-Balderas1, Janete García-Jaimes1, Rita Ríos2, Abraham Zonana-Nacach3, Raquel Tapia- Romero4, Nayeli Villanueva4, Patricia Méndez-Samperio5, Jorge-Luis de-la-Rosa-Arana4 1Rheumatology Department, XXI Century National Medical Center, Mexican Institute of Social Security, Mexico City, Mexico 2Ophthalmology Department, XXI Century National Medical Center, Mexican Institute of Social Security, Mexico City, Mexico 3Rheumatology Department, Regional General Hospital 20, Mexican Institute of Social Security, Tijuana Baja California, Mexico 4National Institute of Diagnostic and Epidemiological Reference, Ministry of Health, Mexico City, Mexico 5Immunology Department, National School of Biological Sciences, National Politecnic Institute, Mexico City, Mexico Purpose:  Since few reports had been published on the prevalence of toxocariasis in ankylosing spondylitis (AS)  patients with acute non-granulomatous anterior uveitis (ANGAU), the aim of this work was to determine the  presence of antibodies against Toxocara canis in AS patients with ANGAU.",Non-OADS,/arxiv_data1/oa_pdf/ac/a9/kjo-28-207.PMC4038725.pdf
2 (http://www.opene - pi.com).,Non-OADS,/arxiv_data1/oa_pdf/ac/a9/kjo-28-207.PMC4038725.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):213-219 http://dx.doi.org/10.3341/kjo.2014.28.3.213 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.213 Original ArticlePatient’s Self-recognition of Reduced Visual Acuity Due to  Recurrence of Macular Edema and Prompt Visitation to the   Hospital in Retinal Vein Occlusion Seong Hun Jeong1, Jae Hui Kim1, Jong Woo Kim1, Tae Gon Lee1,2, Chul Gu Kim1, Su Jin Yoo1, Mun Jung Choi1 1Department of Ophthalmology, Kim ’s Eye Hospital, Konyang University College of Medicine, Seoul, Korea 2Graduate School of Medicine, Kyung Hee University, Seoul, Korea Purpose:  To evaluate patients’ self-recognition of reduced visual acuity due to recurring macular edema in reti - nal vein occlusion.",Non-OADS,/arxiv_data1/oa_pdf/2f/45/kjo-28-213.PMC4038726.pdf
The distance between the hos - pital and the patient’s residence location was measured us - ing an electronic caliper provided by a web-based map  service (http://map.naver.com).,OADS,/arxiv_data1/oa_pdf/2f/45/kjo-28-213.PMC4038726.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):220-225 http://dx.doi.org/10.3341/kjo.2014.28.3.220 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.220 Original ArticleChanges in Peripapillary Retinal Nerve Fiber Layer Thickness after  Pattern Scanning Laser Photocoagulation in Patients with   Diabetic Retinopathy Yi-Ryeung Park, Donghyun Jee Department of Ophthalmology and Visual Science, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine,   Suwon, Korea Purpose:  To examine the effects of panretinal photocoagulation (PRP) using a pattern scanning laser (PASCAL)  system on the retinal nerve fiber layer (RNFL) thickness in patients with diabetic retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/aa/57/kjo-28-220.PMC4038727.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):226-233 http://dx.doi.org/10.3341/kjo.2014.28.3.226 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.226 Original ArticleThe Usefulness of Interferon-gamma Release Assay for Diagnosis of  Tuberculosis-related Uveitis in Korea Seong Joon Ahn1,2*, Ko Eun Kim1,3*, Se Joon Woo1, Kyu Hyung Park1 1Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea 2Department of Ophthalmology, Armed Forces Capital Hospital, Seongnam, Korea 3Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Purpose:  To evaluate the usefulness of the interferon-gamma release assay (IGRA) for diagnosing tuberculosis  (TB)-related uveitis (TRU).",Non-OADS,/arxiv_data1/oa_pdf/81/22/kjo-28-226.PMC4038728.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):234-240 http://dx.doi.org/10.3341/kjo.2014.28.3.234 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.234 Original ArticleRelationship between the Lamina Cribrosa, Outer Retina, and  Choroidal Thickness as Assessed Using Spectral Domain Optical  Coherence Tomography Ho Seok Chung, Kyung Rim Sung, Kyoung Sub Lee, Jong Rak Lee, Soa Kim Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Purpose:  To evaluate the characteristics and  relationship  between  peripapillary choroidal thickness (pCT),  lam- ina cribrosa thickness (LCT), and peripapillary outer retinal layer thickness (pORT) as  determined using spec - tral domain optical coherence tomography (SD-OCT)  enhanced depth imaging (EDI).",Non-OADS,/arxiv_data1/oa_pdf/f2/e9/kjo-28-234.PMC4038729.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):241-245  http://dx.doi.org/10.3341/kjo.2014.28.3.241 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.241 Original ArticleSymptom Based Diagnosis of Infant under One Y ear in   Outpatient Clinic Sangyoun Han1, Ungsoo Samuel Kim1,2     1Department of Ophthalmology, Kim ’s Eye Hospital, Seoul, Korea 2Department of Ophthalmology, Konyang University College of Medicine, Daejeon , Korea Purpose:  We investigated chief complaints and ocular disorders in infants under one year of age and analyzed  the association between complaints and disorders.",Non-OADS,/arxiv_data1/oa_pdf/0a/a8/kjo-28-241.PMC4038730.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):246-256  http://dx.doi.org/10.3341/kjo.2014.28.3.246 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.246 Original ArticleBone Marrow-derived Mesenchymal Stem Cells Affect Immunologic  Profiling of Interleukin-17-secreting Cells in a   Chemical Burn Mouse Model Ja Young Lee1,2, Hyun Jeong Jeong2, Mee Kum Kim1,2, Won Ryang Wee1,2 1Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea 2Laboratory of Ocular Regenerative Medicine and Immunology, Seoul Artificial Eye Center, Seoul National University Hospital  Biomedical Research Institute, Seoul, Korea Purpose : This study investigated interleukin (IL )-17-secreting cell involvement in sterile inflammation, and evalu - ated the effect of mesenchymal stem cells (MSCs) on IL-17-secreting cell immunologic profiling.",Non-OADS,/arxiv_data1/oa_pdf/05/48/kjo-28-246.PMC4038731.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):257-264  http://dx.doi.org/10.3341/kjo.2014.28.3.257 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.257 Original ArticleTopical Prostaglandin Analogue Drugs Inhibit Adipocyte  Differentiation Jae Woo Kim Department of Ophthalmology, Catholic University of Daegu School of Medicine, Daegu, Korea Purpose:  To investigate the effects of topical prostaglandin analogue drugs on the differentiation of adipocytes.",Non-OADS,/arxiv_data1/oa_pdf/ac/34/kjo-28-257.PMC4038732.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):265-267 http://dx.doi.org/10.3341/kjo.2014.28.3.265 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.265Traumatic Rupture of the Superior Oblique Muscle Tendon Hye Jin Chung1, Ji Won Baek2, Young Chun Lee2 1HanGil Eye Hospital, Incheon, Korea 2Department of Ophthalmology and Visual Science, Uijeongbu St. Mary’s Hospital, The Catholic University of   Korea College of Medicine, Seoul, Korea Traumatic rupture of an extraocular muscle is rare.",Non-OADS,/arxiv_data1/oa_pdf/aa/68/kjo-28-265.PMC4038733.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):268-271 http://dx.doi.org/10.3341/kjo.2014.28.3.268 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.268Bilateral Macular Hole Following Myopic Photorefractive  Keratectomy Nasser Shoeibi1, Mohammad Hossein Jabbarpoor Bonyadi2,3, Majid Abrishami1, Mohammad-reza             Ansari-Astaneh1 1Retina Research Center, Mashhad University of Medical Sciences, Mashhad, Iran 2Department of Ophthalmology, Gonabad University of Medical Sciences, Gonabad, Iran 3Center of Excellence for Biodiversity, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran Macular holes can be associated with myopia, trauma,  scleral buckling, pneumatic retinopexy, and vitrectomy  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/6b/b2/kjo-28-268.PMC4038734.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):272-274  http://dx.doi.org/10.3341/kjo.2014.28.3.272 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.272Proteus Syndrome: Report of a Case with Developmental Glaucoma Zuleyha Sik Sarman1, Nursen Yuksel1, Hakan Sarman2, Dilek Bayramgurler3 1Department of Ophthalmology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey 2Department of Orthopaedics and Traumatology, Abant Izzet Baysal University Faculty of Medicine, Bolu, Turkey 3Department of Dermatology and Venereology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey Proteus syndrome (PS) was first described as a clinical  entity by Cohen and Hayden [1] in two patients in 1979.",Non-OADS,/arxiv_data1/oa_pdf/c8/40/kjo-28-272.PMC4038735.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):275-277 http://dx.doi.org/10.3341/kjo.2014.28.3.275 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.275Suspected Bacterial Endophthalmitis Following Sustained-release  Dexamethasone Intravitreal Implant: A Case Report Mücella Arıkan Yorgun1, Melek Mutlu1, Yasin Tok lu1, Hasan Basri Çakmak2, Nurullah Çağıl2 1Ophthalmology Department, Ankara Atatürk Training and Research Hospital, Ankara, Turkey 2Department of Ophthalmology, Yıldırım Beyazıt University, Ankara, Turkey Intravitreal therapy has been consistently used for macu - lar edema following branch retinal vein occlusion (BRVO)  and central retinal vein occlusion (CRVO).",Non-OADS,/arxiv_data1/oa_pdf/38/47/kjo-28-275.PMC4038736.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(3):278-283 http://dx.doi.org/10.3341/kjo.2014.28.3.278 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.278Unilateral Punctate Keratitis Secondary to Wallenberg Syndrome Pino Cidad1, Ana Boto1, Almudena Del Hierro1, Maria Capote1, Susana Noval1, Amanda Garcia1, Susana Santiago2 1Ophthalmology Service, Hospital La Paz, Madrid, Spain 2Neurophysiology Service, Hospital La Paz, Madrid, Spain Wallenberg syndrome consists of a set of signs and  symptoms caused by occlusion of the posterior inferior  cerebellar artery [1].",Non-OADS,/arxiv_data1/oa_pdf/c6/0e/kjo-28-278.PMC4038737.pdf
"The disease is present in 4.0% of individuals aged >40 years of age,1and the incidence13andFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
Neuroimaging Studies of Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
Neuroimaging Studies of Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
Neuroimaging Studies of Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Mov Disord 2010;25:534–541, doi: http://dx.doi.org/10.1002/mds.22838.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Mov Disord 2003;18:389–394, doi: http://dx.doi.org/10.1002/mds.10376.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Jaw tremor: Prevalence and clinical correlates in three essential tremor case samples.Mov Disord 2006;21:1872–1878, doi: http://dx.doi.org/10.1002/mds.21069.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
Tremor Other Hyperkinet Mov 2013; 2013;3: http://tremorjournal.org/article/view/200.,Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"J Neurol Neurosurg Psychiatry 2006;77:1235–1237, doi: http://dx.doi.org/10.1136/jnnp.2005.086579.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"J Neurol Neurosurg Psychiatry 2011;82:761–765, doi: http://dx.doi.org/10.1136/jnnp.2010.229740.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Ann Neurol 2001;49:761–769, doi: http://dx.doi.org/10.1002/ana.1022.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Eur J Neurol 2013;20: 949–954, doi: http://dx.doi.org/10.1111/ene.12123.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Neurology 2007;69:1982–1989, doi: http://dx.doi.org/10.1212/01.wnl.0000279339.87987.d7.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Neurology 2005;64:1721– 1725, doi: http://dx.doi.org/10.1212/01.WNL.0000161852.70374.01.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Prevalence of essential tremor in a multiethnic, community-based study in northern Manhattan, New York, N.Y.Neuroepidemiology 2009;32:208–214, doi: http://dx.doi.org/10.1159/000195691.Louis ED, Huang CC, Dyke JP et al.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
Neuroimaging Studies of Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Brain 1976;99:659–672, doi: http://dx.doi.org/10.1093/brain/99.4.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Mov Disord 2013;28:1759–1761, doi: http://dx.doi.org/10.1002/mds.25645.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Parkinsonism Relat Disord 2012;18:626–628, doi: http://dx.doi.org/10.1016/j.parkreldis.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Parkinsonism Relat Disord 2012;18:1003–1004, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"J Neural Transm 2012;119:1383–1387, doi: http://dx.doi.org/10.1007/s00702-012- 0878-8.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"2):113–139, doi: http://dx.doi.org/10.1093/brain/72.2.113.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Arch Neurol 2003;60:405–410, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Mov Disord 2009;24:626–627, doi: http://dx.doi.org/10.1002/mds.22370.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Neurology 2004;62:734–741, doi: http://dx.doi.org/10.1212/01.WNL.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Neurology 2009;73: 621–625, doi: http://dx.doi.org/10.1212/WNL.0b013e3181b389f1.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Mov Disord 2007;22:1573–1580, doi: http://dx.doi.org/10.1002/mds.21553.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"J Neurol Sci 2013; 335:9–13, doi: http://dx.doi.org/10.1016/j.jns.2013.09.003.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/67.,Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Parkinsonism Relat Disord 2007;13(Suppl 3):S406–S416, doi: http://dx.doi.org/10.1016/S1353-8020(08)70039-7.32.Ashburner J, Friston KJ.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Neuroimage 2000;11(Pt 1):805–821, doi: http://dx.doi.org/10.1006/nimg.2000.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Neurology 2006; 67:1452–1456, doi: http://dx.doi.org/10.1212/01.wnl.0000240130.94408.99.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"AJNR Am J Neuroradiol 2008;29:1692–1697, doi: http://dx.doi.org/10.3174/ajnr.A1190.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"AJNR Am J Neuroradiol 2009; 30:1240–1243, doi: http://dx.doi.org/10.3174/ajnr.A1544.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Mov Disord 2002;17:313–316, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Eur J Neurol 2013;20:725–727, doi: http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"J Neurol Sci 2009;287:138–142, doi: http://dx.doi.org/10.1016/j.jns.2009.08.037.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"J Neuroimaging 2012;22:275–278, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Front Hum Neurosci 2013;7:247, doi: http://dx.doi.org/10.3389/fnhum.2013.00247.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Arch Neurol 2006;63:1100–1104, doi: http://dx.doi.org/10.1001/archneur.63.8.1100.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Mov Disord 2001;16:921–923, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Pediatrics 2004;114:1203–1205, doi: http://dx.doi.org/10.1542/peds.2004- 0031.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Neurobiol Dis 1999;6: 259–268, doi: http://dx.doi.org/10.1006/nbdi.1999.0244.Neuroimaging Studies of Essential Tremor Louis ED, Huang CC, Dyke JP et al.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9,Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Neurosci Lett 2002;333: 17–20, doi: http://dx.doi.org/10.1016/S0304-3940(02)00966-7.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Neurology 2003;60: 1344–1347, doi: http://dx.doi.org/10.1212/01.WNL.0000065885.15875.0D.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"J Neuroimaging 2005;15:362–366, doi: http://dx.doi.org/10.1111/j.1552-6569.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Nat Rev Neurosci 2003;4:469–480, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Neurology 2013;80:857–864, doi: http://dx.doi.org/10.1212/WNL.0b013e318284070c.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"AJNR Am J Neuroradiol 2008;29:151–153, doi: http://dx.doi.org/10.3174/ajnr.A0744.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Neuroimage 2013;73: 239–254, doi: http://dx.doi.org/10.1016/j.neuroimage.2012.06.081.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Mov Disord 2007;22:1182–1185, doi: http://dx.doi.org/10.1002/mds.21287.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Cerebellum 2013;12:199–204, doi: http://dx.doi.org/ 10.1007/s12311-012-0414-2.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor.Neurology 2010;74:988–994, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Hum Brain Mapp 2011;32:896–904, doi: http://dx.doi.org/10.1002/hbm.21077.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"J Neuroimaging 2011;21:370–374, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Parkinsonism Relat Disord 2012;18: 477–482, doi: http://dx.doi.org/10.1016/j.parkreldis.2012.01.006.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"PLoS One 2013;8: e69199, doi: http://dx.doi.org/10.1371/journal.pone.0069199.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Ann Neurol 1997;41:32–40, doi: http://dx.doi.org/10.1002/ana.410410108.62.Passamonti L, Novellino F, Cerasa A, et al.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Brain 2011;134(Pt 8): 2274–2286, doi: http://dx.doi.org/10.1093/brain/awr164.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Neuroreport 2010; 21:148–151, doi: http://dx.doi.org/10.1097/WNR.0b013e328335b42c.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Brain Stimul 2013;6:175–179, doi: http://dx.doi.org/10.1016/j.brs.2012.04.009.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/ view/28.,Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Mov Disord 2013;28:196–200, doi: http://dx.doi.org/10.1002/mds.25263.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"The effect of ethanol on alcohol-responsive essential tremor: A positron emission tomography study.Ann Neurol 1996;39:650–658, doi: http://dx.doi.org/10.1002/ana.410390515.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Lancet 1990;336:1028–1030, doi: http://dx.doi.org/10.1016/0140-6736(90)92489-5.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Ann Neurol 1993;34:82–90, doi: http://dx.doi.org/10.1002/ana.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"J Neurol Sci 1993;114:45–48, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Arch Neurol 1995;52:299–305, doi: http://dx.doi.org/10.1001/ archneur.1995.00540270095025.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Arch Neurol 1999;56:807–808, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"J Nucl Med 2010;51:1030– 1035, doi: http://dx.doi.org/10.2967/jnumed.109.074120.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
"Gaba and serotonin molecular neuroimaging in essential tremor: A clinical correlation study.Parkinsonism Relat Disord 2012;18:876–880, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
Neuroimaging Studies of Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services10,Non-OADS,/arxiv_data1/oa_pdf/72/52/tre-04-235-5549-1.PMC4038743.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e2/cf/thnov04p0678.PMC4038750.pdf
This is an open- access article distributed under the terms of the Creative Common s License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/78/de/thnov04p0693.PMC4038751.pdf
This is an open- access article distributed under the terms of the Creative Comm ons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/7a/thnov04p0701.PMC4038752.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/0b/thnov04p0708.PMC4038753.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/7b/3c/thnov04p0721.PMC4038754.pdf
Pseudocolor image processing was done with  ImageJ ( http://rsbweb.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/7b/3c/thnov04p0721.PMC4038754.pdf
"Cell migration data analysis was performed  using ImageJ software (http://rsbweb.nih.gov/ij/) including the plug -ins Manual Tracking (F. Cord e- liers, Institut Curie, Orsay, France) for imaging si n- gle-cell migration tracks, and Chemotaxis Tool (ibidi,  Martinsried, Germany) to calculate migration veloc i- ty, yFMI, accumulated distance, and en dpoint y.",OADS,/arxiv_data1/oa_pdf/7b/3c/thnov04p0721.PMC4038754.pdf
This is an open- access article distributed un der the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/3f/thnov04p0736.PMC4038755.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/4e/ea/thnov04p0745.PMC4038756.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c5/82/thnov04p0761.PMC4038757.pdf
http://www.who.int/malaria/world_   malaria_report_2010/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/c5/82/thnov04p0761.PMC4038757.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/1f/awt225.PMC4038779.pdf
"Lesionmaps were traced on T 1-weighted images using MRIcron software (C. Rorden, http://www.cabiatl.com/mricron/) guided by additional tissue contrast information derived from T 2-weighted images.",OADS,/arxiv_data1/oa_pdf/e9/1f/awt225.PMC4038779.pdf
"Voxel-based lesion symptom mapping analysis (Bates et al., 2003) was conducted to evaluate differences in lesions density between in- dividuals with atypical compared to typical lateralization using NPM software (http://www.cabiatl.com/mricron/) and Liebermeister statis- tic for binomial data (Rorden et al., 2007).",OADS,/arxiv_data1/oa_pdf/e9/1f/awt225.PMC4038779.pdf
"Tissue segmentation and voxel-based morphometry Volumes of CSF, grey matter and white matter were calculated from 3D-FLASH images using the voxel-based morphometry toolbox (C. Gaser, http://dbm.neuro.uni-jena.de/vbm/) for SPM8 (WellcomeTrust Centre for Neuroimaging, http://www.ﬁl.ion.ucl.ac.uk/spm/soft ware/spm8/).",OADS,/arxiv_data1/oa_pdf/e9/1f/awt225.PMC4038779.pdf
"This was achieved by using the uniﬁed segmentation procedure implemented in SPM8, modiﬁed to include a Hidden Markov Field model as an additional spatial constraint (see http://dbm.neuro.uni- jena.de/vbm/markov-random-ﬁelds/).",OADS,/arxiv_data1/oa_pdf/e9/1f/awt225.PMC4038779.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5126 | DOI: 10.1038/srep05126 5",Non-OADS,/arxiv_data1/oa_pdf/eb/b8/srep05126.PMC4038805.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cd/a9/srep05125.PMC4038806.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5125 | DOI: 10.1038/srep05125 8",Non-OADS,/arxiv_data1/oa_pdf/cd/a9/srep05125.PMC4038806.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a4/e5/srep05130.PMC4038808.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5130 | DOI: 10.1038/srep05130 8",Non-OADS,/arxiv_data1/oa_pdf/a4/e5/srep05130.PMC4038808.pdf
The received sequences were analyzed with the BLASTn tool (http://blast.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/61/95/srep05136.PMC4038809.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5136 | DOI: 10.1038/srep05136 6",Non-OADS,/arxiv_data1/oa_pdf/61/95/srep05136.PMC4038809.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/62/57/srep05133.PMC4038810.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5133 | DOI: 10.1038/srep05133 7",Non-OADS,/arxiv_data1/oa_pdf/62/57/srep05133.PMC4038810.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a9/4b/srep05117.PMC4038811.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5117 | DOI: 10.1038/srep05117 9",Non-OADS,/arxiv_data1/oa_pdf/a9/4b/srep05117.PMC4038811.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6b/6a/srep05120.PMC4038816.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5120 | DOI: 10.1038/srep05120 6",Non-OADS,/arxiv_data1/oa_pdf/6b/6a/srep05120.PMC4038816.pdf
"The haplo.em and haplo.score programs are implemented in the Haplo.Stats software (version 1.4.0) operated in the R language (version 2.14, avail-able at the website http://www.r-project.org).",OADS,/arxiv_data1/oa_pdf/66/8d/srep05116.PMC4038817.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Zhao, H.Y.",Non-OADS,/arxiv_data1/oa_pdf/66/8d/srep05116.PMC4038817.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5116 | DOI: 10.1038/srep05116 7",Non-OADS,/arxiv_data1/oa_pdf/66/8d/srep05116.PMC4038817.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5124 | DOI: 10.1038/srep05124 8",Non-OADS,/arxiv_data1/oa_pdf/05/cd/srep05124.PMC4038819.pdf
"Statistical analysis .Power calculations were done for ‘A’ allele of rs1063192 which is the most replicated SNP in different reported studies by Genetic power calculator software (http://pngu.mgh.harvard.edu/ ,purcell/gpc/) 11.The relative risk was kept constant as 1.8 (for homozygous genotype) and 1.2 (for heterozygous genotype) as reported by Fan B.J.",Non-OADS,/arxiv_data1/oa_pdf/1f/bd/srep05115.PMC4038833.pdf
"217).Presented at the 62 ndAnnual Meeting of The American Society of Human Genetics, November 8, 2012, San Francisco, California (http://abstracts.ashg.org/cgi-bin/swish-ashgw).",Non-OADS,/arxiv_data1/oa_pdf/1f/bd/srep05115.PMC4038833.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1f/bd/srep05115.PMC4038833.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Table 3 |Details of association of three replicated tag SNPs representing three different LD blocks SNP Minor alleleDiscovery phase 350 cases, 354 controlsReplication phase 368 cases, 320 controlsCombined 718 cases, 674 controls MAF(Cases/Controls) p-value MAF(Cases/Controls) p-value MAF(Cases/Controls) p-value rs3217992 A 0.42/0.39 0.20 0.39/0.4 0.74 0.40/0.39 0.51 rs4977756 G 0.24/0.24 0.94 0.27/0.25 0.38 0.25/0.24 0.53rs10116277 C 0.36/0.38 0.50 0.41/0.39 0.39 0.39/0.38 0.84www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5115 | DOI: 10.1038/srep05115 4",Non-OADS,/arxiv_data1/oa_pdf/1f/bd/srep05115.PMC4038833.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/20/da/srep05131.PMC4038835.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5131 | DOI: 10.1038/srep05131 7",Non-OADS,/arxiv_data1/oa_pdf/20/da/srep05131.PMC4038835.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5132 | DOI: 10.1038/srep05132 12",Non-OADS,/arxiv_data1/oa_pdf/39/0f/srep05132.PMC4038836.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5123 | DOI: 10.1038/srep05123 8",Non-OADS,/arxiv_data1/oa_pdf/9a/b3/srep05123.PMC4038838.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/00/cc/srep05107.PMC4038842.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5107 | DOI: 10.1038/srep05107 5",Non-OADS,/arxiv_data1/oa_pdf/00/cc/srep05107.PMC4038842.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0d/38/srep05074.PMC4038843.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5074 | DOI: 10.1038/srep05074 9",Non-OADS,/arxiv_data1/oa_pdf/0d/38/srep05074.PMC4038843.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/23/4a/srep05127.PMC4038844.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5127 | DOI: 10.1038/srep05127 9",Non-OADS,/arxiv_data1/oa_pdf/23/4a/srep05127.PMC4038844.pdf
"S.S. participated in conceiving the experiments,research design, data analysis and writing.’’ Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/49/8f/srep05088.PMC4038850.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5088 | DOI: 10.1038/srep05088 10",Non-OADS,/arxiv_data1/oa_pdf/49/8f/srep05088.PMC4038850.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/45/64/AJNS-9-21.PMC4038861.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/71/be/AJNS-9-29.PMC4038862.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/0e/1d/AJNS-9-3.PMC4038863.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/0e/1d/AJNS-9-3.PMC4038863.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/84/2f/AJNS-9-7.PMC4038869.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/20/30/srep05009.PMC4038916.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5009 | DOI: 10.1038/srep05009 5",Non-OADS,/arxiv_data1/oa_pdf/20/30/srep05009.PMC4038916.pdf
"Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1 To the editor : We read with great interest the article “Isolated Chorea Associated  with LGI1 Antibody” (LGI1, leucine-rich glioma inactivated 1) by Ram- dhani and Frucht.1 The authors presented an important clinical obser - vation about a treatable etiology of chorea in a 53-year-old male, in  whom an underlying tumor could not be detected.",Non-OADS,/arxiv_data1/oa_pdf/2b/7f/tre-04-239-5583-1.PMC4039192.pdf
Case ReportThalamic Deep Brain Stimulation for Orthostatic Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services 2 pronounced CT-PET-findings and the history of excessive smoking led  us to suspect a smoking-associated lung cancer.,Non-OADS,/arxiv_data1/oa_pdf/2b/7f/tre-04-239-5583-1.PMC4039192.pdf
Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1 To the editor : The case presented by Vynogradova and colleagues adds to the ever- expanding etiological spectrum of autoimmune chorea.,Non-OADS,/arxiv_data1/oa_pdf/30/62/tre-04-246-5585-1.PMC4039211.pdf
To view a copy of this licence visit http://creativecommons.org/ licenses/by-nc-sa/3.0/.Selective control of glucose metabolism by insulin R Noguchi et al 12Molecular Systems Biology 2013 &2013 EMBO and Macmillan Publishers Limited,Non-OADS,/arxiv_data1/oa_pdf/f1/95/msb201319.PMC4039368.pdf
To viewa copy of this licence visit http://creativecommons.org/ licenses/by-nc-sa/3.0/.A global SUMO system interactome T Srikumar et al &2013 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2013 9,Non-OADS,/arxiv_data1/oa_pdf/eb/50/msb201323.PMC4039371.pdf
"To date, eight tutorials have been published (http://www.nature.com/psp/tutorials/index.html), providing practical   hands-on introductions to a variety of modeling and simula- tion methodologies and tools.",Non-OADS,/arxiv_data1/oa_pdf/c9/ed/psp20144a.PMC4039390.pdf
"Additionally, PSP just released its first podcast, PSPod, which features an interview with Dr Diane Mould discussing the three Tutorials she coauthored with Dr Richard Upton on basic concepts in population mod-eling, simulation, and model-based drug development (http://www.nature.com/psp/podcast/index.html).",Non-OADS,/arxiv_data1/oa_pdf/c9/ed/psp20144a.PMC4039390.pdf
"PSPod will be a   quarterly feature of PSP that will delve into the advances in quantitative methods as applied in pharmacology, physiology, and therapeutics in humans; the next scheduled topics are “Diabetes” and “PBPK.”  The quality and the efficiency of peer review are crucial  aspects to the success of a journal, and the ~50 distinguished international members of our Editorial Board (http://www.nature.com/psp/editors.html) play a pivotal role in this process.The online nature of PSP provides unique opportuni- ties to communicate Pharmacometrics and Systems Phar-macology science in new and more effective ways to our readers.",Non-OADS,/arxiv_data1/oa_pdf/c9/ed/psp20144a.PMC4039390.pdf
"Another example illustrating how we strive to serve our readers by utilizing the online fea-tures of PSP is the recent introduction of so-called Themed Virtual Issues, which are continuously updated collections of all articles on specific topics, such as Tutorials, Diabetes, Cancer, and PBPK (see e.g., http://www.nature.com/psp/diabetes/index.html).",Non-OADS,/arxiv_data1/oa_pdf/c9/ed/psp20144a.PMC4039390.pdf
"To view a copy of   this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/c9/ed/psp20144a.PMC4039390.pdf
"For example, the Biomarkers of  Anti-TNF Treatment Efficacy in Rheumatoid Arthritis–Unre- sponsive Populations (BATTER-UP) trial is currently evaluat-ing an eight-gene classifier to predict the patients who will not respond to anti–tumor necrosis factor-α agents (http://clinicaltrials.gov/, trial NCT01211678).",Non-OADS,/arxiv_data1/oa_pdf/6e/2e/psp20142a.PMC4039391.pdf
"To view a copy of   this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/6e/2e/psp20142a.PMC4039391.pdf
Data were digitized using Data Digitizer  (http://plotdigitizer.sourceforge.net/).,OADS,/arxiv_data1/oa_pdf/40/63/psp201380a.PMC4039392.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/40/63/psp201380a.PMC4039392.pdf
"RESULTS Disease-Target-Drug DatabaseDisease-Target-Drug Database (http://cadd.whu.edu.cn/ditad/) stores known connections among diseases, targets,  and drugs approved by the US Food and Drug Administra- tion.",OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"The diseases and drugs are curated from the “Pharmaco-poeia of People’s Republic of China, version 2010, three columns” (http://en.wikipedia.org/wiki/Pharmacopoeia_of_ the_People%27s_Republic_of_China), compiled by the  Chinese Pharmacopoeia Commission (http://www.chp.org.cn/cms/about/).",Non-OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
VNP is freely available at http://cadd.whu.edu.cn/ditad/vnpsearch.CPT Pharmacometrics Syst.,OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"4 Table 1 Comparisons with visualization tools Name Website Data Online serverChemoinformatics and bioinformatics  search tools Arena3D http://arena3d.org Time-driven phenotypic differ- ences of gene expression dataDesktop Sequence similarity clustering claimed Users’ network data Not yet based on server Chemoinformatics tools (e.g., chemical   substructure searching) not yet found ArrayXPath http://www.snubi.org/software/ ArrayXPathMicroarray gene expression data Desktop Chemoinformatics tools (e.g., chemical  substructure searching) not yet foundNot yet based on server AVIS http://actin.pharm.mssm.edu/ AVIS2Biological networks Server provided Chemoinformatics (e.g., chemical substruc-ture searching) and bioinformatics tools (e.g.,  sequence analysis) not yet found BioLayout  Express 3Dhttp://www.biolayout.org General network graphs Desktop Chemoinformatics (e.g., chemical substruc-ture searching) and bioinformatics tools   (e.g., sequence analysis) tools not yet foundNot yet based on server Biological-Networkshttp://biologicalnetworks.net Biological networks Desktop Chemoinformatics tools (e.g., chemical  substructure searching) not yet foundNot yet based on server BioTapestry http://www.biotapestry.org Genetic regulatory networks Desktop Chemoinformatics tools (e.g., chemical   substructure searching) not yet foundWeb models provided BisoGenet http://bio.cigb.edu.cu/bisogenet- cytoscapeMolecular interactions information around a set of genes/proteinsDesktop as a Cytoscape plug-inChemoinformatics tools (e.g., chemical  substructure searching) not yet found CellDe- signerhttp://www.celldesigner.org Biochemical networks Desktop Plug-ins needed to run chemoinformatics (e.g., chemical substructure searching) and Not yet based on server Cell  Illustratorhttp://www.cellillustrator.com Biological processes and systems Desktop Chemoinformatics tools (e.g., chemical  substructure searching) not yet foundNot yet based on server CFinder http://www.cfinder.org General networks Desktop Chemoinformatics tools (e.g., chemical   substructure searching) not yet foundNot yet based on server Cytoscape http://www.cytoscape.org General networks Desktop Plug-ins needed to run chemoinformatics   (e.g., chemical substructure searching) and  Not yet based on server GenePro http://wodaklab.org/genepro Protein and gene interaction  networksDesktop as a Cytoscape plug-inChemoinformatics tools (e.g., chemical  substructure searching) not yet found GeneWays http://anya.igsb.anl.gov/  Geneways/GeneWays.htmlMolecular pathway data from the research literatureServer provided Chemoinformatics tools (e.g., chemical  substructure searching) not yet found GEOMIi http://sydney.edu.au/engineering/ it/~visual/valacon/geomi/Complex networks Desktop Chemoinformatics tools (e.g., chemical  substructure searching) not yet foundNot yet based on server Gephi http://gephi.org Networks and complex systems Desktop Chemoinformatics tools (e.g., chemical   substructure searching) not yet foundNot yet based on server Graphviz http://www.graphviz.org Graph visualization Desktop Chemoinformatics tools (e.g., chemical   substructure searching) not yet foundNot yet based on server Gridlayout http://kurata21.bio.kyutech.ac.jp/grid/grid_layout.htmGraph layout Desktop Chemoinformatics tools (e.g., chemical  substructure searching) not yet foundNot yet based on server Guess http://graphexploration.cond.",Non-OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"org/index.htmlGraphs and networks Desktop Chemoinformatics tools (e.g., chemical  substructure searching) not yet foundWeb demo (plug-in needed) Hive Plots http://www.hiveplot.com Drawing networks Desktop Chemoinformatics (e.g., chemical substruc-ture searching) and bioinformatics tools  Not yet based on server Hybridlayout http://www.cadlive.jp/  hybridlayout/hybridlayout.htmlBiochemical network maps Desktop Chemoinformatics (e.g., chemical substructure searching) and bioinformatics tools not yet foundNot yet based on server Hyperdraw http://www.bioconductor.org/ packages/release/bioc/html/ hyperdraw.htmlVisualizing hypergraphs Desktop Chemoinformatics (e.g., chemical substruc- ture searching) and bioinformatics tools   (e.g., sequence analysis) not yet foundNot yet based on server IM Browser http://proteome.wayne.edu/PIMdb.htmlInteraction data Web server Chemoinformatics (e.g., chemical substruc-ture searching) tools not yet foundJava plug-in needed IPath http://pathways.embl.de Pathways maps Server focusing on pathways Chemical names mapped; no chemical   structure searching functions found JNets http://www.manchester.ac.uk/bioinformatics/jnetsProtein interaction networks and general networksDesktop Chemoinformatics (e.g., chemical substruc-ture searching) and bioinformatics tools  Not yet based on server KGML-ED http://kgml-ed.ipk-gatersleben.de KEGG Pathway diagrams Desktop Chemoinformatics tools (e.g., chemical   substructure searching) not yet foundNot yet based on server Table 1 Continued on next page",Non-OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
5 LEDA http://www.algorithmic-  solutions.com/leda/about/index.,OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"htmNetworks or graphs C++ class library Chemoinformatics (e.g., chemical substruc- ture searching) and bioinformatics tools  (e.g., sequence analysis) not yet found MAVisto http://mavisto.ipk-gatersleben.",Non-OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"deMotifs in network Desktop Chemoinformatics (e.g., chemical substruc-ture searching) and bioinformatics tools not Not yet based on server Medusa http://coot.embl.de/medusa Graph visualization Desktop Chemoinformatics (e.g., chemical substruc- ture searching) and bioinformatics tools  (e.g., sequence analysis) not yet foundNot yet based on server ModuLand http://www.linkgroup.hu/ modules.phpComplex networks Desktop as a Cytoscape plug-inChemoinformatics (e.g., chemical substruc-ture searching)and bioinformatics tools  (e.g., sequence analysis) not yet found Multilevel Layouthttps://code.google.com/p/ multilevellayoutMultilevel layout Desktop as a Cytoscape plug-inChemoinformatics (e.g., chemical substruc-ture searching) and bioinformatics tools  (e.g., sequence analysis) not yet found NAViGaTOR http://ophid.utoronto.ca/ navigatorProtein–protein interaction  networksDesktop Chemoinformatics (e.g., chemical   substructure searching)and bioinformatics  tools (e.g., sequence analysis) not yet foundNot yet based on server NetMiner http://www.netminer.com/index.",Non-OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"phpSocial network and general  networksDesktop Chemoinformatics (e.g., chemical substruc-ture searching) and bioinformatics tools  (e.g., sequence analysis) not yet foundNot yet based on server Network  Workbenchhttp://nwb.cns.iu.edu General networks Desktop Chemoinformatics (e.g., chemical substruc-ture searching)and bioinformatics tools Not yet based on server Ondex http://www.ondex.org Networks or graphs Desktop Chemoinformatics (e.g., chemical substruc-ture searching) tools not yet found Not yet based on server Osprey http://biodata.mshri.on.ca/ osprey/servlet/IndexComplex interaction networks Desktop Chemoinformatics (e.g.",Non-OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"chemical substruc-ture searching)and bioinformatics tools Not yet based on server Pajek http://pajek.imfm.si/doku.php Network analysis and  visualizationDesktop Chemoinformatics (e.g., chemical substruc-ture searching)and bioinformatics tools Not yet based on server PathDraw http://rospath.ewha.ac.kr/tool- box/PathwayViewerFrm.jspPathway visualization and  manipulationDesktop Chemoinformatics (e.g., chemical substruc-ture searching)and bioinformatics tools  (e.g., sequence analysis) not yet foundNot yet based on server Pathway  Toolshttp://bioinformatics.ai.sri.com/ptoolsBiological networks Desktop Chemoinformatics tools (e.g., chemical substructure searching) not yet found Not yet based on server PATIKA http://www.patika.org Pathway analysis Server provided Chemoinformatics tools (e.g., chemical substructure searching) not yet found PaVESy http://pavesy.mpimp-golm.mpg.",Non-OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"de/PaVESy.htmPathway visualization and editing Desktop Chemoinformatics tools (e.g., chemical substructure searching) not yet found Not yet based on server PhyloGra- pherhttp://www.atgc.org/PhyloG-rapherEolutionary relationships within families of genes or proteinsDesktop Chemoinformatics tools (e.g., chemical substructure searching) not yet found Not yet based on server PIMWalker http://pimr.hybrigenics.com Hybrigenics’ public interaction dataServer provided Chemoinformatics tools (e.g., chemical substructure searching) not yet found PIVOT http://acgt.cs.tau.ac.il/pivot Protein–protein interactions Desktop Chemoinformatics tools (e.g., chemical  substructure searching) not yet found Not yet based on server PolarMap- perhttp://kdbio.inesc-id.pt/software/polarmapperProtein interaction networks Desktop Chemoinformatics tools (e.g., chemical substructure searching) not yet found Not yet based on server Protein-NetVishttp://graphics.cs.brown.edu/research/sciviz/proteins/home.",Non-OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"htmProtein networks Desktop Chemoinformatics tools (e.g., chemical  substructure searching) not yet found Not yet based on server ProteoLens http://bio.informatics.iupui.edu/ proteolensBiological network Desktop Chemoinformatics (e.g., chemical substruc-ture searching) and sequence analysis Not yet based on server RedeR http://bioconductor.org/ packages/release/bioc/html/ RedeR.htmlNested networks Desktop Chemoinformatics and sequence analysis  tools not yet found Not yet based on server RING http://protein.bio.unipd.it/ring Protein residue interaction net-worksDesktop Chemoinformatics tools (e.g., chemical substructure searching) not yet found Not yet based on server SoNIA http://www.stanford.edu/group/ soniaNetworks data Desktop Chemoinformatics tools (e.g., chemical sub-structure searching) not yet found Not yet based on serverTable 1 Continued Name Website Data Online serverChemoinformatics and bioinformatics  search tools Table 1 Continued on next page",Non-OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
The software package is downloaded from the FASTA (a protein sequence similarity  software) team at Virginia University (http://fasta.bioch.vir- ginia.edu/fasta_www2/fasta_list2.shtml).,OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"This study was supported by grants  from the National Natural Science Foundation of China, the  Ministry of Science and Technology of China (973 and 863 Programs), the program for New Century Excellent Talents in Universities, and the National Mega Project on Major Drug Development.Transcrip- tome- Browserhttp://tagc.univ-mrs.fr/tbrowser Transcriptional signatures Server provided Chemoinformatics tools (e.g., chemical sub- structure searching) not yet found UCSF struc- tureVizhttp://www.cgl.ucsf.edu/ cytoscape/structureVizBiological networks Desktop as a Cytoscape plug-inChemoinformatics tools (e.g., chemical sub-structure searching) not yet found VANTED http://vanted.ipk-gatersleben.de Biological pathways Desktop Chemoinformatics tools (e.g., chemical sub-structure searching) not yet found Not yet based on server VisANT http://visant.bu.edu Biological networks and pathways Server provided Chemoinformatics tools (e.g., chemical sub-structure searching) not yet found VitaPad http://sourceforge.net/projects/vitapadBiological pathways and map ex-perimental data to themDesktop Chemoinformatics tools (e.g., chemical sub-structure searching) not yet found Not yet based on server WebInter- Viewerhttp://interviewer.inha.ac.kr Networks Server provided Chemoinformatics tools (e.g., chemical sub-structure searching) not yet found yFiles http://www.yworks.com/en/index.htmlVisualization of networks and diagramsServer, APP , and packages providedChemoinformatics (e.g., chemical substruc-ture searching) and sequence analysis tools  not yet found yWays http://www.yworks.com/en/products_yfiles_extension packages_ep2.htmVisualization of networks and diagramsServer, APP , and packages providedChemoinformatics (e.g., chemical substruc-ture searching) and sequence analysis tools not yet found VNP http://cadd.whu.edu.cn/ditad/ vnpsearchDiseases-Targets-Drugs network pharmacology relationshipsYe s Chemical substructure searching and sequence similarity calculation functions embedded The tools compared are from Table 1 of ref.",Non-OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"7 Table 2 Comparisons with disease-related networks Type of related data  (types of network  nodes)Name and additional   description, website Reference Data different from VNPNetwork pharmacology  server • Disease Human disease network (Cy- toscape plug-in DisGeNET:  http://ibi.imim.es/DisGeNET/ DisGeNETweb.html)Goh et al., 2007, Feldman et al., 2008, Bauer-Mehren  et al., 2010, and Stegmaier  et al., 2010Drug and drug-related information missingNo online server • Disease-related genes • Disease Gene-based, interactome- enriched, and scientific   publication–based human   disease networksZhang et al., 2011a The Orphan Disease Networks No online server • Disease-related genes Drug and drug-related information  missing • Interactome • Publication • Disease Disease-responsive interac- tome module-based human  disease network (disease  correlations based on disease-induced changes in mRNA  expression of interactome  modules)Suthram et al., 2010 Elucidating relationships between dis-eases using preexisting knowledge of  disease genes; and further found some  disease correlations also sharing com-mon drugsNo online server • Interactome module The drug-related networks missing or not used • mRNA changes • Disease A Bayesian network-based dis- ease-responsive transcriptome  analysis to construct a human  disease networkHuang et al., 2010a Transform public gene expression  repositories into an automated disease  diagnosis database.No online server •  mRNA changes at the  transcriptome levelDisease diagnosis system can be used to characterize complex phenotypes  and to construct a disease–drug con- nectivity map.",OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"• Disease iCTNet: a Cytoscape plug-in to construct an integrative  network of diseases, associ- ated genes, drugs, and tissues  (http://www.cs.queensu.ca/ ictnet)Wang et al., 2011b A large-scale network, assembling human disease–gene association,  tissue–gene association, disease–tissue  associations, protein–DNA interactions,  protein–protein interactions, and drug  target informationRunning as desktop soft-ware acting as a   Cytoscape plug-in.",OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"Software: Practice Experience 21, 1129–1164 (1991).• Patient Disease comorbidity network Rzhetsky et al., 2007 and  Hidalgo et al., 2009Disease–genetic variation relationships No online server • Disease • Disease Etiome: a database + cluster- ing analysis of environmental +  genetic (= etiological) factors of  human diseasesLiu et al., 2009 Associations between disease and  environmental factorsNo online server • Environmental factor • Disease-related genes VNP http://cadd.whu.edu.cn/ditad/ vnpsearch/Diseases-Targets-Drugs network   pharmacology relationshipsNetwork pharmacology server provided.",OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
"To view a copy of   this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/09/83/psp20141a.PMC4039393.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d4/0f/opth-8-993.PMC4039395.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 993–997submit your manuscript | www.dovepress.co m Dove press  993 http: //dx.doi.org/ 10.2147/OPTH.S5960 1Dove press Original researChopen access to scientific and medical research Open access Full T ext articleJournal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Rocha-Bastos et al Running head recto: Retinoblastoma in the North Region of Portugal DOI: http://dx.doi.org/10.2147/OPTH.S59601 retinoblastoma: experience of a referral   center in the north region of Portugal ra da rocha-Bastos1 Jr araújo1 rs silva2 MJ gil-da-Costa2 e Brandão1 nJ Farinha2,3 F Falcão-reis1,4 T Dinah-Bragança1 1Department of Ophthalmology,   hospital são João, 2hematology and  Oncology Unit, Pediatric hospital,   hospital são João, 3Pediatrics  Department, Faculty of Medicine,   University of Porto, 4Department of  sense Organs, Faculty of Medicine,   University of Porto, Porto, PortugalPurpose:  To describe the experience of the  Ophthalmology Department of Hospital São João  (HSJ), a tertiary health care center in North Region, Portugal, in terms of the diagnosis, treat - ment, and follow-up of retinoblastoma.",Non-OADS,/arxiv_data1/oa_pdf/d4/0f/opth-8-993.PMC4039395.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d4/0f/opth-8-993.PMC4039395.pdf
"Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 997retinoblastoma in the north region of Portugal best corrected visual acuity equal or better than 5/10, which   demonstrates the quality of life that can currently be expected  in retinoblastoma patients who undergo successful conserva - tive treatment.",Non-OADS,/arxiv_data1/oa_pdf/d4/0f/opth-8-993.PMC4039395.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/1f/jbm-5-059.PMC4039396.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Blood Medicine 2014:5 59–68Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  59Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S3922 0Targeting GPvi as a novel antithrombotic strategy Robert K Andrews Jane F Arthur elizabeth e Gardiner Australian Centre for Blood Diseases,   Monash University, Melbourne, viC,   Australia Correspondence: elizabeth e Gardiner   Australian Centre for Blood Diseases,  Monash University, Level 6,   89 Commercial Road, Melbourne,   viC, 3004, Australia   Tel +61 39 903 0756   email elizabeth.gardiner@monash.ed uAbstract:  While platelet activation is essential to maintain blood vessel patency and minimize  loss of blood upon injury, untimely or excessive activity can lead to unwanted platelet activa - tion and aggregation.",Non-OADS,/arxiv_data1/oa_pdf/21/1f/jbm-5-059.PMC4039396.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/21/1f/jbm-5-059.PMC4039396.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/1f/jbm-5-059.PMC4039396.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/91/ndt-10-953.PMC4039397.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 953–958Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  953OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S6359 9Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Oran et al Running head recto: Vitamin D deficiency in restless legs syndrome DOI: http://dx.doi.org/10.2147/NDT.S63599 Possible association between vitamin D deficiency  and restless legs syndrome Mustafa Oran1 cuneyt Unsal2 Yakup albayrak2 Feti T ulubas3 Keriman Oguz4 Okan avci1 Nilda T urgut4 recep alp4 ahmet gurel3 1Department of internal Medicine,  2Department of Psychiatry, 3Department  of Biochemistry, 4Department of  Neurology, Namik Kemal University,  Faculty of Medicine, T ekirdag ˘, T urkey correspondence: Mustafa Oran   Department of internal Medicine, school  of Medicine, Namık Kemal University,  T unca Caddesi, T ekirdag ˘, 59100, T urkey   T el +90 542 388 4317   Fax +90 282 250 0001   email oranmmd@yahoo.co mBackground and aim:  Restless legs syndrome (RLS) is a distressing sleep disorder that  occurs worldwide.",Non-OADS,/arxiv_data1/oa_pdf/1e/91/ndt-10-953.PMC4039397.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1e/91/ndt-10-953.PMC4039397.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 958Oran et al 27.,Non-OADS,/arxiv_data1/oa_pdf/1e/91/ndt-10-953.PMC4039397.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/01/fb/rru-6-051.PMC4039398.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pResearch and Reports in Urology 2014:6 51–57Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  51Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S4466 5emerging treatments for overactive bladder:  clinical potential of botulinum toxins Douglas G Tincello1,2 Tina Rashid2 vladimir Revicky2 1Reproductive Sciences Section,   Cancer Studies and Molecular  Medicine, University of Leicester,   Leicester, UK;  2Urogynecology Unit,   women’s and Children’s Clinical  Business Unit, University Hospitals  of Leicester National Health Service  Trust, Leicester, UK Correspondence: Douglas G Tincello   Reproductive Sciences Section,   Cancer Studies and Molecular Medicine,  Robert Kilpatrick Clinical Sciences  Building, University of Leicester,   Leicester Royal Infirmary, PO Box  65,   Leicester Le2  7LX, UK   Tel +44 116 252 3165  email dgt4@le.ac.u kAbstract:  Overactive bladder (OAB) is a symptom syndrome including urgency, frequency,  and nocturia – with or without incontinence.",Non-OADS,/arxiv_data1/oa_pdf/01/fb/rru-6-051.PMC4039398.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/01/fb/rru-6-051.PMC4039398.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/fb/rru-6-051.PMC4039398.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a8/ea/opth-8-1017.PMC4039399.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1017–1020Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1017Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S6359 3Journal name: Clinical Ophthalmology Journal Designation: Case report Y ear: 2014 Volume: 8 Running head verso: Abe et al Running head recto: Optical coherence tomographic findings in a case of macular coloboma DOI: http://dx.doi.org/10.2147/OPTH.S63593 Optical coherence tomographic findings at the  fixation point in a case of bilateral congenital  macular coloboma Kosuke Abe1,2 Jumi shirane2 Masuo sakamoto1 Fumi Tanabe1 Kazuki Kuniyoshi1 Chota Matsumoto1 Y oshikazu shimomura1 1Department of Ophthalmology, Kinki  University Faculty of Medicine, Osaka- sayama, Osaka, Japan; 2Nara Hospital,   Kinki University Faculty of Medicine,   Ikoma, Nara, JapanBackground:  Congenital macular coloboma is a rare ocular disease that consists of atrophic  lesions in the macula with well-circumscribed borders.",Non-OADS,/arxiv_data1/oa_pdf/a8/ea/opth-8-1017.PMC4039399.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a8/ea/opth-8-1017.PMC4039399.pdf
"Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1020Abe et al  8. von Noorden GK, Mackensen G. Phenomenology of eccentric fixation.",Non-OADS,/arxiv_data1/oa_pdf/a8/ea/opth-8-1017.PMC4039399.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0a/0f/opth-8-1021.PMC4039400.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1021–1024Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1021Case RepOR topen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S6422 8Journal name: Clinical Ophthalmology Journal Designation: Case Report Y ear: 2014 Volume: 8 Running head verso: Gratton and Lam Running head recto: Visual loss and optic nerve head swelling in thiamine deficiency DOI: http://dx.doi.org/10.2147/OPTH.S64228 Visual loss and optic nerve head swelling   in thiamine deficiency without prolonged   dietary deficiency sean M Gratton Byron L Lam Bascom palmer eye Institute,   University of Miami, Miller school   of Medicine, Miami, FL, UsaAbstract:  Visual loss due to optic neuropathy is a rare manifestation of thiamine deficiency.",Non-OADS,/arxiv_data1/oa_pdf/0a/0f/opth-8-1021.PMC4039400.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0a/0f/opth-8-1021.PMC4039400.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1024Gratton and Lam Figure 3 MRI scans of the patient’s brain on initial presentation.,Non-OADS,/arxiv_data1/oa_pdf/0a/0f/opth-8-1021.PMC4039400.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/77/opth-8-937.PMC4039401.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 937–943Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  937Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5700 9Long-term visual outcomes after Crystalens®   HD intraocular lens implantation alexandra e Karavitaki ioannis G Pallikaris sophia i Panagopoulou George a Kounis George Kontadakis George D Kymionis institute of Vision and Optics,   University of Crete, Crete, Greece Correspondence: alexandra e Karavitaki   institute of Vision and Optics (iVO),   University of Crete, Medical school,   71003 Heraklion, Crete, Greece   Tel +30 28 1037 1800   Fax +30 28 1039 4653   email karavitaki@gmail.co mPurpose:  Our purpose was to evaluate the long-term visual outcomes after bilateral  implantation  of Crystalens® HD (Bausch and Lomb, Inc.) accommodative intraocular lenses.",Non-OADS,/arxiv_data1/oa_pdf/78/77/opth-8-937.PMC4039401.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/78/77/opth-8-937.PMC4039401.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/77/opth-8-937.PMC4039401.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/26/ott-7-779.PMC4039402.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 779–787OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  779Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5987 2Preparation and functional studies of hydroxyethyl  chitosan nanoparticles loaded with anti-human  death receptor  5 single-chain antibody Jingjing Yang1,3,*  Xiaoping huang1,3,* Fanghong luo1 Xiaofeng cheng3  lianna cheng3 Bin liu4 lihong chen2 ruyi hu1,3 chunyan shi1,3 guohong Zhuang1,3 Ping Yin2 1anti-cancer research center,  Medical college, Xiamen University,  Fujian, People’s republic of china,  2The Department of Pathology,  Zhongshan hospital, Xiamen  University, Xiamen, People’s republic  of china, 3Organ transplantation  institution, Xiamen University,  Xiamen, People’s republic of china,  4Jilin Vocational college of industry  and Technology, Jilin, People’s  republic of china *These authors contributed equally  to this work correspondence: guohong Zhuang/   Ping Yin   anticancer research center, Medical  college/Department of Pathology,  Zhongshan hospital, Xiamen University,   chengzhi Building 308, Xiangan campus,  Xindian district/201 –209 hubin nanlu,  Xiamen, Fujian  361102/361004,   People’s republic of china   Tel +86 592 218 7157   Fax +86 592 218 6731  email zhgh@xmu.edu.c n/ yinping2002@163.co mObjective:  To prepare hydroxyethyl chitosan nanoparticles loaded with anti-human death  receptor  5 single-chain antibody, and study their characteristics, functions, and mechanisms  of action.",Non-OADS,/arxiv_data1/oa_pdf/f9/26/ott-7-779.PMC4039402.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f9/26/ott-7-779.PMC4039402.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/26/ott-7-779.PMC4039402.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7a/73/ott-7-771.PMC4039403.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 771–777OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  771Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6025 3Manumycin induces apoptosis in prostate   cancer cells Jing-gao li1,* Miao-rong she2,* ci-Y ong lu3 shan-shan Wei2 Ping-Fang Xia2 Ze-sheng lu2 Qi Peng2 1Department of n ephrology,    sun Yat-sen Memorial hospital,    sun Yat-sen University,  2Department   of hematology, guangdong general   hospital, guangdong academy of   Medical sciences,  3school of Public   health, sun Yat-sen University,    guangzhou, People’s republic of   china *These authors contributed equally   to this work correspondence: Miao-rong she   Department of hematology,   guangdong general hospital,   guangdong academy of Medical   sciences,  106 Zhongshan er road,   guangzhou, guangdong  510080,   People’s republic of china   T el +86 137 1072 8112  email shemiaorong@hotmail.co mBackground:  Manumycin exhibits an antitumor effect in a variety of cancer cell lines, including  prostate cancer cell lines (DU145 and PC-3).",Non-OADS,/arxiv_data1/oa_pdf/7a/73/ott-7-771.PMC4039403.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7a/73/ott-7-771.PMC4039403.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/73/ott-7-771.PMC4039403.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/61/ndt-10-915.PMC4039404.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 915–927Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  915Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6073 5Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Review Y ear: 2014 Volume: 10 Running head verso: Leonidas and Santos Running head recto: Social support networks and eating disorders DOI: http://dx.doi.org/10.2147/NDT.S60735 Social support networks and eating disorders:   an integrative review of the literature Carolina Leonidas Manoel Antônio dos Santos Department of Psychology, Faculty  of Philosophy, Sciences and Letters  of Ribeirão Preto, University of São  Paulo, Brazil Correspondence: Carolina Leonidas University of São Paulo, Bandeirantes  Avenue, 3900 – Monte Alegre, 14040-901  Ribeirão Preto, São Paulo, Brazil  T el +55 16 3602 3645 email carol_leonidas@hotmail.co mAims:  This study aimed to analyze the scientific literature about social networks and social  support in eating disorders (ED).",Non-OADS,/arxiv_data1/oa_pdf/4e/61/ndt-10-915.PMC4039404.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/4e/61/ndt-10-915.PMC4039404.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 927Social support networks and eating disorders  19.,Non-OADS,/arxiv_data1/oa_pdf/4e/61/ndt-10-915.PMC4039404.pdf
"To our knowledge, this  is the first report of VPTRs in association with GFS, and  the VPTRs successfully resolved with TTT and cryotherapy.Molecular Vision  2014; 20:724-731 <http://www.molvis.org/molvis/v 20/724> Received 12 January 2014 | Accepted 27 May 2014 | Published 29 May 2014© 2014 Molecular Vision 724A novel mutation in the NR2E3  gene associated with Goldmann- Favre syndrome and vasoproliferative tumor of the retina George J. Manayath,1 Prasanthi Namburi,2 Sundaresan Periasamy,2 Jeevan A. Kale,1 Venkatapathy  Narendran,1 Anuradha Ganesh3 1Department of Retina and Ocular Oncology, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Coimbatore,  Tamilnadu, India; 2Department of Genetics, Aravind Medical Research Foundation, Aravind Eye Hospital, Madurai, Tamilnadu,  India; 3Department of Ophthalmology, Sultan Qaboos University Hospital, Muscat, Oman Purpose:  Various autosomal recessive retinal dystrophies are reported to be associated with mutations in nuclear re - ceptor subfamily 2, group E, member 3 ( NR2E3,  also called PNR) gene.",Non-OADS,/arxiv_data1/oa_pdf/d5/8b/mv-v20-724.PMC4039415.pdf
Molecular Vision  2014; 20:724-731 <http://www.molvis.org/molvis/v 20/724> © 2014 Molecular Vision  725METHODS The study was performed after receiving approval from the  institutional ethics review board and in accordance with  the Declaration of Helsinki.,Non-OADS,/arxiv_data1/oa_pdf/d5/8b/mv-v20-724.PMC4039415.pdf
Molecular Vision  2014; 20:724-731 <http://www.molvis.org/molvis/v 20/724> © 2014 Molecular Vision  726effect of the identified missense mutation.,Non-OADS,/arxiv_data1/oa_pdf/d5/8b/mv-v20-724.PMC4039415.pdf
Molecular Vision  2014; 20:724-731 <http://www.molvis.org/molvis/v 20/724> © 2014 Molecular Vision  727His BCVA was 6/6 BE.,Non-OADS,/arxiv_data1/oa_pdf/d5/8b/mv-v20-724.PMC4039415.pdf
Molecular Vision  2014; 20:724-731 <http://www.molvis.org/molvis/v 20/724> © 2014 Molecular Vision  728 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/d5/8b/mv-v20-724.PMC4039415.pdf
Molecular Vision  2014; 20:724-731 <http://www.molvis.org/molvis/v 20/724> © 2014 Molecular Vision  729ligand-binding domain (LBD) at the C-terminus end.,Non-OADS,/arxiv_data1/oa_pdf/d5/8b/mv-v20-724.PMC4039415.pdf
